EurekaMag PDF full texts Chapter 55,732

Duarte, R.F.; Sánchez-Ortega, I.; Cuesta, I.; Arnan, M.; Patiño, B.; Fernández de Sevilla, A.; Gudiol, C.; Ayats, J.; Cuenca-Estrella, M. 2014: Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 59(12): 1696-1702

Hastings, M.C.; Afshan, S.; Sanders, J.T.; Kane, O.; Eison, T.M.; Lau, K.K.; Moldoveanu, Z.; Julian, B.A.; Novak, J.; Wyatt, R.J. 2012: Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy. International Journal of Nephrology 2012: 315467

Saussez, S.; Glinoer, D.; Chantrain, G.; Pattou, F.; Carnaille, B.; André, S.; Gabius, H.-J.; Laurent, G. 2008: Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease. Thyroid: Official Journal of the American Thyroid Association 18(7): 705-712

Barrow, H.; Guo, X.; Wandall, H.H.; Pedersen, J.W.; Fu, B.; Zhao, Q.; Chen, C.; Rhodes, J.M.; Yu, L.-G. 2011: Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(22): 7035-7046

Lee, Y.J.; Kang, S.W.; Song, J.K.; Park, J.J.; Bae, Y.D.; Lee, E.Y.; Lee, E.B.; Song, Y.W. 2007: Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity. Clinical and Experimental Rheumatology 25(4 Suppl. 45): S41-S45

Weigert, J.; Neumeier, M.; Wanninger, J.; Bauer, S.; Farkas, S.; Scherer, M.N.; Schnitzbauer, A.; Schäffler, A.; Aslanidis, C.; Schölmerich, J.ür.; Buechler, C. 2010: Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 95(3): 1404-1411

Özden, M.G.; Caycı, Y.T.; Tekin, H.; Çoban, A.Y.; Aydın, F.; Sentürk, N.; Bek, Y.; Cantürk, T.; Turanlı, A.Y. 2011: Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up. Journal of the European Academy of Dermatology and Venereology: JEADV 25(10): 1168-1173

Yilmaz, H.; Celik, H.T.; Ozdemir, O.; Kalkan, D.; Namuslu, M.; Abusoglu, S.; Atalay, C.R.; Yigitoglu, R. 2014: Serum galectin-3 levels in women with PCOS. Journal of Endocrinological Investigation 37(2): 181-187

Yilmaz, H.; Inan, O.; Darcin, T.; Bilgic, M.A.; Akcay, A. 2015: Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever. Clinical and Experimental Nephrology 19(3): 436-442

Jin, Q.-h.; Lou, Y.-f.; Li, T.-l.; Chen, H.-h.; Liu, Q.; He, X.-j. 2013: Serum galectin-3: a risk factor for vascular complications in type 2 diabetes mellitus. Chinese Medical Journal 126(11): 2109-2115

Liang, M.-y.; Lu, Y.-m.; Zhang, Y.; Zhang, S.-l. 2008: Serum galectin-9 in cervical cancer. Zhonghua Yi Xue Za Zhi 88(39): 2783-2785

Rajagopal, G.; Rafi, K.M.M. 2005: Serum gamma glutamyl transferase (γ-GT) activity in alcoholics with liver abscess and chronic alcoholics. Indian Journal of Clinical Biochemistry: Ijcb 20(2): 198-199

Arinc, H.; Sarli, B.; Baktir, A.O.; Saglam, H.; Demirci, E.; Dogan, Y.; Kurtul, S.; Karaman, H.; Erden, A.; Karaman, A. 2013: Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis. Upsala Journal of Medical Sciences 118(4): 228-234

Thapa, P.B.; Maharjan, D.K.; Suwal, B.; Byanjankar, B.; Singh, D.R. 2010: Serum gamma glutamyl transferase and alkaline phosphatase in acute cholecystitis. Journal of Nepal Health Research Council 8(2): 78-81

Shabbir, S.; Khan, D.A.; Khan, F.A.; Elahi, M.M.; Matata, B.M. 2011: Serum gamma glutamyl transferase: a novel biomarker for screening of premature coronary artery disease. Cardiovascular Revascularization Medicine: Including Molecular Interventions 12(6): 367-374

Simic, T.; Dragicevic, D.; Savic-Radojevic, A.; Cimbaljevic, S.; Tulic, C.; Mimic-Oka, J. 2007: Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma. International Journal of Urology: Official Journal of the Japanese Urological Association 14(4): 289-293

Ermis, N.; Yagmur, J.; Acikgoz, N.; Cansel, M.; Cuglan, B.; Pekdemir, H.; Ozdemir, R. 2012: Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clinical and Experimental Hypertension 34(5): 311-315

Sen, N.; Basar, N.; Maden, O.; Ozcan, F.; Ozlu, M.F.; Gungor, O.; Turak, O.; Malcok, O.; Atak, R.; Demir, A.D.; Balbay, Y. 2008: Serum gamma-glutamyl transferase activity increased in patients with coronary artery ectasia. Coronary Artery Disease 19(7): 455-458

Kanbay, A.; Kaya, E.; Buyukoglan, H.; Ozdogan, N.; Kaya, M.G.; Oymak, F.S.; Gulmez, I.; Demir, R.; Kokturk, O. 2011: Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Respiratory Medicine 105(4): 637-642

Jo, S.-K.; Lee, W.-Y.; Rhee, E.-J.; Won, J.-C.; Jung, C.-H.; Park, C.-Y.; Oh, K.-W.; Park, S.-W.; Kim, S.-W. 2009: Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clinica Chimica Acta; International Journal of Clinical Chemistry 403(1-2): 234-240

Ulus, T.; Yildirir, A.; Sade, L.E.; Temiz, A.; Polat, E.; Bozbaş, H.üs.; Aydinalp, A.; Eroğlu, S.; Ozin, B.ül.; Müderrisoğlu, H. 2008: Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?. Coronary Artery Disease 19(7): 489-495

Stojakovic, T.; Scharnagl, H.; Trauner, M.; Pieske, B.; Wellnitz, B.; Seelhorst, U.; Schilling, D.; Winkelmann, B.R.; Boehm, B.O.; März, W. 2010: Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 208(2): 564-571

Dhingra, R.; Gona, P.; Wang, T.J.; Fox, C.S.; D'Agostino, R.B.; Vasan, R.S. 2010: Serum gamma-glutamyl transferase and risk of heart failure in the community. Arteriosclerosis Thrombosis and Vascular Biology 30(9): 1855-1860

Kim, N.H.; Huh, J.K.; Kim, B.J.; Kim, M.W.; Kim, B.S.; Kang, J.H. 2012: Serum gamma-glutamyl transferase level is an independent predictor of incident hypertension in Korean adults. Clinical and Experimental Hypertension 34(6): 402-409

Turfan, M.; Tasal, A.; Erdogan, E.; Vatankulu, M.A.ıf.; Jafarov, P.; Sonmez, O.; Ertas, G.; Bacaksız, A.; Ergelen, M.; Goktekın, O. 2014: Serum gamma-glutamyl transferase levels and in-hospital mortality in patients with acute heart failure. Kardiologia Polska 72(8): 735-739

Kawamoto, R.; Kohara, K.; Tabara, Y.; Miki, T.; Otsuka, N. 2009: Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. Journal of Atherosclerosis and Thrombosis 16(4): 355-362

Kawamoto, R.; Tabara, Y.; Kohara, K.; Miki, T.; Ohtsuka, N.; Kusunoki, T.; Takayama, S.; Abe, M. 2011: Serum gamma-glutamyl transferase within its normal concentration range is related to the presence of impaired fasting glucose and diabetes among Japanese community-dwelling persons. Endocrine Research 36(2): 64-73

Chen, T.; Ren, Y.; Liu, Y.; Long, Y.; Zhang, X.; Yu, H.; Xu, J.; Yu, T.; Tian, H. 2010: Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority. Diabetes Research and Clinical Practice 90(3): 352-357

Mao, Y.; Qi, X.; Xu, W.; Song, H.; Xu, M.; Ma, W.; Zhou, L. 2014: Serum gamma-glutamyl transferase: a novel biomarker for coronary artery disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 20: 706-710

Cakar, M.; Balta, S.; Demirkol, S.; Altun, B.; Demirbas, S. 2013: Serum gamma-glutamyltransferase (GGT) should be evaluated together with other inflammatory markers in clinical practice. Angiology 64(5): 401

Bozbaş, H.üs. 2013: Serum gamma-glutamyltransferase activity and acute coronary syndromes. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 41(4): 282-283

Bozbas, H.; Yildirir, A.; Demir, O.; Cakmak, A.; Karacaglar, E.; Yilmaz, M.; Eroglu, S.; Pirat, B.; Ozin, B.; Muderrisoglu, H. 2008: Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis. Journal of Heart Valve Disease 17(4): 371-375

Ulus, T.; Yıldırır, A.; Sade, L.E.; Balta, S.; Ozin, B.ül.; Sezgin, A.; Müderrisoğlu, H. 2011: Serum gamma-glutamyltransferase activity: a new marker for coronary artery bypass graft disease. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 39(3): 205-213

Lippi, G.; Danese, E.; Montagnana, M. 2013: Serum gamma-glutamyltransferase and alanine aminotransferase levels are correlated with hematocrit in a general population of outpatients. Scandinavian Journal of Clinical and Laboratory Investigation 73(1): 95-96

Pompella, A.; Emdin, M.; Paolicchi, A.; Franzini, M. 2011: Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. Angiology 62(2): 105-106

Duran, M.; Uysal, O.K.; Yılmaz, Y.üc.; Günebakmaz, O.ür.; Arınç, H.üs.; Topsakal, R.; Eryol, N.ık.K.; Ergin, A.; Oğuzhan, A.; Kaya, M.G.ün.ör. 2013: Serum gamma-glutamyltransferase and the burden of atherosclerosis in patients with acute coronary syndrome. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 41(4): 275-281

Kim, K.-M.; Kim, B.-T.; Lee, D.-J.; Park, S.-B.; Joo, N.-S.; Kim, K.-N. 2012: Serum gamma-glutamyltransferase as a risk factor for general cardiovascular disease prediction in Koreans. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 60(8): 1199-1203

Kim, K.-N.; Kim, K.-M.; Lee, D.-J.; Joo, N.-S. 2011: Serum gamma-glutamyltransferase concentration correlates with Framingham risk score in Koreans. Journal of Korean Medical Science 26(10): 1305-1309

Franzini, M.; Fornaciari, I.; Siciliano, G.; Volpi, L.; Ricci, G.; Marchi, S.; Gagliardi, G.; Baggiani, A.; Torracca, F.; Fierabracci, V.; Miccoli, M.; Pompella, A.; Emdin, M.; Paolicchi, A. 2010: Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease. Clinical Biochemistry 43(15): 1246-1248

Jung, C.H.; Yu, J.H.; Bae, S.J.; Koh, E.H.; Kim, M.-S.; Park, J.-Y.; Kim, H.-K.; Lee, W.J. 2011: Serum gamma-glutamyltransferase is associated with arterial stiffness in healthy individuals. Clinical Endocrinology 75(3): 328-334

Liang, J.; Gong, Y.; Wang, Y.; Qiu, Q.; Zou, C.; Dou, L.; Liu, X.; Song, H. 2014: Serum gamma-glutamyltransferase is associated with impaired fasting glucose in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study. Cell Biochemistry and Biophysics 70(3): 1823-1828

Bianchi, C.; Penno, G.; Del Prato, S.; Miccoli, R. 2009: Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findings. Atherosclerosis 203(1): 49-50

Shankar, A.; Li, J.; Klein, B.E.K.; Nieto, F.J.; Klein, R. 2008: Serum gamma-glutamyltransferase level and peripheral arterial disease. Atherosclerosis 199(1): 102-109

Yilmaz, M.I.; Turgut, F.; Kanbay, M.; Saglam, M.; Sonmez, A.; Yaman, H.; Demirbas, S.; Unal, H.U.; Gok, M.; Karaman, M.; Ay, S.A.; Demirkaya, E.; Covic, A.; Carrero, J.J. 2013: Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. International Urology and Nephrology 45(4): 1071-1078

Bianchi, C.; Penno, G.; Crisci, I.; Daniele, G.; Agostini, A.; Del Prato, S.; Miccoli, R. 2010: Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation. Diabetes/Metabolism Research and Reviews 26(3): 181-186

Pompella, A.; Emdin, M.; Franzini, M.; Paolicchi, A. 2009: Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis?. Clinical Chemistry and Laboratory Medicine 47(12): 1583-1584

Lee, D.-H.; Jacobs, D.R. 2009: Serum gamma-glutamyltransferase: new insights about an old enzyme. Journal of Epidemiology and Community Health 63(11): 884-886

Tahan, V.; Canbakan, B.; Balci, H.; Dane, F.; Akin, H.; Can, G.; Hatemi, I.; Olgac, V.; Sonsuz, A.; Ozbay, G.; Yurdakul, I.; Senturk, H. 2008: Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepato-Gastroenterology 55(85): 1433-1438

Radić, B.; Vukelić, Z.; Bognar, S.K. 2008: Serum gangliosides in patients with brain tumors. Collegium Antropologicum 32(Suppl 1): 171-175

Vigen, R.A.; Chen, D.; Syversen, U.; Stunes, K.; Hakanson, R.; Zhao, C.-M. 2011: Serum gastrin and gastric enterochromaffin-like cells during estrous cycle, pregnancy and lactation, and in response to estrogen-like agents in rats. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 62(3): 335-340

Shafaghi, A.; Mansour-Ghanaei, F.; Joukar, F.; Sharafkhah, M.; Mesbah, A.; Askari, K.; Geranmayeh, S.; Mehrvarz, A.; Souti, F.; Sokhanvar, H.; Fakhrieh, S.; Aminian, K.; Yousefi-Mashhour, M.; Khosh-Sorur, M.; Rasoulian, J. 2013: Serum gastrin and the pepsinogen I/Ii ratio as markers for diagnosis of premalignant gastric lesions. Asian Pacific Journal of Cancer Prevention: Apjcp 14(6): 3931-3936

Czaja, M.; Szarszewski, A.; Kamińska, B.; Bogotko-Szarszewska, M.; Luczak, G.; Kozielska, E.; Delińska-Galińska, A.; Korzon, M. 2008: Serum gastrin concentration and changes in G and D cell densities in gastric antrum in children with chronic gastritis. International Journal of Clinical Practice 62(7): 1044-1049

Semeniuk, J.; Kaczmarski, M.; Wasilewska, J. 2011: Serum gastrin concentrations in children with primary gastroesophageal reflux and gastroesophageal reflux secondary to cow's milk allergy. Advances in Medical Sciences 56(2): 186-192

Mazaki-Tovi, M.; Segev, G.; Yas-Natan, E.; Lavy, E. 2012: Serum gastrin concentrations in dogs with liver disorders. Veterinary Record 171(1): 19

Arinton, I.G. 2010: Serum gastrin level and pepsinogen I/Ii ratio as biomarker of Helicobacter pylori chronic gastritis. Acta Medica Indonesiana 42(3): 142-146

Li, Z.-l.; Ye, H.-m.; Wang, J.-s.; Han, T.-y.; Wang, X.-l. 2008: Serum gastrin levels and clinical conditions in response to early minimal feeding in premature infants. Zhonghua Er Ke Za Zhi 46(4): 243-246

Urganci, N.; Ozcelik, G.; Kalyoncu, D.; Geylani Gulec, S.; Akinci, N. 2012: Serum gastrin levels and gastroduodenal lesions in children with chronic renal failure on continuous ambulatory peritoneal dialysis: a single-center experience. European Journal of Gastroenterology and Hepatology 24(8): 924-928

Myśliwiec, J.; Adamczyk, M.łg.; Pawłowski, P.ła.; Nikołajuk, A.; Górska, M. 2007: Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy. Endokrynologia Polska 58(2): 105-109

Liu, X.; Borooah, M.; Stone, J.; Chakkarapani, E.; Thoresen, M. 2009: Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics 124(1): 310-315

Uzum, A.K.; Aydin, M.M.; Tutuncu, Y.; Omer, B.; Kiyan, E.; Alagol, F. 2014: Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients. European Journal of Internal Medicine 25(4): 364-369

Ozsoy, S.; Besirli, A.ı; Abdulrezzak, U.; Basturk, M. 2014: Serum ghrelin and leptin levels in patients with depression and the effects of treatment. Psychiatry Investigation 11(2): 167-172

Vartiainen, J.; Rajala, U.; Jokelainen, J.; Keinänen-Kiukaanniemi, S.; Kesäniemi, Y.A.; Ukkola, O. 2010: Serum ghrelin and the prediction of the development of impaired glucose regulation and Type 2 diabetes in middle-aged subjects. Journal of Endocrinological Investigation 33(7): 496-500

El-Hodhod, M.A.; Emam, E.K.; Zeitoun, Y.A.; El-Araby, A.M. 2009: Serum ghrelin in infants with protein-energy malnutrition. Clinical Nutrition 28(2): 173-177

Bellar, D.; Glickman, E.L.; Judge, L.W.; Gunstad, J. 2013: Serum ghrelin is associated with verbal learning and adiposity in a sample of healthy, fit older adults. Biomed Research International 2013: 202757

Spitznagel, M.B.; Benitez, A.; Updegraff, J.; Potter, V.; Alexander, T.; Glickman, E.; Gunstad, J. 2010: Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiatry and Clinical Neurosciences 64(6): 608-611

Mitkov, M.; Pehlivanov, B.; Orbetzova, M. 2008: Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(11): 625-630

Jaskula, M.; Wasko, R.; Komarowska, H.; Dziubandowska, A.; Sowinski, J. 2009: Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly. Neuro Endocrinology Letters 30(2): 245-255

Bagheri, M.; Ansari, S.; Sotoudeh, G.; Mahmoudi, M.; Speakman, J.R.; Djafarian, K. 2015: Serum ghrelin levels and gender-related indices of body composition in prepubertal children: a cross-sectional study. European Journal of Nutrition 54(2): 283-290

Ishitobi, Y.; Kohno, K.; Kanehisa, M.; Inoue, A.; Imanaga, J.; Maruyama, Y.; Ninomiya, T.; Higuma, H.; Okamoto, S.; Tanaka, Y.; Tsuru, J.; Hanada, H.; Isogawa, K.; Akiyoshi, J. 2012: Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder. Neuropsychobiology 66(3): 185-192

Tander, B.; Atmaca, A.; Aliyazicioglu, Y.; Canturk, F. 2007: Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome. Joint Bone Spine 74(5): 477-481

Tarantini, B.; Ciuoli, C.; Checchi, S.; Montanaro, A.; Bonato, V.; Theodoropoulou, A.; Pasqui, L.; Pacini, F. 2009: Serum ghrelin levels in growth hormone-sufficient and growth hormone-deficient patients during growth hormone-releasing hormone plus arginine test. Journal of Endocrinological Investigation 32(4): 335-337

Koizumi, M.; Hosoya, Y.; Dezaki, K.; Yada, T.; Hosoda, H.; Kangawa, K.; Nagai, H.; Lefor, A.T.; Sata, N.; Yasuda, Y. 2014: Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy. Surgery Today 44(11): 2131-2137

Deveci, Y.; Deveci, F.; Ilhan, N.; Karaca, I.ın.; Turgut, T.; Muz, M.H. 2010: Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease. Tuberkuloz Ve Toraks 58(2): 162-172

Tóth, G.; Rauh, M.; Nyul, Z.án.; Sulyok, E.; Rascher, W. 2009: Serum ghrelin, adipokine and insulin levels in children with acute hepatitis. European Journal of Gastroenterology and Hepatology 21(7): 739-743

Bideci, A.; Camurdan, M.O.; Yeşilkaya, E.; Demirel, F.; Cinaz, P. 2008: Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 34(4): 578-584

Sadjadi, A.; Yazdanbod, A.; Lee, Y.Y.; Boreiri, M.; Samadi, F.; Alizadeh, B.Z.; Islami, F.; Fyfe, V.; Babaei, M.; Namazi, M.J.; Going, J.J.; Sotoudeh, M.; de Bock, G.H.; Malekzadeh, R.; Derakhshan, M.H. 2013: Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis. Plos one 8(9): E74440

Kohno, K.; Matsuo, H.; Takahashi, H.; Niihara, H.; Chinuki, Y.; Kaneko, S.; Honjoh, T.; Horikawa, T.; Mihara, S.; Morita, E. 2013: Serum gliadin monitoring extracts patients with false negative results in challenge tests for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergology International: Official Journal of the Japanese Society of Allergology 62(2): 229-238

Zhang, J.; Zhang, C.-H.; Lin, X.-L.; Zhang, Q.; Wang, J.; Shi, S.-L. 2013: Serum glial fibrillary acidic protein as a biomarker for differentiating intracerebral hemorrhage and ischemic stroke in patients with symptoms of acute stroke: a systematic review and meta-analysis. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 34(11): 1887-1892

Sato, Y.; Shimamura, S.; Mashita, T.; Kobayashi, S.; Okamura, Y.; Katayama, M.; Kamishina, H.; Sato, R.; Uzuka, Y.; Yasuda, J. 2013: Serum glial fibrillary acidic protein as a diagnostic biomarker in dogs with progressive myelomalacia. Journal of Veterinary Medical Science 75(7): 949-953

Kaneko, T.; Kasaoka, S.; Miyauchi, T.; Fujita, M.; Oda, Y.; Tsuruta, R.; Maekawa, T. 2009: Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation 80(7): 790-794

Miyake, H.; Inoue, A.; Tanaka, M.; Matsuki, N. 2013: Serum glial fibrillary acidic protein as a specific marker for necrotizing meningoencephalitis in Pug dogs. Journal of Veterinary Medical Science 75(11): 1543-1545

Honda, M.; Tsuruta, R.; Kaneko, T.; Kasaoka, S.; Yagi, T.; Todani, M.; Fujita, M.; Izumi, T.; Maekawa, T. 2010: Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. Journal of Trauma 69(1): 104-109

Kim, J.-Y.; Hyun, Y.-Y.; Lee, J.-E.; Yoon, H.-R.; Kim, G.-H.; Yoo, H.-W.; Cho, S.-T.; Chun, N.-W.; Jeoung, B.-C.; Kim, H.-J.; Kim, K.-W.; Kim, S.-N.; Kim, Y.-A.; Lee, H.-A.; Lee, J.-Y.; Lee, Y.-C.; Lim, H.-K.; Oh, K.-S.; Son, S.-H.; Yu, B.-H.; Wee, K.-S.; Lee, E.-J.; Lee, Y.-K.; Noh, J.-W.; Kim, S.-J.; Choi, K.-B.; Yu, S.-H.; Pyo, H.-J.; Kwon, Y.-J. 2010: Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea. Korean Journal of Internal Medicine 25(4): 415-421

Correia, H.S.T.; Domingues, A.L.C.; Lopes, E.P.A.; Morais, C.N.L.; Sarteschi, C.; Moura, I.M.F. 2009: Serum globulin levels and intensity of hepatic fibrosis in patients with mansonic schistosomiasis. Arquivos de Gastroenterologia 46(3): 194-198

Schmilovitz-Weiss, H.; Cohen, M.; Pappo, O.; Sulkes, J.; Braun, M.; Tur-Kaspa, R.; Ben-Ari, Z. 2007: Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection. Clinical Transplantation 21(3): 391-397

Alexandrescu, D.T.; Wiernik, P.H. 2008: Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. Medical Oncology 25(3): 309-314

Xu, Y.; Wang, L.; Wang, J.; Liang, H.; Jiang, X. 2011: Serum globulins contribute to the discrepancies observed between the bromocresol green and bromocresol purple assays of serum albumin concentration. British Journal of Biomedical Science 68(3): 120-125

Ustundag, Y.; Hekimoğlu, K.; Ilikhan, S.; Zaimoğlu, G.; Acikgöz, S.; Aydemir, S. 2011: Serum glucagon and cystatin C levels with renal doppler sonography findings in non-azotemic liver cirrhosis cases. Hepato-Gastroenterology 58: 107-108

Gil, A.G.ál.; Martínez-Mateos, M.M.; Lorenzo-García, P.; Illera, J.C. 2010: Serum glucocorticoid concentrations after three different anaesthetic/analgesic protocols in rabbits. Veterinary Record 166(18): 562-563

Ferrelli, F.; Pastore, D.; Capuani, B.; Lombardo, M.F.; Blot-Chabaud, M.; Coppola, A.; Basello, K.; Galli, A.; Donadel, G.; Romano, M.; Caratelli, S.; Pacifici, F.; Arriga, R.; Di Daniele, N.; Sbraccia, P.; Sconocchia, G.; Bellia, A.; Tesauro, M.; Federici, M.; Della-Morte, D.; Lauro, D. 2015: Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia. Acta Diabetologica 52(1): 55-64

Tenhola, S.; Todorova, B.; Jääskeläinen, J.; Jänne, O.A.; Raivio, T.; Voutilainen, R. 2010: Serum glucocorticoids and adiponectin associate with insulin resistance in children born small for gestational age. European Journal of Endocrinology 162(3): 551-557

Hegen, H.; Auer, M.; Deisenhammer, F. 2014: Serum glucose adjusted cut-off values for normal cerebrospinal fluid/serum glucose ratio: implications for clinical practice. Clinical Chemistry and Laboratory Medicine 52(9): 1335-1340

Wulaningsih, W.; Holmberg, L.; Garmo, H.; Zethelius, B.ör.; Wigertz, A.; Carroll, P.; Lambe, M.; Hammar, N.; Walldius, G.ör.; Jungner, I.; Van Hemelrijck, M. 2013: Serum glucose and fructosamine in relation to risk of cancer. Plos one 8(1): E54944

Van Noord, C.; Sturkenboom, M.C.J.M.; Straus, S.M.J.M.; Hofman, A.; Kors, J.A.; Witteman, J.C.M.; Stricker, B.H.C. 2010: Serum glucose and insulin are associated with QTc and RR intervals in nondiabetic elderly. European Journal of Endocrinology 162(2): 241-248

Martínez-Quintana, Eén.; Rodríguez-González, F.; Nieto-Lago, V.; Nóvoa, F.J.; López-Rios, L.; Riaño-Ruiz, M. 2010: Serum glucose and lipid levels in adult congenital heart disease patients. Metabolism, Clinical and Experimental 59(11): 1642-1648

Bradley, P.; Tobias, J.D. 2007: Serum glucose changes during insulin therapy in pediatric patients with diabetic ketoacidosis. American Journal of Therapeutics 14(3): 265-268

Lukaszewicz-Hussain, A. 2013: Serum glucose concentration in subacute intoxication with chlorpyrifos - organophosphate insecticide. Medycyna Pracy 64(4): 527-531

Mudaliar, S. 2009: Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?. Current Atherosclerosis Reports 11(5): 384-390

Chrysohoou, C.; Pitsavos, C.; Aggelopoulos, P.; Skoumas, J.; Tsiamis, E.; Panagiotakos, D.B.; Stefanadis, C. 2010: Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: the Hellenic Heart Failure Study. Heart and Vessels 25(3): 209-216

Boĭko, E.R.; Burykh, E.A.; Potolitsina, N.N.; Liudinina, A.I.; Vakhnina, N.A.; Shadrina, V.D.; Parshukova, O.I.; Irzhak, L.I.; Soroko, S.I. 2010: Serum glucose level in acute severe hypoxia in human at rest. Fiziologiia Cheloveka 36(3): 110-116

Ekwempu, A.I.; Wuyep, Z.S.; Longkem, B. 2011: Serum glucose level of healthy adolescents within Bukuru metropolis, Jos South Local Government Area, Plateau State, Nigeria. Journal of Multidisciplinary Healthcare 4: 353-355

Lepper, P.M.; Ott, S.; Nüesch, E.; von Eynatten, M.; Schumann, C.; Pletz, M.W.; Mealing, N.M.; Welte, T.; Bauer, T.T.; Suttorp, N.; Jüni, P.; Bals, R.; Rohde, G.; Hauptmeier, B.; von Baum, H.; Marre, R.; Schaberg, T.; Hering, I.; Dalhoff, K.; Heyer, P.; Kunitz, F.; Schütte, H.; Tessmer, A.; Stolz, D.; Rademacher, J.; Gillissen, A.; Drewelow, B.; Majcher-Peszynska, J.; Krüger, S.; Martus, P.; Illmann, T.; Wallner, M.; Barten, G.; Gosman, L. 2012: Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. Bmj 344: E3397

Hui, L.; Yuai, W.; Xia, Q.; Hong, Y. 2010: Serum glucose- and C-reactive protein-based assessment of stress status in a healthy population. Clinical Laboratory 56(5-6): 227-230

Liao, Y.; Hartmann, T.; Ao, J-hong.; Yang, R-ya. 2012: Serum glucuronoxylomannan may be more appropriate for the diagnosis and therapeutic monitoring of Trichosporon fungemia than serum β-D-glucan. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 16(8): E638

Aubrecht, J.; Schomaker, S. 2013: Serum glutamate dehydrogenase as a potential biomarker of mitochondrial dysfunction. Toxicological Sciences: An Official Journal of the Society of Toxicology 134(1): 223

Jaeschke, H.; McGill, M.R. 2013: Serum glutamate dehydrogenase--biomarker for liver cell death or mitochondrial dysfunction?. Toxicological Sciences: An Official Journal of the Society of Toxicology 134(1): 221-222

Koochekpour, S.; Majumdar, S.; Azabdaftari, G.; Attwood, K.; Scioneaux, R.; Subramani, D.; Manhardt, C.; Lorusso, G.D.; Willard, S.S.; Thompson, H.; Shourideh, M.; Rezaei, K.; Sartor, O.; Mohler, J.L.; Vessella, R.L. 2012: Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(21): 5888-5901

Lin, J.-D.; Lin, P.-Y.; Chen, L.-M.; Fang, W.-H.; Lin, L.-P.; Loh, C.-H. 2010: Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities. Research in Developmental Disabilities 31(1): 172-177

Nakazato, M.; Hashimoto, K.; Schmidt, U.; Tchanturia, K.; Campbell, I.C.; Collier, D.A.; Iyo, M.; Treasure, J. 2010: Serum glutamine, set-shifting ability and anorexia nervosa. Annals of General Psychiatry 9: 29

McGrath, D.R.; Frydoonfar, H.; Hunt, J.J.; Dunkley, C.J.; Spigelman, A.D. 2010: Serum glutathione transferase does not respond to indole-3-carbinol: a pilot study. Therapeutics and Clinical Risk Management 6: 225-231

Miyahara, K.; Nouso, K.; Miyake, Y.; Nakamura, S.; Obi, S.; Amano, M.; Hirose, K.; Nishimura, S.-I.; Yamamoto, K. 2014: Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib. Hepatology 59(1): 355-356

Miyahara, K.; Nouso, K.; Saito, S.; Hiraoka, S.; Harada, K.; Takahashi, S.; Morimoto, Y.; Kobayashi, S.; Ikeda, F.; Miyake, Y.; Shiraha, H.; Takaki, A.; Okada, H.; Amano, M.; Hirose, K.; Nishimura, S.-I.; Yamamoto, K. 2013: Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis. Plos one 8(10): E74861

Ozcan, S.; Barkauskas, D.A.; Renee Ruhaak, L.; Torres, J.; Cooke, C.L.; An, H.J.; Hua, S.; Williams, C.C.; Dimapasoc, L.M.; Han Kim, J.; Camorlinga-Ponce, M.; Rocke, D.; Lebrilla, C.B.; Solnick, J.V. 2014: Serum glycan signatures of gastric cancer. Cancer Prevention Research 7(2): 226-235

Mori, A.; Lee, P.; Mizutani, H.; Takahashi, T.; Azakami, D.; Mizukoshi, M.; Fukuta, H.; Sakusabe, N.; Sakusabe, A.; Kiyosawa, Y.; Arai, T.; Sako, T. 2009: Serum glycated albumin as a glycemic control marker in diabetic cats. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 21(1): 112-116

Lee, J.W.; Kim, H.J.; Kwon, Y.S.; Jun, Y.H.; Kim, S.K.; Choi, J.W.; Lee, J.E. 2013: Serum glycated albumin as a new glycemic marker in pediatric diabetes. Annals of Pediatric Endocrinology and Metabolism 18(4): 208-213

Wang, F.; Ma, X.; Hao, Y.; Yang, R.; Ni, J.; Xiao, Y.; Tang, J.; Bao, Y.; Jia, W. 2012: Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. Plos one 7(11): E51098

Koga, M.; Saito, H.; Mukai, M.; Otsuki, M.; Kasayama, S. 2009: Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetologica 46(2): 141-144

Koga, M.; Murai, J.; Saito, H.; Mukai, M.; Kasayama, S. 2010: Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels. Clinical Biochemistry 43(12): 1023-1025

Song, S.O.; Kim, K.J.; Lee, B.-W.; Kang, E.S.; Cha, B.S.; Lee, H.C. 2012: Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis 225(2): 450-455

Pan, J.; Li, Q.; Zhang, L.; Jia, L.; Tang, J.; Bao, Y.; Jia, W. 2014: Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study. Journal of Diabetes and its Complications 28(6): 772-778

Koga, M.; Murai, J.; Saito, H.; Kasayama, S.; Imagawa, A.; Hanafusa, T.; Kobayashi, T. 2010: Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus. Annals of Clinical Biochemistry 47(Part 4): 313-317

Koga, M.; Murai, J.; Saito, H.; Mukai, M.; Kasayama, S. 2010: Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men. Acta Diabetologica 47(2): 173-177

Koga, M.; Murai, J.; Saito, H.; Mukai, M.; Kasayama, S. 2010: Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia. Journal of Diabetes Investigation 1(5): 202-207

Sako, T.; Mori, A.; Lee, P.; Sato, T.; Mizutani, H.; Takahashi, T.; Kiyosawa, Y.; Tazaki, H.; Arai, T. 2009: Serum glycated albumin: Potential use as an index of glycemic control in diabetic dogs. Veterinary research communications 33(5): 473-479

Daimon, M.; Soga, T.; Hozawa, A.; Oizumi, T.; Kaino, W.; Takase, K.; Karasawa, S.; Jimbu, Y.; Wada, K.; Kameda, W.; Susa, S.; Kayama, T.; Saito, K.; Tomita, M.; Kato, T. 2012: Serum glycerophosphate levels are increased in Japanese men with type 2 diabetes. Internal Medicine 51(6): 545-551

Lustgarten, M.S.; Price, L.L.; Phillips, E.M.; Fielding, R.A. 2013: Serum glycine is associated with regional body fat and insulin resistance in functionally-limited older adults. Plos one 8(12): E84034

Upadhya, S.; Upadhya, S.; Prabhu, K.S. 2002: Serum glycoconjugates and ceruloplasmin in cancer of uterine cervix. Indian Journal of Clinical Biochemistry: Ijcb 17(1): 20-24

Bersinger, N.A.; Birkhäuser, M.H.; Yared, M.; Wunder, D.M. 2009: Serum glycodelin pattern during the menstrual cycle in healthy young women. Acta Obstetricia et Gynecologica Scandinavica 88(11): 1215-1221

Shimizu, Y.; Takise, A.; Morita, H.; Hosomi, Y.; Kasahara, N.; Kawata, T.; Horie, T.; Ishii, Y.; Yamada, M. 2014: Serum glycopeptidolipid core IgA antibody levels in patients with chest computed tomography features of mycobacterium aviumintracellulare complex pulmonary disease. Journal of Biological Regulators and Homeostatic Agents 28(3): 399-405

Jing, R.; Hu, H.; Sun, C.; Huang, T.; Deng, W.; Li, J.; Yu, J.; Liu, Y.; Zhang, C. 2014: Serum glycoprotein profiling by lectin affinity microarray to distinguish the various stages of primary liver carcinogenesis. Zhonghua Gan Zang Bing Za Zhi 22(5): 358-363

Li, X.; Wu, K.; Fan, D. 2009: Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Hepatology 50(5): 1682

Day, F.T.; Rowlands, I.W. 1947: Serum gonadotrophin in Welsh and Shetland ponies. Journal of Endocrinology 5(1): 1-8

Qiao, Y.; Chen, J.; Li, X.; Wei, H.; Xiao, F.; Chang, L.; Zhang, R.; Hao, X.; Wei, H. 2014: Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection. Clinical Biochemistry 47(16-17): 216-222

Barber, R.C.; Edwards, M.I.; Xiao, G.; Huebinger, R.M.; Diaz-Arrastia, R.; Wilhelmsen, K.C.; Hall, J.R.; O'Bryant, S.E. 2012: Serum granulocyte colony-stimulating factor and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders Extra 2(1): 353-360

Yildiz, R.; Coskun, U.; Buyukberber, S.; Sancak, B.; Kaya, A.O.; Gulbahar, O.; Benekli, M. 2011: Serum granulocyte colony-stimulating factor levels in gliomas. Journal of BUON: Official Journal of the Balkan Union of Oncology 16(1): 138-141

Demirci, U.; Coskun, U.; Sancak, B.; Ozturk, B.; Bahar, B.; Benekli, M.; Buyukberber, S. 2009: Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma?. Asian Pacific Journal of Cancer Prevention: Apjcp 10(6): 1021-1024

Nagasawa, M.; Ogawa, K.; Nagata, K.; Shimizu, N. 2010: Serum granulysin as a possible biomarker of natural killer cell neoplasms. British Journal of Haematology 148(5): 812-814

Ono, S.; Otsuka, A.; Yamamoto, Y.; Kataoka, T.R.; Koyanagi, I.; Miyachi, Y.; Kabashima, K. 2014: Serum granulysin as a possible key marker of the activity of alopecia areata. Journal of Dermatological Science 73(1): 74-79

Suda, G.; Yamamoto, Y.; Nagasaka, A.; Furuya, K.; Kudo, M.; Chuganji, Y.; Tsukuda, Y.; Tsunematsu, S.; Sato, F.; Terasita, K.; Nakai, M.; Horimoto, H.; Sho, T.; Natsuizaka, M.; Ogawa, K.; Ohnishi, S.; Chuma, M.; Fujita, Y.; Abe, R.; Taniguchi, M.; Nakagawa, M.; Asahina, Y.; Sakamoto, N. 2015: Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions. Hepatology Research: the Official Journal of the Japan Society of Hepatology 45(8): 837-845

Kim, H.-A.; Nam, J.-Y.; Jung, J.-Y.; Bae, C.-B.; An, J.-M.; Jeon, J.-Y.; Kim, B.-S.; Suh, C.-H. 2014: Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease. Clinical Rheumatology 33(6): 865-868

Tarkun, P.; Birtas Atesoglu, E.; Mehtap, O.; Musul, M.M.; Hacihanefioglu, A. 2014: Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients. Acta Haematologica 131(3): 173-178

Bradley, J.C.; Bradley, R.H.; McCartney, D.L.; Mannis, M.J. 2008: Serum growth factor analysis in dry eye syndrome. Clinical and Experimental Ophthalmology 36(8): 717-720

Kang, W.D.; Kim, C.H.; Cho, M.K.; Kim, J.W.; Cho, H.Y.; Kim, Y.H.; Choi, H.S.; Kim, S.M. 2010: Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 20(8): 1424-1428

Wide, L.; Eriksson, K.; Sluss, P.M.; Hall, J.E. 2009: Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. Journal of Clinical Endocrinology and Metabolism 94(3): 958-964

Browne, F.W.; Cooper, S.J.; Wilson, R.; King, D.J. 1988: Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients. Journal of Psychopharmacology 2(2): 94-103

Kovcić, V.; Jelić, S.; Filipović, I.; Tomasević, Z. 1994: Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer. Srpski Arhiv Za Celokupno Lekarstvo 122(11-12): 311-313

Smith, B.I.; Kauffold, J.; Sherman, L. 2010: Serum haptoglobin concentrations in dairy cattle with lameness due to claw disorders. Veterinary Journal 186(2): 162-165

Crawford, K.; Warman, S.M.; Marques, A.I.; Yool, D.A.; Eckersall, P.D.; McCulloch, E.; Lynn, K.; Mellanby, R.J.; Gow, A.G. 2013: Serum haptoglobin concentrations in dogs with liver disease. Veterinary Record 173(23): 579

Robert, L. 2013: Serum haptoglobin in clinical biochemistry: change of a paradigm. Pathologie-Biologie 61(6): 277-279

Yalcindag, F.N.; Yalcindag, A.; Caglayan, O.; Ozdemir, O. 2008: Serum haptoglobin levels in ocular Behçet disease and acute phase proteins in the course of Behçet disease. European Journal of Ophthalmology 18(5): 787-791

Erdem, M.; Celik, C.; Cayci, T.; Ozdemir, B.; Kurt, Y.G.; Akgul, E.O.; Yaman, H.; Balikci, A.; Uzun, O. 2011: Serum haptoglobin levels in patients with melancholic and nonmelancholic major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35(4): 944-947

Bannikov, G.A.; Hinds, C.A.; Rajala-Schultz, P.J.; Premanandan, C.; Rings, D.M.; Lakritz, J. 2011: Serum haptoglobin-matrix metalloproteinase 9 (Hp-MMP 9) complex as a biomarker of systemic inflammation in cattle. Veterinary Immunology and Immunopathology 139(1): 41-49

Ye, W.; Xu, P.; Zhong, S.; Threlfall, W.R.; Frasure, C.; Feng, E.; Li, H.; Lin, S.-H.; Liu, J.-Y.; Lin, Y.C. 2010: Serum harvested from heifers one month post-zeranol implantation stimulates MCF-7 breast cancer cell growth. Experimental and Therapeutic Medicine 1(6): 963-968

Akbal, E.; Özbek, M.; Güneş, F.; Akyürek, Öm.; Üreten, K.; Delibaşı, T. 2009: Serum heart type fatty acid binding protein levels in metabolic syndrome. Endocrine 36(3): 433-437

Ozbek, M.; Erdogan, M.; Dogan, M.; Akbal, E.; Ozturk, M.A.; Ureten, K. 2011: Serum heart-type fatty acid binding protein levels in acromegaly patients. Journal of Endocrinological Investigation 34(8): 576-579

Shirakabe, A.; Hata, N.; Kobayashi, N.; Okazaki, H.; Shinada, T.; Tomita, K.; Yamamoto, M.; Tsurumi, M.; Matsushita, M.; Yamamoto, Y.; Yokoyama, S.; Asai, K.; Shimizu, W. 2015: Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure. Circulation Journal: Official Journal of the Japanese Circulation Society 79(1): 119-128

Lesniak, A.; Campbell, A.; Monopoli, M.P.; Lynch, I.; Salvati, A.; Dawson, K.A. 2010: Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31(36): 9511-9518

Gruden, G.; Bruno, G.; Chaturvedi, N.; Burt, D.; Schalkwijk, C.; Pinach, S.; Stehouwer, C.D.; Witte, D.R.; Fuller, J.H.; Perin, P.C. 2008: Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes 57(7): 1966-1970

Burut, D.F.P.; Borai, A.; Livingstone, C.; Ferns, G. 2010: Serum heat shock protein 27 antigen and antibody levels appear to be related to the macrovascular complications associated with insulin resistance: a pilot study. Cell Stress and Chaperones 15(4): 379-386

Liao, W.-C.; Wu, M.-S.; Wang, H.-P.; Tien, Y.-W.; Lin, J.-T. 2009: Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Pancreas 38(4): 422-426

Kakugawa, T.; Yokota, S.-I.; Ishimatsu, Y.; Hayashi, T.; Nakashima, S.; Hara, S.; Sakamoto, N.; Kubota, H.; Mine, M.; Matsuoka, Y.; Mukae, H.; Nagata, K.; Kohno, S. 2014: Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia. Bmc Pulmonary Medicine 14: 48

Kakugawa, T.; Yokota, S.-i.; Ishimatsu, Y.; Hayashi, T.; Nakashima, S.; Hara, S.; Sakamoto, N.; Matsuoka, Y.; Kubota, H.; Mine, M.; Mukae, H.; Nagata, K.; Kohno, S. 2013: Serum heat shock protein 47 levels in patients with drug-induced lung disease. Respiratory Research 14: 133

Wu, C.-T.C.; Ou, L.-S.; Yeh, K.-W.; Lee, W.-I.; Huang, J.-L. 2011: Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis. Clinical Rheumatology 30(7): 959-965

Bonanad, C.; Núñez, J.; Sanchis, J.; Bodi, V.; Chaustre, F.; Chillet, M.; Miñana, G.; Forteza, M.J.é; Palau, P.; Núñez, E.; Navarro, D.; Llàcer, A.; Chorro, F.J. 2013: Serum heat shock protein 60 in acute heart failure: a new biomarker?. Congestive Heart Failure 19(1): 6-10

Nakhjavani, M.; Morteza, A.; Meysamie, A.; Esteghamati, A.; Khalilzadeh, O.; Esfahanian, F.; Khajeali, L.; Feiz, F. 2011: Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter?. Cell Stress and Chaperones 16(2): 195-201

Molvarec, A.; Szarka, A.ás.; Walentin, S.; Beko, G.; Karádi, I.án.; Prohászka, Z.án.; Rigó, J.án. 2011: Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clinica Chimica Acta; International Journal of Clinical Chemistry 412(21-22): 1957-1962

Gelain, D.P.; de Bittencourt Pasquali, M.A.; M Comim, C.; Grunwald, M.S.; Ritter, C.; Tomasi, C.D.; Alves, S.C.; Quevedo, J.; Dal-Pizzol, F.; Moreira, J.é C.áu.F. 2011: Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 35(5): 466-470

Lee, H.-C.; Chen, Y.-S.; Kang, B.-H.; Wan, F.-J.; Chang, L.-P.; Huang, K.-L. 2009: Serum heat shock protein after simulated deep diving in Navy divers. Chinese Journal of Physiology 52(5): 295-298

Razi, C.H.; Akin, O.; Harmanci, K.; Akin, B.; Renda, R. 2011: Serum heavy metal and antioxidant element levels of children with recurrent wheezing. Allergologia et Immunopathologia 39(2): 85-89

Pigatto, P.D.; Brambilla, L.; Ferrucci, S.; Guzzi, G. 2011: Serum heavy metals and childhood skin diseases. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 22(3): 342; author reply 343

Al-Malki, A.L. 2009: Serum heavy metals and hemoglobin related compounds in Saudi Arabia firefighters. Journal of Occupational Medicine and Toxicology 4: 18

Rokadia, H.K.; Agarwal, S. 2013: Serum heavy metals and obstructive lung disease: results from the National Health and Nutrition Examination Survey. Chest 143(2): 388-397

Sato, T.; Saito, Y.; Inoue, S.; Shimosato, T.; Takagi, S.; Kaneko, T.; Ishigatsubo, Y. 2012: Serum heme oxygenase-1 as a marker of lung function decline in patients with chronic silicosis. Journal of Occupational and Environmental Medicine 54(12): 1461-1466

Mateo, I.; Infante, J.; Sánchez-Juan, P.; García-Gorostiaga, I.; Rodríguez-Rodríguez, E.; Vázquez-Higuera, J.L.; Berciano, J.; Combarros, O. 2010: Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurologica Scandinavica 121(2): 136-138

Ascenzi, P.; Fasano, M. 2009: Serum heme-albumin: an allosteric protein. Iubmb Life 61(12): 1118-1122

Rumjon, A.; Sarafidis, P.; Brincat, S.; Musto, R.; Malyszko, J.; Bansal, S.S.; Macdougall, I.C. 2012: Serum hemojuvelin and hepcidin levels in chronic kidney disease. American Journal of Nephrology 35(3): 295-304

Nishio, M.; Yamanaka, T.; Matsumoto, K.; Kimura, H.; Sakai, K.; Sakai, A.; Sone, T.; Horiike, A.; Koizumi, F.; Kasahara, K.; Ohira, T.; Ikeda, N.; Saijo, N.; Arao, T.; Nishio, K. 2011: Serum heparan sulfate concentration is correlated with the failure of epidermal growth factor receptor tyrosine kinase inhibitor treatment in patients with lung adenocarcinoma. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 6(11): 1889-1894

Hofmann-Kiefer, K.F.; Kemming, G.I.; Chappell, D.; Flondor, M.; Kisch-Wedel, H.; Hauser, A.; Pallivathukal, S.; Conzen, P.; Rehm, M. 2009: Serum heparan sulfate levels are elevated in endotoxemia. European Journal of Medical Research 14: 526-531

Uemura, H.; Katsuura-Kamano, S.; Yamaguchi, M.; Sawachika, F.; Arisawa, K. 2014: Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population. Plos one 9(4): E95981

Thompson, A.J.V.; Nguyen, T.; Iser, D.; Ayres, A.; Jackson, K.; Littlejohn, M.; Slavin, J.; Bowden, S.; Gane, E.J.; Abbott, W.; Lau, G.K.K.; Lewin, S.R.; Visvanathan, K.; Desmond, P.V.; Locarnini, S.A. 2010: Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 51(6): 1933-1944

Su, T.-H.; Hsu, C.-S.; Chen, C.-L.; Liu, C.-H.; Huang, Y.-W.; Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H. 2010: Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Therapy 15(8): 1133-1139

Wong, G.L.-H.; Chan, H.L.-Y.; Lo, A.O.-S.; Chan, H.-Y.; Tse, C.-H.; Chim, A.M.-L.; Wong, V.W.-S. 2013: Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues. Antiviral Therapy 18(8): 979-986

Karayiannis, P. 2012: Serum hepatitis B surface antigen levels and their utility as a predictor of sustained virological response after antiviral treatment. Hepatitis Monthly 12(7): 420-422

Gupta, E.; Kumar, A.; Choudhary, A.; Kumar, M.; Sarin, S.K. 2012: Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study. Indian Journal of Medical Microbiology 30(2): 150-154

Tseng, T.-C.; Liu, C.-J.; Yang, H.-C.; Su, T.-H.; Wang, C.-C.; Chen, C.-L.; Hsu, C.-A.; Kuo, S.F.-T.; Liu, C.-H.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H. 2013: Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology 57(2): 441-450

Chen, C.-H.; Chiu, Y.-C.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Hu, T.-H.; Hung, C.-H. 2014: Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues. World Journal of Gastroenterology 20(24): 7686-7695

Gramenzi, A.; Loggi, E.; Micco, L.; Cursaro, C.; Fiorino, S.; Galli, S.; Gitto, S.; Galli, C.; Furlini, G.; Bernardi, M.; Andreone, P. 2011: Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients. Journal of Viral Hepatitis 18(10): E468-E474

Xun, Y.-H.; Zang, G.-Q.; Guo, J.-C.; Yu, X.-L.; Liu, H.; Xiang, J.; Liu, J.; Shi, J.-P. 2013: Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers. Journal of Gastroenterology and Hepatology 28(11): 1746-1755

Chan, H.Lik-Yuen.; Wong, V.Wai-Sun.; Tse, A.Mei-Ling.; Tse, C-Hang.; Chim, A.Mei-Ling.; Chan, H-Yun.; Wong, G.Lai-Hung.; Sung, J.Jao-Yiu. 2007: Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 5(12): 1462-1468

Yasunaka, T.; Takaki, A.; Yagi, T.; Iwasaki, Y.; Sadamori, H.; Koike, K.; Hirohata, S.; Tatsukawa, M.; Kawai, D.; Shiraha, H.; Miyake, Y.; Ikeda, F.; Kobashi, H.; Matsuda, H.; Shinoura, S.; Yoshida, R.; Satoh, D.; Utsumi, M.; Onishi, T.; Yamamoto, K. 2011: Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis. Hepatology International 5(4): 918-926

Papatheodoridis, G.V.; Manesis, E.K.; Manolakopoulos, S.; Archimandritis, A.J. 2007: Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection. Hepatology 46(2): 606-7; Author Reply 607

Tseng, T.-C.; Liu, C.-J.; Chen, C.-L.; Wang, C.-C.; Su, T.-H.; Kuo, S.F.-T.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H. 2012: Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. Journal of Infectious Diseases 205(1): 54-63

Cheung, M.R. 2013: Serum hepatitis a antibody positivity correlates with higher pancreas cancer mortality in adults: implications for hepatitis vaccination in high risk areas. Asian Pacific Journal of Cancer Prevention: Apjcp 14(5): 2707-2710

Leibowitz, S.; Greenwald, L. 1949: Serum hepatitis in a blood bank worker. Journal of the American Medical Association 140(17): 1331-1333

Otsuka, M.; Adachi, H.; Jacobs, D.R.; Hirai, Y.; Enomoto, M.; Fukami, A.; Kumagae, S.-i.; Nanjo, Y.; Yoshikawa, K.; Esaki, E.; Kumagai, E.; Yokoi, K.; Ogata, K.; Tsukagawa, E.; Kasahara, A.; Ohbu, K.; Imaizumi, T. 2012: Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population. Journal of Epidemiology 22(5): 395-401

Ujiie, H.; Tomida, M.; Akiyama, H.; Nakajima, Y.; Okada, D.; Yoshino, N.; Takiguchi, Y.; Tanzawa, H. 2012: Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer. Anticancer Research 32(8): 3251-3258

Toiyama, Y.; Miki, C.; Inoue, Y.; Okugawa, Y.; Tanaka, K.; Kusunoki, M. 2009: Serum hepatocyte growth factor as a prognostic marker for stage Ii or IIi colorectal cancer patients. International Journal of Cancer 125(7): 1657-1662

Balaban, Y.H.; Batman, F.; Us, D.; Hascelik, G.; Bayraktar, Y. 2007: Serum hepatocyte growth factor in autoimmune and hepatitis B-associated liver diseases. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 26(4): 192-193

Yuan, J.; Watanabe, M.; Suliman, M.; Qureshi, A.R.; Axelsson, J.; Bárány, P.; Heimbürger, O.; Stenvinkel, P.; Lindholm, B. 2015: Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 30(2): 274-282

Ruggeri, R.M.; Sciacchitano, S.; Vitale, A.; Cardelli, P.; Galletti, M.; Vitarelli, E.; Barresi, G.; Benvenga, S.; Trimarchi, F.; Trovato, M. 2009: Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals. Journal of Endocrinological Investigation 32(5): 465-469

Kanehisa, M.; Ishitobi, Y.; Ando, T.; Okamoto, S.; Maruyama, Y.; Kohno, K.; Ninomiya, T.; Higuma, H.; Tanaka, Y.; Tsuru, J.; Hanada, H.; Kodama, K.; Akiyoshi, J. 2010: Serum hepatocyte growth factor levels and the effects of antidepressants in panic disorder. Neuropeptides 44(5): 431-435

Joob, B.; Wiwanitkit, V. 2012: Serum hepcidin and chronic obstructive pulmonary disease. Annals of Thoracic Medicine 7(3): 171

Kossiva, L.; Gourgiotis, D.I.; Tsentidis, C.; Anastasiou, T.; Marmarinos, A.; Vasilenko, H.; Sdogou, T.; Georgouli, H. 2012: Serum hepcidin and ferritin to iron ratio in evaluation of bacterial versus viral infections in children: a single-center study. Pediatric Infectious Disease Journal 31(8): 795-798

Tarkun, P.; Mehtap, O.; Atesoğlu, E.B.; Geduk, A.; Musul, M.M.; Hacihanefioglu, A. 2013: Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia. European Journal of Haematology 91(3): 228-235

Valenti, L.; Dongiovanni, P.; Motta, B.M.; Swinkels, D.W.; Bonara, P.; Rametta, R.; Burdick, L.; Frugoni, C.; Fracanzani, A.L.; Fargion, S. 2011: Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arteriosclerosis Thrombosis and Vascular Biology 31(3): 683-690

Oustamanolakis, P.; Koutroubakis, I.E.; Messaritakis, I.; Malliaraki, N.; Sfiridaki, A.; Kouroumalis, E.A. 2011: Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 23(3): 262-268

Delaby, C.; Beaumont, C. 2012: Serum hepcidin assay in 2011: where do we stand?. Annales de Biologie Clinique 70(4): 377-386

Sasu, B.J.; Li, H.; Rose, M.J.; Arvedson, T.L.; Doellgast, G.; Molineux, G. 2010: Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Molecules and Diseases 45(3): 238-245

Weiss, G.; Theurl, I.; Eder, S.; Koppelstaetter, C.; Kurz, K.; Sonnweber, T.; Kobold, U.; Mayer, G. 2009: Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. European Journal of Clinical Investigation 39(10): 883-890

Mecklenburg, I.; Reznik, D.; Fasler-Kan, E.; Drewe, J.ür.; Beglinger, C.; Hruz, P. 2014: Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease. Journal of Crohn's and Colitis 8(11): 1392-1397

Jaspers, A.él.; Baron, F.éd.ér.; Willems, E.; Seidel, L.; Wiegerinck, E.T.; Swinkels, D.W.; Beguin, Y. 2014: Serum hepcidin following autologous hematopoietic cell transplantation: an illustration of the interplay of iron status, erythropoiesis and inflammation. Haematologica 99(3): E35-E37

Xu, Y.; Ding, X.Q.; Zou, J.Z.; Liu, Z.H.; Jiang, S.H.; Chen, Y.M. 2011: Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation. Journal of International Medical Research 39(5): 1961-1967

Bergamaschi, G.; Di Sabatino, A.; Albertini, R.; Costanzo, F.; Guerci, M.; Masotti, M.; Pasini, A.; Massari, A.; Campostrini, N.; Corbella, M.; Girelli, D.; Corazza, G.R. 2013: Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflammatory Bowel Diseases 19(10): 2166-2172

Derbent, A.U.; Simavli, S.A.; Kaygusuz, I.; Gumus, I.I.; Yılmaz, S.; Yildirim, M.; Uysal, S. 2013: Serum hepcidin is associated with parameters of glucose metabolism in women with gestational diabetes mellitus. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 26(11): 1112-1115

Galesloot, T.E.; Holewijn, S.; Kiemeney, L.A.L.M.; de Graaf, J.; Vermeulen, S.H.; Swinkels, D.W. 2014: Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population. Arteriosclerosis Thrombosis and Vascular Biology 34(2): 446-456

Young, M.F.; Glahn, R.P.; Ariza-Nieto, M.; Inglis, J.; Olbina, G.; Westerman, M.; O'Brien, K.O. 2009: Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. American Journal of Clinical Nutrition 89(2): 533-538

Kanda, J.; Mizumoto, C.; Kawabata, H.; Tsuchida, H.; Tomosugi, N.; Matsuo, K.; Uchiyama, T. 2008: Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica 93(10): 1550-1554

Xue, D.; He, X.; Zhou, C. 2014: Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation. Transplantation Proceedings 46(1): 156-159

Demircioğlu, F.; Görünmez, G.ök.; Dağıstan, E.; Göksügür, S.B.; Bekdaş, M.; Tosun, M.; Kızıldağ, B.ül.; Kısmet, E. 2014: Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study. European Journal of Pediatrics 173(7): 947-951

Choi, H.S.; Song, S.H.; Lee, J.H.; Kim, H.-J.; Yang, H.R. 2012: Serum hepcidin levels and iron parameters in children with iron deficiency. Korean Journal of Hematology 47(4): 286-292

Eguchi, A.; Mochizuki, T.; Tsukada, M.; Kataoka, K.; Hamaguchi, Y.; Oguni, S.; Nitta, K.; Tsuchiya, K. 2012: Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients. International Journal of Nephrology 2012: 239476

Samouilidou, E.; Pantelias, K.; Petras, D.; Tsirpanlis, G.; Bakirtzi, J.; Chatzivasileiou, G.; Tzanatos, H.; Grapsa, E. 2014: Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease. Therapeutic Apheresis and Dialysis: Official Peer-Reviewed Journal of the International Society for Apheresis the Japanese Society for Apheresis the Japanese Society for Dialysis Therapy 18(3): 279-283

Tsochatzis, E.; Papatheodoridis, G.V.; Koliaraki, V.; Hadziyannis, E.; Kafiri, G.; Manesis, E.K.; Mamalaki, A.; Archimandritis, A.J. 2010: Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. Journal of Viral Hepatitis 17(11): 800-806

Azab, S.F.A.; Esh, A.M.H. 2013: Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case-control study. Annals of Hematology 92(11): 1477-1483

Röhrig, G.; Rappl, G.; Vahldick, B.; Kaul, I.; Schulz, R.J. 2014: Serum hepcidin levels in geriatric patients with iron deficiency anemia or anemia of chronic diseases. Zeitschrift für Gerontologie und Geriatrie 47(1): 51-56

Malvoisin, E.; Makhloufi, D.; Livrozet, J.-M. 2014: Serum hepcidin levels in women infected with HIV-1 under antiviral therapy. Journal of Medical Virology 86(10): 1656-1660

Zipperer, E.; Post, J.G.; Herkert, M.; Kündgen, A.; Fox, F.; Haas, R.; Gattermann, N.; Germing, U. 2013: Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Annals of Hematology 92(12): 1617-1623

Suzuki, H.; Toba, K.; Kato, K.; Ozawa, T.; Tomosugi, N.; Higuchi, M.; Kusuyama, T.; Iso, Y.; Kobayashi, N.; Yokoyama, S.-i.; Fukuda, N.; Saitoh, H.; Akazawa, K.; Aizawa, Y. 2009: Serum hepcidin-20 is elevated during the acute phase of myocardial infarction. Tohoku Journal of Experimental Medicine 218(2): 93-98

Chand, S.; Ward, D.G.; Ng, Z.-Y.V.; Hodson, J.; Kirby, H.; Steele, P.; Rooplal, I.; Bantugon, F.; Iqbal, T.; Tselepis, C.; Drayson, M.T.; Whitelegg, A.; Chowrimootoo, M.; Borrows, R. 2015: Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease. Journal of Nephrology 28(1): 81-88

Thomas, C.; Kobold, U.; Thomas, L. 2011: Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis. Clinical Chemistry and Laboratory Medicine 49(2): 207-213

Peters, H.P.E.; Laarakkers, C.M.M.; Swinkels, D.W.; Wetzels, J.F.M. 2010: Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(3): 848-853

Thomas, C.; Kobold, U.; Balan, S.; Roeddiger, R.; Thomas, L. 2011: Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. International Journal of Laboratory Hematology 33(2): 187-193

Abdel-Khalek, M.A.; El-Barbary, A.M.; Essa, S.A.-M.; Ghobashi, A.S. 2011: Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. Journal of Rheumatology 38(10): 2153-2159

Bergamaschi, G.; Villani, L. 2009: Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism. Haematologica 94(12): 1631-1633

Galesloot, T.E.; Vermeulen, S.H.; Geurts-Moespot, A.J.; Klaver, S.M.; Kroot, J.J.; van Tienoven, D.; Wetzels, J.F.M.; Kiemeney, L.A.L.M.; Sweep, F.C.; den Heijer, M.; Swinkels, D.W. 2011: Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117(25): E218-E225

Tin, S.S.; Wiwantikit, V. 2014: Serum high density lipoprotein cholesterol and Duke Treadmill score. Journal of Postgraduate Medicine 60(4): 415

Uzawa, A.; Kawaguchi, N.; Kanai, T.; Himuro, K.; Kuwabara, S. 2015: Serum high mobility group box 1 is upregulated in myasthenia gravis. Journal of Neurology Neurosurgery and Psychiatry 86(6): 695-697

Shang, G.-H.; Jia, C.-Q.; Tian, H.; Xiao, W.; Li, Y.; Wang, A.-H.; Dong, L.; Lin, D.-J. 2009: Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respiratory Medicine 103(12): 1949-1953

Li, Y.; Tian, J.; Fu, X.; Chen, Y.; Zhang, W.; Yao, H.; Hao, Q. 2014: Serum high mobility group box protein 1 as a clinical marker for ovarian cancer. Neoplasma 61(5): 579-584

Chung, H.W.; Lee, S.-G.; Kim, H.; Hong, D.J.; Chung, J.B.; Stroncek, D.; Lim, J.-B. 2009: Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. Journal of Translational Medicine 7: 38

Chung, H.W.; Lim, J.-B.; Jang, S.; Lee, K.J.; Park, K.H.; Song, S.Y. 2012: Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Cancer Science 103(9): 1714-1721

Kawamoto, R.; Tabara, Y.; Kohara, K.; Miki, T.; Kusunoki, T.; Katho, T.; Ohtsuka, N. 2011: Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocrine Research 36(2): 53-63

Kawamoto, R.; Tabara, Y.; Kohara, K.; Miki, T.; Abe, M.; Kusunoki, T.; Katoh, T.; Ohtsuka, N. 2010: Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. Journal of Atherosclerosis and Thrombosis 17(11): 1141-1148

Shibata, S.; Saeki, H.; Tada, Y.; Karakawa, M.; Komine, M.; Tamaki, K. 2009: Serum high molecular weight adiponectin levels are decreased in psoriasis patients. Journal of Dermatological Science 55(1): 62-63

Masood, A.; Jafar, S.S.; Akram, Z. 2011: Serum high sensitivity C-reactive protein levels and the severity of coronary atherosclerosis assessed by angiographic gensini score. JPMA. Journal of the Pakistan Medical Association 61(4): 325-327

Takagi, H.; Manabe, H.; Kawai, N.; Goto, S.-N.; Umemoto, T. 2010: Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis. International Angiology: a Journal of the International Union of Angiology 29(4): 371-375

Kim, Y.; Park, S.K.; Han, W.; Kim, D.-H.; Hong, Y.-C.; Ha, E.H.; Ahn, S.-H.; Noh, D.-Y.; Kang, D.; Yoo, K.-Y. 2009: Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(2): 508-515

Zhao, Q.-H.; Peng, F.-H.; Wei, H.; He, J.; Chen, F.-D.; Di, R.-M.; Jiang, X.; Jiang, R.; Chen, Y.-J.; Heresi, G.A.; Jing, Z.-C. 2012: Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension. American Journal of Cardiology 110(3): 433-439

Formiga, F.; Ferrer, A.; Chivite, D.; Pinto, X.; Cuerpo, S.; Pujol, R.ón. 2011: Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenarians. Geriatrics and Gerontology International 11(3): 358-364

Lin, G.-X.; Wang, T.; Chen, M.-H.; Hu, Z.-H.; Ouyang, W. 2014: Serum high-mobility group box 1 protein correlates with cognitive decline after gastrointestinal surgery. Acta Anaesthesiologica Scandinavica 58(6): 668-674

Nin, J.W.M.; Ferreira, I.; Schalkwijk, C.G.; Prins, M.H.; Chaturvedi, N.; Fuller, J.H.; Stehouwer, C.D.A.; Karamanos, B.; Kofinis, A.; Petrou, K.; Giorgino, F.; Picca, G.; Angarano, A.; De Pergola, G.; Laviola, L.; Giorgino, R.; Ionescu-Tirgoviste, C.; Coszma, A.; Guja, C.; Songini, M.; Casu, A.; Pedron, M.; Pintus, S.; Fossarello, M.; Ferriss, J.B.; Grealy, G.; Keefe, D.O.; Toeller, M.; Arden, C.; Rottiers, R.; Tuyttens, C.; Priem, H.; Ebeling, P.; Kylliäinen, M.; Koivisto, V.A.; Idzior-Walus, B.; Sieradzki, J.; Cyganek, K.; Solnica, B.; Lemkes, H.H.P.J.; Lemkes-Stuffken, J.C.; Nunes-Correa, J.; Rogado, M.C.; Gardete-Correia, L.; Cardoso, M.C.; Silva, A.; Boavida, J.; Machado Sa Marques, M.; Michel, G.; Wirion, R.; Cardillo, S.; Pozza, G. 2012: Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. European Journal of Endocrinology 166(2): 325-332

Ozeki, N.; Hara, K.; Yatsuka, C.; Nakano, T.; Matsumoto, S.; Suetsugu, M.; Nakamachi, T.; Takebayashi, K.; Inukai, T.; Haruki, K.; Aso, Y. 2009: Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Metabolism, Clinical and Experimental 58(10): 1470-1476

Iwase, M.; Iino, K.; Oku, M.; Nohara, S.; Asano, T.; Doi, Y.; Iida, M. 2009: Serum high-molecular weight adiponectin is related to early postprandial glycemic increases and gastric emptying in patients with type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews 25(4): 344-350

Hirose, H.; Yamamoto, Y.; Seino-Yoshihara, Y.; Kawabe, H.; Saito, I. 2010: Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. Journal of Atherosclerosis and Thrombosis 17(12): 1201-1211

Azarpazhooh, M.R.; Mobarra, N.; Parizadeh, S.M.R.; Tavallaie, S.; Bagheri, M.; Rahsepar, A.A.; Ghayour-Mobarhan, M.; Sahebkar, A.; Ferns, G.A.A. 2010: Serum high-sensitivity C-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis. Angiology 61(6): 607-612

Makedos, A.; Goulis, D.G.; Papanikolaou, A.; Panidis, D. 2010: Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study. Angiology 61(6): 595-601

Shahid, H.S.; Kurdi, M.I.; Zohair, A.A. 2011: Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease. Medical Journal of Malaysia 66(2): 113-116

Hayashino, Y.; Mashitani, T.; Tsujii, S.; Ishii, H.; Okamura, S.; Furuya, M.; Kitatani, M.; Kuwata, H.; Tsujii, S.; Hayashino, Y.; Ishii, H.; Mashitani, T.; Matsunaga, S.; Kondo, Y.; Fujita, N.; Ueda, R.; Kurokawa, R.; Tanaka, M. 2014: Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]). Diabetes Care 37(11): 2947-2952

Başkurt, M.; Aktürk, F.; Keskin, K.; Canbolat, P.; Karadag, B.; Kaya, A.; Yildiz, A.; Coskun, U.; Kilickesmez, K.; Esen, O.; Muniboglu, S.K. 2011: Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia. Cardiovascular Journal of Africa 22(2): 85-89

Kitagawa, M.; Sugiyama, H.; Morinaga, H.; Inoue, T.; Takiue, K.; Kikumoto, Y.; Uchida, H.A.; Kitamura, S.; Maeshima, Y.; Toh, N.; Nakamura, K.; Ito, H.; Makino, H. 2011: Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease. Nephron Extra 1(1): 166-177

Youn, C.S.; Choi, S.P.; Kim, S.H.; Oh, S.H.; Jeong, W.J.; Kim, H.J.; Park, K.N. 2012: Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. American Journal of Emergency Medicine 30(1): 124-128

Ertugrul, D.T.; Karadag, A.S.; Takci, Z.; Bilgili, S.G.; Ozkol, H.U.; Tutal, E.; Akin, K.O. 2013: Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in alopecia areata patients. Cutaneous and Ocular Toxicology 32(1): 1-3

Nazarinia, M.; Shams, M.; Kamali Sarvestani, E.; Shenavande, S.; Khademalhosseini, M.; Khademalhosseini, Z. 2013: Serum homocystein level in patients with scleroderma. Iranian Red Crescent Medical Journal 15(1): 29-31

Gulhan, I.; Bozkaya, G.; Bilgir, F.; Kebapcilar, L.; Bilgir, O.; Kavrut, M.; Dogan, E. 2011: Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(8): 568-571

Wald, D.S.; Kasturiratne, A.; Simmonds, M. 2011: Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 7(4): 412-417

Gopinath, B.; Flood, V.M.; Rochtchina, E.; Thiagalingam, A.; Mitchell, P. 2012: Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults. European Journal of Preventive Cardiology 19(6): 1420-1429

Gopinath, B.; Flood, V.M.; Rochtchina, E.; McMahon, C.M.; Mitchell, P. 2010: Serum homocysteine and folate concentrations are associated with prevalent age-related hearing loss. Journal of Nutrition 140(8): 1469-1474

Kim, T.H.; Moon, S.W. 2011: Serum homocysteine and folate levels in korean schizophrenic patients. Psychiatry Investigation 8(2): 134-140

Fazio, F.; Casella, S.; Giannetto, C.; Caola, G.; Piccione, G. 2009: Serum homocysteine and oxidative stress evaluation during exercise in horse. Polish Journal of Veterinary Sciences 12(2): 169-174

Silverberg, J.I.; Silverberg, N.B. 2011: Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. Journal of the American Academy of Dermatology 64(2): 445-447

Naureen, A.; Munazza, B.; Shaheen, R.; Khan, S.A.; Fatima, F. 2012: Serum homocysteine as a risk factor for coronary heart disease. Journal of Ayub Medical College Abbottabad: Jamc 24(1): 59-62

Tu, W.-j.; Yin, C.-h.; Guo, Y.-q.; Li, S.-o.; Chen, H.; Zhang, Y.; Feng, Y.-l.; Long, B.-h. 2013: Serum homocysteine concentrations in Chinese children with autism. Clinical Chemistry and Laboratory Medicine 51(2): E19-E22

Brandão, M.Piedade.; Pimentel, F.Luís.; Cardoso, M.Fonseca. 2011: Serum homocysteine concentrations in Portuguese young adults reference interval. Acta Medica Portuguesa 24(2): 271-278

Anand, P.; Awasthi, S.; Mahdi, A.; Tiwari, M.; Agarwal, G.G. 2009: Serum homocysteine in Indian adolescents. Indian Journal of Pediatrics 76(7): 705-709

Ravari, H.; Zafarghandi, M.R.; Alvandfar, D.; Saadat, S. 2009: Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: a case-control study. Pakistan Journal of Biological Sciences: Pjbs 12(14): 1019-1024

Hoque, M.M.; Bulbul, T.; Mahal, M.; Islam, N.-A.-F.; Ferdausi, M. 2008: Serum homocysteine in pre-eclampsia and eclampsia. Bangladesh Medical Research Council Bulletin 34(1): 16-20

Gadhok, A.K.; Sinha, M.; Khunteta, R.; Vardey, S.Kumar.; Upadhyaya, C.; Sharma, T.Kumar.; Jha, M. 2011: Serum homocysteine level and its association with folic acid and vitamin B12 in the third trimester of pregnancies complicated with intrauterine growth restriction. Clinical Laboratory 57(11-12): 933-938

Başkan, B.M.; Sivas, F.; Aktekin, L.A.; Doğan, Y.P.; Ozoran, K.ür.şa.; Bodur, H. 2009: Serum homocysteine level in patients with ankylosing spondylitis. Rheumatology International 29(12): 1435-1439

Chao, M.-C.; Hu, S.-L.; Hsu, H.-S.; Davidson, L.E.; Lin, C.-H.; Li, C.-I.; Liu, C.-S.; Li, T.-C.; Lin, C.-C.; Lin, W.-Y. 2014: Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population. Journal of Nephrology 27(3): 299-305

Dias, V.V.; Brissos, S.; Cardoso, C.; Andreazza, A.C.; Kapczinski, F.áv. 2009: Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. Journal of Affective Disorders 113(3): 285-290

Basar, M.M.; Ozkan, Y.; Kisa, U.; Simsek, B. 2013: Serum homocysteine levels and sildenafil 50 mg response in young-adult male patients without vascular risk factors. Indian Journal of Biochemistry and Biophysics 50(3): 215-220

Kim, H.; Lee, K.J. 2014: Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer's disease. Neuropsychiatric Disease and Treatment 10: 1887-1896

Owecki, M.; Dorszewska, J.; Sawicka-Gutaj, N.; Oczkowska, A.; Owecki, M.ł K.; Michalak, M.ł; Fischbach, J.; Kozubski, W.; Ruchała, M. 2014: Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis. Bmc Endocrine Disorders 14: 18

Nemec, V.ír.; Botkayová, E.; Kutílek, S.án. 2012: Serum homocysteine levels in Czech children and adolescents. Acta Medica 55(2): 87-90

Rehackova, P.; Skalova, S.; Kutilek, S. 2013: Serum homocysteine levels in children and adolescents with impaired bone health. Revista Brasileira de Reumatologia 53(6): 464-468

Polyzos, S.A.; Kountouras, J.; Patsiaoura, K.; Katsiki, E.; Zafeiriadou, E.; Deretzi, G.; Zavos, C.; Gavalas, E.; Katsinelos, P.; Mane, V.; Slavakis, A. 2012: Serum homocysteine levels in patients with nonalcoholic fatty liver disease. Annals of Hepatology 11(1): 68-76

Stoĭkova, V.; Ivanov, S.; Mazneĭkova, V.; Tsoncheva, A. 2005: Serum homocysteine levels in pregnant women with preeclampsia. Akusherstvo i Ginekologiia 44(6): 16-19

Teunissen, C.E.; Killestein, J.; Kragt, J.J.; Polman, C.H.; Dijkstra, C.D.; Blom, H.J. 2008: Serum homocysteine levels in relation to clinical progression in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 79(12): 1349-1353

Piovesan, F.; Veronese, F.J.é V.ís.; Santos, A.F.; Pozza, R.; Sarturi, P.ér.S.; Tognon, A.; Garcia, V.D.; Keitel, E.; Saitovitch, D. 2007: Serum homocysteine levels in renal transplant recipients with and without hypercholesterolemia. Arquivos Brasileiros de Cardiologia 89(3): 154-159; 170-175

Leach, N.V.; Dronca, E.; Vesa, S.C.; Sampelean, D.P.; Craciun, E.C.; Lupsor, M.; Crisan, D.; Tarau, R.; Rusu, R.; Para, I.; Grigorescu, M. 2014: Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. European Journal of Internal Medicine 25(8): 762-767

Toker, A.; Yerlikaya, F.; Yener, Y.; Toy, H. 2013: Serum homocysteine, arginine, citrulline and asymmetric dimethyl arginine levels, and histopathologic examination of the abdominal aorta in rats exposed to acrylamide. Biotechnic and Histochemistry: Official Publication of the Biological Stain Commission 88(2): 103-108

Melichar, B.; Kalábová, H.; Krcmová, L.; Kasparová, M.ét.; Malírová, E.; Melicharová, K.; Pecka, M.; Hyspler, R.ír.; Solichová, D. 2009: Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. Anticancer Research 29(11): 4813-4820

Polyzos, S.A.; Anastasilakis, A.D.; Efstathiadou, Z.; Litsas, I.; Kita, M.; Panagiotou, A.; Papatheodorou, A.; Arsos, G.; Moralidis, E.; Barmpalios, G.; Zafeiriadou, E.; Triantafillidou, E.; Makrigiannaki, E.; Terpos, E. 2010: Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid. Journal of Bone and Mineral Metabolism 28(3): 314-319

Shargorodsky, M.; Boaz, M.; Pasternak, S.; Hanah, R.; Matas, Z.; Fux, A.; Beigel, Y.; Mashavi, M. 2009: Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?. Diabetes/Metabolism Research and Reviews 25(1): 70-75

Balci, D.D.; Yonden, Z.; Yenin, J.Z.; Okumus, N. 2009: Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. European Journal of Dermatology: Ejd 19(4): 382-383

Tan, A.Grace.; Mitchell, P.; Rochtchina, E.; Flood, V.M.; Cumming, R.G.; Wang, J.Jin. 2014: Serum homocysteine, vitamin B12, and folate, and the prevalence and incidence of posterior subcapsular cataract. Investigative Ophthalmology and Visual Science 56(1): 216-220

Yasar, A.; Gunduz, K.; Onur, E.; Calkan, M. 2012: Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo. Disease Markers 33(2): 85-89

Cascalheira, Jé.F.; João, S.S.; Pinhanços, S.S.; Castro, R.; Palmeira, M.; Almeida, S.; Faria, M.C.; Domingues, F.C. 2009: Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia. Clinical Biochemistry 42(9): 783-790

Seliatitskaia, V.G.; Kuz'minova, O.I.; Nikolaev, I.A.; Galanova, Z.M. 2011: Serum hormonal levels in diamond-extracting industry workers of Yakutia, with surface and underground type of work. Meditsina Truda i Promyshlennaia Ekologiia 10: 23-27

Camacho, L.E.; Benavidez, J.M.; Hallford, D.M. 2012: Serum hormone profiles, pregnancy rates, and offspring performance of Rambouillet ewes treated with recombinant bovine somatotropin before breeding. Journal of Animal Science 90(8): 2826-2835

Ishikawa, T.; Yamaguchi, K.; Chiba, K.; Takenaka, A.; Fujisawa, M. 2009: Serum hormones in patients with nonobstructive azoospermia after microdissection testicular sperm extraction. Journal of Urology 182(4): 1495-1499

Santtila, M.; Kyröläinen, H.; Häkkinen, K. 2009: Serum hormones in soldiers after basic training: effect of added strength or endurance regimens. Aviation Space and Environmental Medicine 80(7): 615-620

Song, I.-U.; Cho, H.-J.; Kim, J.-S.; Park, I.-S.; Lee, K.-S. 2014: Serum hs-CRP levels are increased in de Novo Parkinson's disease independently from age of onset. European Neurology 72(5-6): 285-289

Huang, C.-F.; Hsieh, M.-Y.; Yang, J.-F.; Chen, W.-C.; Yeh, M.-L.; Huang, C.-I.; Dai, C.-Y.; Yu, M.-L.; Lin, Z.-Y.; Chen, S.-C.; Chuang, W.-L.; Huang, J.-F. 2010: Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients. Hepatology International 4(3): 621-627

Oktay, B.; Ozgur, Y.A.; Metin, K.; Naim, A.; Zeliha, A.; Mehmet, Y.ıl.ız.; Ayse, K.; Sebahat, B.; Bora, A.; Yasar, N.ıg. 2015: Serum hsCRP and procalcitonin levels in dyspeptic patients infected with CagA-positive Helicobacter pylori. Journal of Clinical Laboratory Analysis 29(6): 469-473

Hekmat, R.; Gholami, F.; Ahmadnia, H.; Ahmadi, M.; Hassannia, T. 2013: Serum human T-lymphotropic virus 1 proviral load in patients on hemodialysis. Iranian Journal of Kidney Diseases 7(2): 124-128

Wcislo-Dziadecka, D.; Kotulska, A.; Brzezińska-Wcislo, L.; Widuchowska, M.; Lis-Swiety, A.; Kopec-Medrek, M.; Kucharz, E.J. 2010: Serum human cartilage glycoprotein-39 in patients with systemic sclerosis: relationship to skin and articular manifestation. Clinical Rheumatology 29(8): 933-935

Lockwood, C.M.; Grenache, D.G.; Gronowski, A.M. 2009: Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid: Official Journal of the American Thyroid Association 19(8): 863-868

Arrieta, O.; Michel Ortega, R.M.; Angeles-Sánchez, J.án.; Villarreal-Garza, C.; Avilés-Salas, A.; Chanona-Vilchis, J.é G.; Aréchaga-Ocampo, E.; Luévano-González, A.; Jiménez, M.A.; Aguilar, J.é L. 2009: Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors. Journal of Experimental and Clinical Cancer Research: Cr 28: 120

Zhang, Q.; Yan, J.; Tang, R.; Gao, X.; Zhang, B.; Chen, Z.-J. 2014: Serum human chorionic gonadotropin level measured 17 days after oocyte retrieval can predict final clinical pregnancy outcomes in IVF/ICSi treatment cycles. Journal of Reproductive Medicine 59(5-6): 285-292

Levy, G.; Hill, M.J.; Ramirez, C.; Plowden, T.; Pilgrim, J.; Howard, R.S.; Segars, J.H.; Csokmay, J. 2013: Serum human chorionic gonadotropin levels on the day before oocyte retrieval do not correlate with oocyte maturity. Fertility and Sterility 99(6): 1610-1614

Kim, H.-A.; Lee, J.K.; Kim, E.-K.; Seol, H.; Noh, W.C. 2014: Serum human epidermal growth factor receptor 2 levels as a real-time marker for tumor burden in breast cancer patients. Journal of Surgical Oncology 109(5): 421-425

Nagy, B.él.; Bhattoa, H.P.; Steiber, Z.án.; Csobán, M.ár.; Szilasi, M.ár.; Méhes, G.áb.; Müller, M.ón.; Lázár, J.óz.; Kappelmayer, J.án.; Antal-Szalmás, P.ét. 2014: Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer. Clinical Chemistry and Laboratory Medicine 52(11): 1639-1648

Li, W.; Zhao, Y.; Ren, L.; Wu, X. 2014: Serum human kallikrein 7 represents a new marker for cervical cancer. Medical Oncology 31(10): 208

Motawi, T.M.K.; Zakhary, N.I.; Salman, T.M.; Tadros, S.A. 2012: Serum human leukocyte antigen-G and soluble interleukin 2 receptor levels in acute lymphoblastic leukemic pediatric patients. Asian Pacific Journal of Cancer Prevention: Apjcp 13(11): 5399-5403

Marinho, C.C.; Bretas, T.; Voieta, I.; Queiroz, L.C.d.; Ruiz-Guevara, R.; Teixeira, A.ôn.L.úc.; Antunes, C.M.íc.; Prata, A.íz.; Lambertucci, J.é R. 2010: Serum hyaluronan and collagen IV as non-invasive markers of liver fibrosis in patients from an endemic area for schistosomiasis mansoni: a field-based study in Brazil. Memorias do Instituto Oswaldo Cruz 105(4): 471-478

Parsian, H.; Rahimipour, A.; Nouri, M.; Somi, M.H.; Qujeq, D.; Fard, M.K.; Agcheli, K. 2010: Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Journal of Gastrointestinal and Liver Diseases: Jgld 19(2): 169-174

Geramizadeh, B.; Janfeshan, K.; Saberfiroozi, M. 2008: Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 14(4): 174-177

Filková, M.; Senolt, L.; Braun, M.; Hulejová, H.; Pavelková, A.; Sléglová, O.; Kupka, K.; Gatterová, J.; Pavelka, K. 2009: Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis and Cartilage 17(12): 1615-1619

Nath, N.C.; Rahman, M.A.; Khan, M.R.; Hasan, M.S.; Bhuiyan, T.M.; Hoque, M.N.; Kabir, M.M.; Raha, A.K.; Jahan, B. 2011: Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection. Mymensingh Medical Journal: Mmj 20(4): 614-619

Hayashi, T.; Inuzuka, R.; Shindo, T.; Hirata, Y.; Shimizu, N.; Oka, A. 2014: Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics. Pediatric Cardiology 35(4): 608-615

Valenti, L.; Dongiovanni, P. 2010: Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach. Translational Research: the Journal of Laboratory and Clinical Medicine 156(4): 226-228

Seki, M.; Asano, K.; Sakai, M.; Kanno, N.; Teshima, K.; Edamura, K.; Tanaka, S. 2010: Serum hyaluronic acid in dogs with congenital portosystemic shunts. Journal of Small Animal Practice 51(5): 260-263

Silva, M.B.; Silva, M.G.; Shinjo, S.K. 2014: Serum hyaluronic acid in polymyositis: high serum levels tend to correlate with disease activity. Acta Reumatologica Portuguesa 39(3): 248-253

Arain, S.A.; Meo, S.A.; Jamal, Q. 2011: Serum hyaluronic acid level does not reliably differentiate minimal and significant liver disease in chronic hepatitis C. Saudi Medical Journal 32(12): 1241-1245

Kim, M.Y.; Baik, S.K.; Jang, Y.O.; Suk, K.T.; Kim, J.W.; Kim, H.S.; Cho, M.Y.; Choi, S.J.; Um, S.H.; Han, K.-H. 2008: Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model. Korean Journal of Hepatology 14(2): 159-167

Kim, J.-S.; Lee, S.-S.; Kim, T.-J.; Park, Y.-W. 2010: Serum hyaluronic acid levels do not explain morning stiffness in patients with fibromyalgia. Clinical Rheumatology 29(5): 535-539

Duruöz, M.T.; Turan, Y.; Cerrahoglu, L.; Isbilen, B. 2008: Serum hyaluronic acid levels in patients with ankylosing spondylitis. Clinical Rheumatology 27(5): 621-626

Crawford, D.H.G.; Murphy, T.L.; Ramm, L.E.; Fletcher, L.M.; Clouston, A.D.; Anderson, G.J.; Subramaniam, V.N.; Powell, L.W.; Ramm, G.A. 2009: Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology 49(2): 418-425

Li, X.-y.; Guo, X.; Wang, L.-x.; Geng, D.; Kang, L.-l.; Wang, S.; Wang, Z.-f.; Gu, Q.-s. 2007: Serum hyaluronic acid, tumor necrosis factor -alpha, vascular endothelial growth factor, NO, and Se levels in adult patients with Kashin-Beck disease. Nan Fang Yi Ke da Xue Xue Bao 27(7): 941-944

Shiha, G. 2008: Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 14(4): 161-162

Chen, Y.-H.; Yao, W.-Z.; Gao, J.-Z.; Geng, B.; Wang, P.-P.; Tang, C.-S. 2009: Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections. Respirology 14(5): 746-752

Zhang, Y.-D.; Gu, F.; Xie, H.-Q.; Ji, C.-Y.; Zhang, X.-L.; Zhang, Y.; Pang, W.-W. 2014: Serum hydrogen sulfide levels in children with benign infantile convulsions associated with mild gastroenteritis. Zhongguo Dang Dai Er Ke Za Zhi 16(11): 1096-1099

Endo, N.; Oowada, S.; Sueishi, Y.; Shimmei, M.; Makino, K.; Fujii, H.; Kotake, Y. 2009: Serum hydroxyl radical scavenging capacity as quantified with iron-free hydroxyl radical source. Journal of Clinical Biochemistry and Nutrition 45(2): 193-201

Hou, Y.-C.; Chang, Y.-L.; Kuo, S.-C.; Chiang, C.-F.; Chiang, C.-Y.; Lin, Y.-F.; Weng, P.-C.; Hu, F.-C.; Wu, J.-H.; Lai, C.-H. 2014: Serum hyperglycemia might be not related to fat composition of diet and vegetable composition of diet might improve sugar control in taiwanese diabetic subjects. International Journal of Medical Sciences 11(5): 515-521

Keikkala, E.; Ranta, J.K.; Vuorela, P.; Leinonen, R.; Laivuori, H.; Väisänen, S.; Marttala, J.; Romppanen, J.; Pulkki, K.; Stenman, U.-H.åk.; Heinonen, S. 2014: Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia. Prenatal Diagnosis 34(7): 699-705

Bersinger, N.A.; Wunder, D.M.; Nicolas, M.; Birkhäuser, M.H.; Porquet, D.; Guibourdenche, J. 2008: Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies. Fetal Diagnosis and Therapy 24(1): 74-78

Porrett, P.M.; Baranov, E.; ter Horst, M. 2015: Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list. Transplantation 99(1): 158-163

Kanmaz, G.; Erdeve, O.; Canpolat, F.Emre.; Oğuz, S.Suna.; Uras, N.; Altug, N.; Greijdanus, B.; Dilmen, Uğur. 2013: Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus. European Journal of Clinical Pharmacology 69(5): 1075-1081

French, M.A.; King, M.S.; Tschampa, J.M.; da Silva, B.A.; Landay, A.L. 2009: Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. Journal of infectious diseases 200(8): 1212-1215

Neamatzadeh, H.; Ramazani, V.; Kalantar, S.M.; Ebrahimi, M.; Sheikhha, M.H. 2016: Serum immune reactivity against β2-Glycoprotein-i and anti-neutrophil cytoplasmic auto-antibodies by ELI-P-Complex Screening Technology in recurrent miscarriage. Minerva Ginecologica 68(3): 243-249

Rintamäki, H.; Sipponen, T.; Salo, H.-M.; Vaarala, O.; Kolho, K.-L. 2010: Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease. World Journal of Gastroenterology 16(46): 5845-5851

Urken, M.L.; Roche, A.M.; Kiplagat, K.J.; Dewey, E.H.; Lazarus, C.; Likhterov, I.; Buchbinder, D.; Okay, D.J. 2018: Comprehensive approach to functional palatomaxillary reconstruction using regional and free tissue transfer: Report of reconstructive and prosthodontic outcomes of 140 patients. Head and Neck 40(8): 1639-1666

Elistratova, E.I.; Gruden', M.A.; Davydova, T.V.; Sherstnev, V.V. 2011: Serum immunoboichemical markers in patients suffered with hypertension-induced cerebrovascular diseases. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 25-28

Pesonen, M.; Kallio, M.J.T.; Siimes, M.A.; Savilahti, E.; Ranki, A. 2011: Serum immunoglobulin a concentration in infancy, but not human milk immunoglobulin A, is associated with subsequent atopic manifestations in children and adolescents: a 20-year prospective follow-up study. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 41(5): 688-696

Maleki, I.; Aminafshari, M.R.; Taghvaei, T.; Hosseini, V.; Rafiei, A.; Torabizadeh, Z.; Barzin, M.; Orang, E. 2014: Serum immunoglobulin a concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World Journal of Gastroenterology 20(35): 12566-12573

Zhang, J.; Wang, C.; Tang, Y.; Peng, H.; Ye, Z.-C.; Li, C.-C.; Lou, T.-Q. 2013: Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin a nephropathy. Nephrology 18(2): 125-131

Chiappini, E.; Nanni, S.; Bonsignori, F.; Azzari, C.; Ballotti, S.; Galli, L.; de Martino, M. 2009: Serum immunoglobulin D levels by age in a healthy Italian pediatric population. Clinical and Experimental Rheumatology 27(3): 537

Lee, S.; Ahn, K.; Paik, H.Y.; Chung, S.-J. 2012: Serum immunoglobulin e (IgE) levels and dietary intake of Korean infants and young children with atopic dermatitis. Nutrition Research and Practice 6(5): 429-435

Mishra, O.P.; Teli, A.S.; Singh, U.; Abhinay, A.; Prasad, R. 2014: Serum immunoglobulin e and interleukin-13 levels in children with idiopathic nephrotic syndrome. Journal of Tropical Pediatrics 60(6): 467-471

Shao, Y.-N.; Chen, Y.-C.; Jenq, C.-C.; Hsu, H.-H.; Chang, M.-Y.; Tian, Y.-C.; Fang, J.-T.; Yang, C.-W. 2009: Serum immunoglobulin e can predict minimal change disease before renal biopsy. American Journal of the Medical Sciences 338(4): 264-267

Tsai, W.-J.; Lin, J.-Y.; Yang, Y.-H.; Lee, J.-H.; Chiang, B.-L. 2009: Serum immunoglobulin e levels in patients with primary hypogammaglobulinemia - experience from a tertiary hospital in Taiwan. Journal of Microbiology Immunology and Infection 42(3): 271-275

Bock, J.M.; Burtis, C.C.; Poetker, D.M.; Blumin, J.H.; Frank, M.O. 2012: Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 146(1): 63-67

Katchman, E.; Varon-Grady, M.; Leibovich, C.; Giladi, M.; Avidor, B. 2012: Serum immunoglobulin G avidity test as a tool for improving diagnosis of cat scratch disease. Vector Borne and Zoonotic Diseases 12(8): 645-649

Raina, A.; Krasinskas, A.M.; Greer, J.B.; Lamb, J.; Fink, E.; Moser, A.J.; Zeh, H.J.; Slivka, A.; Whitcomb, D.C. 2008: Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Archives of Pathology and Laboratory Medicine 132(1): 48-53

Yomota, M.; Amano, I.; Horita, N.; Takezawa, T.; Arai, T.; To, M.; To, Y. 2012: Serum immunoglobulin G is a marker for the risk of opportunistic infection in steroid-dependent severe asthmatic patients. Internal Medicine 51(19): 2715-2719

Yap, D.Y.H.; Yung, S.; Ma, M.K.M.; Mok, M.M.Y.; Kwan, L.P.Y.; Chan, G.C.W.; Chan, T.M. 2014: Serum immunoglobulin G level in patients with lupus nephritis and the effect of treatment with corticosteroids and mycophenolate mofetil. Lupus 23(7): 678-683

Deshmukh, T.M.; Shah, R.R.; Gurav, Y.K.; Arankalle, V.A. 2013: Serum immunoglobulin G subclass responses in different phases of hepatitis e virus infection. Journal of Medical Virology 85(5): 828-832

Kaushik, K.; Khurana, S.; Wanchu, A.; Malla, N. 2009: Serum immunoglobulin G, M and a response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients. Bmc Infectious Diseases 9: 179

Roy, R.R.; Roy, E.; Rahman, M.H.; Hossain, M.M. 2009: Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. World Journal of Pediatrics: Wjp 5(2): 127-131

Boonstra, K.; Culver, E.L.; de Buy Wenniger, L.M.; van Heerde, M.J.; van Erpecum, K.J.; Poen, A.C.; van Nieuwkerk, K.M.J.; Spanier, B.W.M.; Witteman, B.J.M.; Tuynman, H.A.R.E.; van Geloven, N.; van Buuren, H.; Chapman, R.W.; Barnes, E.; Beuers, U.; Ponsioen, C.Y. 2014: Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59(5): 1954-1963

Kaji, R.; Takedatsu, H.; Okabe, Y.; Ishida, Y.; Sugiyama, G.; Yonemoto, K.; Mitsuyama, K.; Tsuruta, O.; Sata, M. 2012: Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients. Journal of Gastroenterology and Hepatology 27(2): 268-272

Ngwa, T.N.; Law, R.; Murray, D.; Chari, S.T. 2014: Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 43(5): 704-707

Rastawicki, W.; Rokosz-Chudziak, N.; Wolaniuk, N. 2014: Serum immunoglobulin IgG subclass distribution of antibody responses to Francisella tularensis in patients with tularemia. Medycyna Doswiadczalna i Mikrobiologia 66(1): 11-15

Rastawicki, W.; Jakubczak, A. 2007: Serum immunoglobulin IgG subclass distribution of antibody responses to Yop proteins and lipopolysaccharide of Yersinia enterocolitica in patients with yersiniosis. Polish Journal of Microbiology 56(4): 233-238

Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough. Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274

Song, K.; Du, H.; Zhang, Q.; Wang, C.; Guo, Y.; Wu, H.; Liu, L.; Jia, Q.; Wang, X.; Shi, H.; Sun, S.; Niu, K. 2014: Serum immunoglobulin M concentration is positively related to metabolic syndrome in an adult population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study. Plos one 9(2): E88701

Tomita, K.; Teratani, T.; Yokoyama, H.; Suzuki, T.; Irie, R.; Ebinuma, H.; Saito, H.; Hokari, R.; Miura, S.; Hibi, T. 2011: Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. Digestive Diseases and Sciences 56(12): 3648-3654

Olson, S.H.; Hsu, M.; Wiemels, J.L.; Bracci, P.M.; Zhou, M.; Patoka, J.; Reisacher, W.R.; Wang, J.; Kurtz, R.C.; Silverman, D.T.; Stolzenberg-Solomon, R.Z. 2014: Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(7): 1414-1420

Mittal, R.R.; Chopra, A.; Kaur, K. 1996: Serum immunoglobulin estimation in 30 cases of cutaneous vasculitis. Indian Journal of Dermatology Venereology and Leprology 62(6): 359-360

Wang, C.; Su, W.; Zhang, W.; Di, Q.; Duan, M.-H.; Ji, W.; Cao, X.-X.; Zhou, D.-B.; Li, J. 2014: Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Annals of Hematology 93(7): 1201-1206

Leleu, X.; Moreau, A-Sophie.; Weller, E.; Roccaro, A.M.; Coiteux, VéRie.; Manning, R.; Nelson, M.; Leduc, R.; Robu, D.; Dupire, S.; Hatjiharissi, E.; Burwick, N.; Darre, Séphane.; Hennache, B.; Treon, S.P.; Facon, T.; Gertz, M.A.; Ghobrial, I.M. 2008: Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia. Leukemia and Lymphoma 49(6): 1104-1107

Knipping, K.; Colson, D.; Soulaines, P.; Redegeld, F.; Garssen, J.; Dupont, C. 2014: Serum immunoglobulin free light chain levels are higher in girls than boys during eosinophilic oesophagitis. Acta Paediatrica 103(7): 766-774

Stankowski-Drengler, T.; Gertz, M.A.; Katzmann, J.A.; Lacy, M.Q.; Kumar, S.; Leung, N.; Hayman, S.R.; Buadi, F.; Kyle, R.A.; Rajkumar, S.V.; Dispenzieri, A. 2010: Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. American Journal of Hematology 85(6): 431-434

Lubimova, N.V.; Turko, T.A.; Votyakova, O.M.; Kushlinskii, N.E. 2012: Serum immunoglobulin free light chains in patients with monoclonal gammapathies. Bulletin of Experimental Biology and Medicine 153(2): 249-254

Kayserova, J.; Capkova, S.; Skalicka, A.; Vernerova, E.; Polouckova, A.; Malinova, V.; Bartunkova, J.; Sediva, A. 2010: Serum immunoglobulin free light chains in severe forms of atopic dermatitis. Scandinavian Journal of Immunology 71(4): 312-316

Kumar, S.; Dispenzieri, A.; Katzmann, J.A.; Larson, D.R.; Colby, C.L.; Lacy, M.Q.; Hayman, S.R.; Buadi, F.K.; Leung, N.; Zeldenrust, S.R.; Ramirez-Alvarado, M.; Clark, R.J.; Kyle, R.A.; Rajkumar, S.V.; Gertz, M.A. 2010: Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features. Blood 116(24): 5126-5129

Besada, E.; Koldingsnes, W.; Nossent, J.C. 2014: Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis. Rheumatology 53(10): 1818-1824

Baris, S.; Karakoc-Aydiner, E.; Ozen, A.; Ozdemir, C.; Bahceciler, N.N.; Barlan, I.B. 2011: Serum immunoglobulin levels as a predictive factor for a better outcome of non-atopic childhood asthma. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 22(3): 298-304

Shvidel, L.; Tadmor, T.; Braester, A.; Bairey, O.; Rahimi-Levene, N.; Herishanu, Y.; Klepfish, A.; Ruchlemer, R.; Berrebi, A.; Polliack, A. 2014: Serum immunoglobulin levels at diagnosis have no prognostic significance in stage a chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group. European Journal of Haematology 93(1): 29-33

Kiani-Amin, M.; Daneshi, M.; Ayazi, P.; Mohammadian, S.; Rezaei, N. 2011: Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia. Iranian Journal of Pediatrics 21(1): 95-98

Awartani, F. 2010: Serum immunoglobulin levels in type 2 diabetes patients with chronic periodontitis. Journal of Contemporary Dental Practice 11(3): 001-008

McPherson, S.; Henderson, E.; Burt, A.D.; Day, C.P.; Anstee, Q.M. 2014: Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology 60(5): 1055-1062

Martinović, J.; Trifković, M.; Dotlić, R.; Stosić, V. 1989: Serum immunoglobulin values in children with altered spirometric values. Srpski Arhiv Za Celokupno Lekarstvo 117(9-10): 623-631

Biocina-Lukenda, D.; Cekić-Arambasin, A.; Markeljević, J.; Buković, D. 2008: Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber. Collegium Antropologicum 32(1): 161-163

Furst, D.E. 2009: Serum immunoglobulins and risk of infection: how low can you go?. Seminars in Arthritis and Rheumatism 39(1): 18-29

Rao, I.V.; Gopinath, P.S.; Jayasimha, N.; Rama Rao, B.S.; Subbakrishna, D.K. 1985: Serum immunoglobulins and schizophrenia. Indian Journal of Psychiatry 27(4): 325-328

Bertoli, L.F.; Pappas, D.G.; Barton, J.C.; Barton, J.C. 2014: Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3. Bmc Immunology 15: 43

Planinc-Peraica, A.; Kolonić, S.O.ć; Radić-Kristo, D.; Dominis, M.; Jaksić, B. 2010: Serum immunoglobulins in non-Hodgkin's lymphoma patients. Collegium Antropologicum 34(2): 407-411

Sadeghian, M.H.; Keramati, M.R.; Ayatollahi, H.; Manavifar, L.; Enaiati, H.; Mahmoudi, M. 2010: Serum immunoglobulins in patients with iron deficiency anemia. Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 26(2): 45-48

De la Torre, M.C.; Bolíbar, I.; Vendrell, M.; de Gracia, J.; Vendrell, E.; Rodrigo, M.J.é; Boquet, X.; Torrebadella, P.; Yébenes, J.-C.; Serra-Prat, M.; Rello, J.; Torres, A.; Almirall, J. 2013: Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia. Respiratory Medicine 107(12): 2038-2045

Shamji, M.H.; James, L.K.; Durham, S.R. 2011: Serum immunologic markers for monitoring allergen-specific immunotherapy. Immunology and Allergy Clinics of North America 31(2): 311

Zhou, S.-F.; Mo, F.-R.; Bin, Y.-H.; Hou, G.-Q.; Xie, X.-X.; Luo, G.-R. 2011: Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma. Clinical Biochemistry 44(4): 331-336

Toiyama, Y.; Miki, C.; Inoue, Y.; Okugawa, Y.; Koike, Y.; Watanabe, H.; Yokoe, T.; Hiro, J.; Ojima, E.; Tanaka, K.; Kusunoki, M. 2008: Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition. Journal of Surgical Oncology 97(5): 404-408

Anonymous 1926: Serum in the Treatment of Acute Poliomyelitis. Canadian Medical Association Journal 16(1): 75-76

Lazzeri, M.; Briganti, A.; Scattoni, V.; Lughezzani, G.; Larcher, A.; Gadda, G.M.; Lista, G.; Cestari, A.; Buffi, N.òm.; Bini, V.; Freschi, M.; Rigatti, P.; Montorsi, F.; Guazzoni, G. 2012: Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy. Journal of Urology 188(4): 1137-1143

Mo, X.; Pi, L.; Yang, J.; Xiang, Z.; Tang, A. 2014: Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 21(3): 482-486

Umino, D.; Ohtomo, Y.; Hara, S.; Someya, T.; Fujinaga, S.; Shimizu, T. 2010: Serum indoxyl sulfate as an early marker for detecting chronic cyclosporine nephrotoxicity. Pediatrics International: Official Journal of the Japan Pediatric Society 52(2): 257-261

Namba, S.; Okuda, Y.; Morimoto, A.; Kojima, T.; Morita, T. 2010: Serum indoxyl sulfate is a useful predictor for progression of chronic kidney disease. Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 448-453

Barreto, F.C.; Barreto, D.V.; Liabeuf, S.; Meert, N.; Glorieux, G.; Temmar, M.; Choukroun, G.; Vanholder, R.; Massy, Z.A. 2009: Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clinical Journal of the American Society of Nephrology: Cjasn 4(10): 1551-1558

Atoh, K.; Itoh, H.; Haneda, M. 2009: Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function. Diabetes Research and Clinical Practice 83(2): 220-226

Kimura, T.; Takatsuki, S.; Inagawa, K.; Katsumata, Y.; Nishiyama, T.; Nishiyama, N.; Fukumoto, K.; Aizawa, Y.; Tanimoto, Y.; Tanimoto, K.; Fukuda, K. 2014: Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation. Heart Lung and Circulation 23(7): 636-643

Moohebati, M.; Falsoleiman, H.; Dehghani, M.; Fazlinezhad, A.; Daloee, M.H.; Esmaeili, H.; Parizadeh, S.M.R.; Tavallaie, S.; Rahsepar, A.A.; Paydar, R.; Kazemi-Bajestani, S.M.R.; Pourghadam-Yari, H.; Rad, M.A.; Zoghdar-Moghadam, T.; Ghayour-Mobarhan, M.; Ferns, G.A. 2011: Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention. Angiology 62(2): 184-190

Dufek, M.; Hamanová, M.; Lokaj, J.; Goldemund, D.; Rektorová, I.; Michálková, Z.; Sheardová, K.; Rektor, I. 2009: Serum inflammatory biomarkers in Parkinson's disease. Parkinsonism and Related Disorders 15(4): 318-320

Duan, G.; Yang, H.; Shi, L.; Sun, W.; Sui, M.; Zhang, R.; Wang, X.; Wang, F.; Zhang, W.; Xi, Y.; Fan, Q. 2014: Serum inflammatory cytokine levels correlate with hand-foot-mouth disease severity: a nested serial case-control study. Plos one 9(11): E112676

Koleva-Georgieva, D.N.; Sivkova, N.P.; Terzieva, D. 2011: Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Medica 53(2): 44-50

Tajfard, M.; Latiff, L.A.; Rahimi, H.R.; Mouhebati, M.; Esmaeily, H.; Taghipour, A.; Mahdipour, E.; Davari, H.; Saghiri, Z.; Hanachi, P.; Ghayour Mobarhan, M.; Ferns, G.A.; Azizian, M. 2014: Serum inflammatory cytokines and depression in coronary artery disease. Iranian Red Crescent Medical Journal 16(7): E17111

Barak, V.; Selmi, C.; Schlesinger, M.; Blank, M.; Agmon-Levin, N.; Kalickman, I.; Gershwin, M.E.; Shoenfeld, Y. 2009: Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. Journal of Autoimmunity 33(3-4): 178-182

Yang, F.; Dou, H.-L.; Ma, Z.; Li, Y.-L.; Lu, X.-R.; Wang, X.; He, P.-P. 2010: Serum inflammatory factors in patients with idiopathic choroidal neovascularization. Ocular Immunology and Inflammation 18(5): 390-394

Qureshi, A.I. 2008: Serum inflammatory markers after postcardiac arrest resuscitation: surrogate markers of efficacy, therapeutic targets, or innocent bystanders. Critical Care Medicine 36(9): 2698-2699

Du, M.; Basu, A.; Fu, D.; Wu, M.; Centola, M.; Jenkins, A.J.; Hanssen, K.F.; Garg, S.K.; Hammad, S.M.; Scardo, J.A.; Aston, C.E.; Lyons, T.J. 2013: Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care 36(7): 2054-2061

Ananthakrishnan, A.N.; Cheng, S.-C.; Cai, T.; Cagan, A.; Gainer, V.S.; Szolovits, P.; Shaw, S.Y.; Churchill, S.; Karlson, E.W.; Murphy, S.N.; Kohane, I.; Liao, K.P. 2014: Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 12(8): 1342-8.E1

Liu, J.Z.; Saleh, A.; Klika, A.K.; Barsoum, W.K.; Higuera, C.A. 2014: Serum inflammatory markers for periprosthetic knee infection in obese versus non-obese patients. Journal of Arthroplasty 29(10): 1880-1883

Nadeem, R.; Molnar, J.; Madbouly, E.M.; Nida, M.; Aggarwal, S.; Sajid, H.; Naseem, J.; Loomba, R. 2013: Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 9(10): 1003-1012

Neuman, G.; Sagi, R.; Shalitin, S.; Reif, S. 2010: Serum inflammatory markers in overweight children and adolescents with non-alcoholic fatty liver disease. Israel Medical Association Journal: Imaj 12(7): 410-415

Talebi-Taher, M.; Babazadeh, S.; Barati, M.; Latifnia, M. 2014: Serum inflammatory markers in the elderly: are they useful in differentiating sepsis from SIRS?. Acta Medica Iranica 52(6): 438-442

Soloski, M.J.; Crowder, L.A.; Lahey, L.J.; Wagner, C.A.; Robinson, W.H.; Aucott, J.N. 2014: Serum inflammatory mediators as markers of human Lyme disease activity. Plos one 9(4): E93243

Michalowicz, B.S.; Novak, M.John.; Hodges, J.S.; DiAngelis, A.; Buchanan, W.; Papapanou, P.N.; Mitchell, D.A.; Ferguson, J.E.; Lupo, V.; Bofill, J.; Matseoane, S.; Steffen, M.; Ebersole, J.L. 2009: Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes. Journal of Periodontology 80(11): 1731-1741

Becker, A.M.; Das, S.; Xia, Z.; Liu, Z.; Adam, B.-L.; Kountakis, S.E. 2008: Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis. American Journal of Rhinology 22(2): 139-143

Hoshi, T.; Yamagami, H.; Furukado, S.; Miwa, K.; Tanaka, M.; Sakaguchi, M.; Sakoda, S.; Kitagawa, K. 2010: Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors. European Journal of Neurology 17(9): 1134-1140

Hämäläinen, A.; Sipponen, T.; Kolho, K.-L. 2013: Serum infliximab concentrations in pediatric inflammatory bowel disease. Scandinavian Journal of Gastroenterology 48(1): 35-41

Dannepond, C.; Maruani, A.; Machet, L.; Ternant, D.; Paintaud, G.; Samimi, M. 2015: Serum infliximab concentrations in psoriatic patients treated with infliximab: a systematic review. Acta Dermato-Venereologica 95(4): 401-406

Zeghimi, A.; Novell, A.; Thépault, R.-A.; Vourc'h, P.; Bouakaz, A.; Escoffre, J.-M. 2014: Serum influence on in-vitro gene delivery using microbubble-assisted ultrasound. Journal of Drug Targeting 22(8): 748-760

Kruczek, C.; Qaisar, U.; Colmer-Hamood, J.A.; Hamood, A.N. 2014: Serum influences the expression of Pseudomonas aeruginosa quorum-sensing genes and QS-controlled virulence genes during early and late stages of growth. Microbiologyopen 3(1): 64-79

Sibai, B.M.; Koch, M.A.; Freire, S.; Pinto e Silva, J.L.; Rudge, M.V.C.; Martins-Costa, S.ér.; Bartz, J.; de Barros Santos, C.; Cecatti, J.G.; Costa, R.; Ramos, J.é G.; Spinnato, J.A. 2008: Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?. American Journal of Obstetrics and Gynecology 199(3): 268.E1-9

Walentowicz, P.; Krintus, M.; Sadlecki, P.; Grabiec, M.; Mankowska-Cyl, A.; Sokup, A.; Walentowicz-Sadlecka, M. 2014: Serum inhibin a and inhibin B levels in epithelial ovarian cancer patients. Plos one 9(3): E90575

Segal, S.; Elmadjian, M.; Takeshige, T.; Karp, S.; Mercado, R.; Rivnay, B. 2010: Serum inhibin a concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reproductive Biomedicine Online 20(5): 675-680

Paiwattananupant, K.; Phupong, V. 2008: Serum inhibin A level in preeclampsia and normotensive pregnancy. Hypertension in Pregnancy 27(4): 337-343

Goulis, D.G.; Tsametis, C.; Iliadou, P.K.; Polychronou, P.; Kantartzi, P.-D.; Tarlatzis, B.C.; Bontis, I.N.; Papadimas, I. 2009: Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoospermia. Fertility and Sterility 91(4): 1279-1284

Manzoor, S.M.; Sattar, A.; Hashim, R.; Khan, F.A.; Younas, M.; Ali, A.; Dilawar, M.; Ijaz, A. 2012: Serum inhibin B as a diagnostic marker of male infertility. Journal of Ayub Medical College Abbottabad: Jamc 24(3-4): 113-116

Nowroozi, M.-R.; Radkhah, K.; Ayati, M.; Jamshidian, H.; Ranjbaran, A.; Jabalameli, P. 2008: Serum inhibin B concentration as a prognostic factor for prediction of sperm retrieval in testis biopsy of patients with azoospermia. Archives of Iranian Medicine 11(1): 54-56

Belva, F.; Bonduelle, M.; Painter, R.C.; Schiettecatte, J.; Devroey, P.; De Schepper, J. 2010: Serum inhibin B concentrations in pubertal boys conceived by ICSI: first results. Human Reproduction 25(11): 2811-2814

Decanter, C.; Pigny, P.; Lefebvre, C.; Thomas, P.; Leroy, M.; Dewailly, D. 2009: Serum inhibin B during controlled ovarian hyperstimulation: an additional criterion for deciding whether to proceed with egg retrieval. Fertility and Sterility 91(6): 2419-2425

Cetković, A. 2008: Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction. Srpski Arhiv Za Celokupno Lekarstvo 136(7-8): 379-383

Cavarzere, P.; Sulpasso, M.; Maines, E.; Vincenzi, M.; Gaudino, R.; Monti, E.; Chironi, C.; Tatò, L.; Antoniazzi, F. 2011: Serum inhibin B levels before and after varicocelectomy in early adolescence. Journal of Endocrinological Investigation 34(9): E265-E267

Hofland, J.; Feelders, R.A.; van der Wal, R.; Kerstens, M.N.; Haak, H.R.; de Herder, W.W.; de Jong, F.H. 2012: Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas. European Journal of Endocrinology 166(2): 281-289

Lackner, J.E.; Maerk, I.; Koller, A.; Bieglmayer, C.; Marberger, M.; Kratzik, C.; Schatzl, G. 2008: Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?. Urology 72(5): 1121-1124

Goulis, D.G.; Polychronou, P.; Mikos, T.; Grimbizis, G.; Gerou, S.; Pavlidou, V.; Papanikolaou, A.; Tarlatzis, B.C.; Bontis, I.N.; Papadimas, I. 2008: Serum inhibin-B and follicle stimulating hormone as predictors of the presence of sperm in testicular fine needle aspirate in men with azoospermia. Hormones 7(2): 140-147

Jørgensen, N.; Liu, F.; Andersson, A.-M.; Vierula, M.; Irvine, D.S.; Auger, J.; Brazil, C.K.; Drobnis, E.Z.; Jensen, T.K.; Jouannet, P.; Overstreet, J.W.; Redmon, J.B.; Sparks, A.; Toppari, J.; Wang, C.; Skakkebæk, N.E.; Swan, S.H. 2010: Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men. Fertility and Sterility 94(6): 2128-2134

Barriere, S.L.; Farrell, D.J.; Rhomberg, P.R.; Jones, R.N. 2014: Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease. Diagnostic Microbiology and Infectious Disease 80(4): 327-329

Hammond, A.; Dertien, J.; Colmer-Hamood, J.A.; Griswold, J.A.; Hamood, A.N. 2010: Serum inhibits P. aeruginosa biofilm formation on plastic surfaces and intravenous catheters. Journal of Surgical Research 159(2): 735-746

Ihlo, C.A.; Aksglaede, K.B.; Laursen, T.; Lauritzen, T.; Christiansen, J.S. 2009: Serum insulin aspart concentrations following high-dose insulin aspart administered directly into the duodenum of healthy subjects: an open-labeled, single-blinded, and uncontrolled exploratory trial. Journal of Diabetes Science and Technology 3(5): 1183-1191

Kawada, T.; Inagaki, H.; Wakayama, Y.; Li, Q.; Katsumata, M. 2010: Serum insulin is significantly related to components of the metabolic syndrome in Japanese working men. Journal of Clinical Hypertension 12(4): 309-314

Owecki, M.; El Ali, Z.; Nikisch, E.; Sowiński, J. 2008: Serum insulin levels and the degree of thyroid dysfunction in hypothyroid women. Neuro Endocrinology Letters 29(1): 137-140

Nowakowska-Zajdel, E.; Muc-Wierzgoń, M.łg.; Kokot, T.; Romanowski, W.; Zubelewicz-Szkodzińska, B.; Brodziak, A.; Wiczkowski, A.; Strzelczyk, J.; Kozowicz, A. 2008: Serum insulin levels in patients with colorectal cancer. Polskie Archiwum Medycyny Wewnetrznej 118(5): 273-279

Colakoğlu, O.; Taşkiran, B.ür.; Colakoğlu, G.ül.; Kizildağ, S.; Ari Ozcan, F.; Unsal, B. 2007: Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis. Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology 18(4): 245-249

Bellar, D.; Glickman, E.L.; Juvancic-Heltzel, J.; Gunstad, J. 2011: Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults. Neuroscience 178: 133-137

Seneviratne, H.R.; Lankeshwara, D.; Wijeratne, S.; Somasunderam, N.; Athukorale, D. 2009: Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome. Bjog: An International Journal of Obstetrics and Gynaecology 116(13): 1722-1728

Cansu, A.; Serdaroglu, A.; Camurdan, O.; Hırfanoğlu, T.; Cinaz, P. 2011: Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate. Hormone Research in Paediatrics 76(1): 65-71

Albanes, D.; Weinstein, S.J.; Wright, M.E.; Männistö, S.; Limburg, P.J.; Snyder, K.; Virtamo, J. 2009: Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. Journal of the National Cancer Institute 101(18): 1272-1279

Rollison, D.E.; Giuliano, A.R.; Risendal, B.C.; Sweeney, C.; Boulware, D.; Laronga, C.; Baumgartner, K.B.; Byers, T.; Slattery, M.L. 2010: Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Research and Treatment 121(3): 661-669

Serin, I.Serdar.; Tanriverdi, F.; Yilmaz, M.Oguz.; Ozcelik, B.; Unluhizarci, K. 2008: Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(3): 117-121

Morgillo, F.; De Vita, F.; Antoniol, G.; Orditura, M.; Auriemma, P.P.; Diadema, M.R.; Lieto, E.; Savastano, B.; Festino, L.; Laterza, M.M.; Fabozzi, A.; Ventriglia, J.; Petrillo, A.; Ciardiello, F.; Barbarisi, A.; Iovino, F. 2013: Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Current Oncology 20(4): E283-E288

Lygren, T.; Hansen, S.; Langberg, H.; Fjeldborg, J.; Jacobsen, S.; Nielsen, M.O.; Schjerling, P.; Markussen, B.; Thomsen, P.D.; Berg, L.C. 2014: Serum insulin-like growth factor 1 in the aging horse. Veterinary Clinical Pathology 43(4): 557-560

Popovic, V.; Mattsson, A.F.; Gaillard, R.C.; Wilton, P.; Koltowska-Häggström, M.; Ranke, M.B. 2010: Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database). Journal of Clinical Endocrinology and Metabolism 95(9): 4449-4454

Spilcke-Liss, E.; Friedrich, N.; Dörr, M.; Schminke, U.; Völzke, H.; Brabant, G.; Nauck, M.; Wallaschofski, H. 2011: Serum insulin-like growth factor i and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP). Clinical Endocrinology 75(1): 70-75

Lu, S.; Purohit, S.; Sharma, A.; Zhi, W.; He, M.; Wang, Y.; Li, C.-J.; She, J.-X. 2012: Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications. International Journal of Clinical and Experimental Medicine 5(3): 229-237

Borai, A.; Livingstone, C.; Ghayour-Mobarhan, M.; Abuosa, A.; Shafi, S.; Mehta, S.; Heidari, A.; Emadzadeh, A.; Wark, G.; Ferns, G. 2010: Serum insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation status in subjects with and without ischaemic heart disease. Atherosclerosis 208(2): 593-598

Borai, A.; Livingstone, C.; Zarif, H.; Ferns, G. 2009: Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance. Annals of Clinical Biochemistry 46(Part 2): 109-113

Tuncel, D.; Inanc Tolun, F.; Toru, I. 2009: Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease. Mediators of Inflammation 2009: 132464

Hu, D.; Pawlikowska, L.; Kanaya, A.; Hsueh, W.-C.; Colbert, L.; Newman, A.B.; Satterfield, S.; Rosen, C.; Cummings, S.R.; Harris, T.B.; Ziv, E. 2009: Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study. Journal of the American Geriatrics Society 57(7): 1213-1218

Shao, Y.-Y.; Huang, C.-C.; Lin, S.-D.; Hsu, C.-H.; Cheng, A.-L. 2012: Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(14): 3992-3997

Guitelman, M.; Radczuk, G.; Basavilbaso, N.G.ía.; Oneto, A.; Basso, A. 2010: Serum insulin-like growth factor-1 measurement in the diagnosis and follow-up of patients with acromegaly: preliminary data. Frontiers of Hormone Research 38: 145-151

Tvarijonaviciute, A.; Tecles, F.; Carrillo, J.é M.; Carillo, J.é M.; Rubio, M.; Ceron, J.é J. 2011: Serum insulin-like growth factor-1 measurements in dogs: performance characteristics of an automated assay and study of some sources of variation. Canadian Journal of Veterinary Research 75(4): 312-316

Cho, E.; Kim, H.-C.; Lee, J.-H.; Jeong-Ju Yoo; Choi, W.-M.; Cho, Y.Y.; Lee, M.J.; Cho, Y.; Lee, D.H.; Lee, Y.B.; Yu, S.J.; Kim, Y.J.; Yoon, J.-H.; Chung, J.W.; Kim, C.Y.; Lee, H.-S. 2014: Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization. Plos one 9(3): E90862

Bedogni, G.; Giannone, G.; Maghnie, M.; Giacomozzi, C.; Di Iorgi, N.; Pedicelli, S.; Peschiaroli, E.; Melioli, G.; Muraca, M.; Cappa, M.; Cianfarani, S. 2012: Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 22(3-4): 134-138

Kurtoglu, S.; Ozturk, M.A.; Koklu, E.; Gunes, T.; Akcakus, M.; Hatipoglu, N. 2008: Serum insulin-like growth factor-i (IGF-I), IGF-binding protein-3, and growth hormone levels in collodion babies: a case-control study. Journal of Pediatric Endocrinology and Metabolism: Jpem 21(7): 689-694

Jakobsdóttir, S.; van Nieuwpoort, I.C.; Schaap, L.A.; van Schoor, N.M.; Lips, P.; Drent, M.L. 2010: Serum insulin-like growth factor-i and body composition in community dwelling older people. Clinical Endocrinology 73(2): 173-180

Cesur, Yşar.; Yordaman, N.; Doğan, M. 2009: Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with zinc deficiency and the effect of zinc supplementation on these parameters. Journal of Pediatric Endocrinology and Metabolism: Jpem 22(12): 1137-1143

Rogozina, O.P.; Bonorden, M.J.L.; Grande, J.P.; Cleary, M.P. 2009: Serum insulin-like growth factor-i and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice. Cancer Prevention Research 2(8): 712-719

Pasanisi, P.; Venturelli, E.; Morelli, D.; Fontana, L.; Secreto, G.; Berrino, F. 2008: Serum insulin-like growth factor-i and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(7): 1719-1722

Guha, N.; Erotokritou-Mulligan, I.; Burford, C.; Strobridge, G.; Brigg, J.; Drake, T.; Bassett, E.E.; Cowan, D.; Bartlett, C.; Sönksen, P.H.; Holt, R.I.G. 2010: Serum insulin-like growth factor-i and pro-collagen type IIi N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. Journal of Clinical Endocrinology and Metabolism 95(6): 2969-2976

Movérare-Skrtic, S.; Svensson, J.; Karlsson, M.K.; Orwoll, E.; Ljunggren, O.; Mellström, D.; Ohlsson, C. 2009: Serum insulin-like growth factor-i concentration is associated with leukocyte telomere length in a population-based cohort of elderly men. Journal of Clinical Endocrinology and Metabolism 94(12): 5078-5084

Payne, J.F.; Tangpricha, V.; Cleveland, J.; Lynn, M.J.; Ray, R.; Srivastava, S.K. 2011: Serum insulin-like growth factor-i in diabetic retinopathy. Molecular Vision 17: 2318-2324

Kanazawa, I.; Yamaguchi, T.; Sugimoto, T. 2011: Serum insulin-like growth factor-i is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 22(4): 1191-1198

Cho, E.J.; Lee, J.-H.; Yoo, J.-J.; Choi, W.-M.; Lee, M.J.; Cho, Y.; Lee, D.H.; Lee, Y.B.; Kwon, J.H.; Yu, S.J.; Lee, J.M.; Suh, K.-S.; Kim, K.; Kim, Y.J.; Yoon, J.-H.; Kim, C.Y.; Lee, H.-S. 2013: Serum insulin-like growth factor-i level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(15): 4218-4227

Kanazawa, I.; Yamaguchi, T.; Yamamoto, M.; Yamauchi, M.; Yano, S.; Sugimoto, T. 2007: Serum insulin-like growth factor-i level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 18(12): 1675-1681

Jitpean, S.; Holst, B.S.öm.; Höglund, O.V.; Pettersson, A.; Olsson, U.; Strage, E.; Södersten, F.; Hagman, R. 2014: Serum insulin-like growth factor-I, iron, C-reactive protein, and serum amyloid a for prediction of outcome in dogs with pyometra. Theriogenology 82(1): 43-48

De Kort, S.W.K.; van Doorn, J.; van de Sande, A.G.M.; Leunissen, R.W.J.; Hokken-Koelega, A.C.S. 2010: Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age. Journal of Clinical Endocrinology and Metabolism 95(2): 864-871

Kim, M.S.; Lee, D.-Y. 2014: Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism: Jpem 27(9-10): 857-861

Sakauchi, F.; Nojima, M.; Mori, M.; Wakai, K.; Suzuki, S.; Tamakoshi, A.; Ito, Y.; Watanabe, Y.; Inaba, Y.; Tajima, K.; Nakachi, K. 2009: Serum insulin-like growth factors i and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study. Asian Pacific Journal of Cancer Prevention: Apjcp 10 Suppl: 51-55

Saute, J.A.M.; da Silva, A.C.F.; Muller, A.P.; Hansel, G.; de Mello, A.S.; Maeda, F.áb.; Vedolin, L.; Saraiva-Pereira, M.L.; Souza, D.O.; Arpa, J.; Torres-Aleman, I.; Portela, L.V.C.; Jardim, L.B. 2011: Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3. Movement Disorders: Official Journal of the Movement Disorder Society 26(4): 731-735

Godau, J.; Knauel, K.; Weber, K.; Brockmann, K.; Maetzler, W.; Binder, G.; Berg, D. 2011: Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Archives of Neurology 68(7): 925-931

Dehghani, S.M.; Karamifar, H.; Hamzavi, S.S.; Haghighat, M.; Malek-Hosseini, S.A. 2012: Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 10(3): 252-257

Mirza, M.A.I.; Larsson, A.; Melhus, H.åk.; Lind, L.; Larsson, T.E. 2009: Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207(2): 546-551

Gnudi, L. 2008: Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(1): 24-26

Yano, Y.; Masaki, C.; Sugino, K.; Nagahama, M.; Kitagawa, W.; Sibuya, H.; Ito, K. 2012: Serum intact parathyroid hormone level after total thyroidectomy or total thyroidectomy plus lymph node dissection for thyroid nodules: report from 296 surgical cases. International Journal of Endocrinology and Metabolism 10(4): 594-598

Agapitou, V.; Dimopoulos, S.; Mpouchla, A.; Samartzis, L.; Tseliou, E.; Kaldara, E.; Terrovitis, J.; Tasoulis, A.; Karga, E.; Nanas, S. 2011: Serum intact parathyroid hormone levels independently predict exercise capacity in stable heart failure patients. International Journal of Cardiology 146(3): 462-464

Sugimoto, T.; Tanigawa, T.; Onishi, K.; Fujimoto, N.; Matsuda, A.; Nakamori, S.; Matsuoka, K.; Nakamura, T.; Koji, T.; Ito, M. 2009: Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 95(5): 395-398

Papavasiliou, K.A.; Nikopoulou, A.; Kenanidis, E.I.; Potoupnis, M.E.; Kyrkos, M.J.; Sayegh, F.E.; Kapetanos, G.A. 2012: Serum intact-parathyroid hormone level following total knee arthroplasty. Journal of Orthopaedic Surgery 20(1): 27-31

Posch, F.; Setinek, U.; Flores, R.M.; Bernhard, D.; Hannigan, G.E.; Mueller, M.R.; Watzka, S.B. 2014: Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 16(5): 455-462

Garantziotis, S.; Zudaire, E.; Trempus, C.S.; Hollingsworth, J.W.; Jiang, D.; Lancaster, L.H.; Richardson, E.; Zhuo, L.; Cuttitta, F.; Brown, K.K.; Noble, P.W.; Kimata, K.; Schwartz, D.A. 2008: Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury. American Journal of Respiratory and Critical Care Medicine 178(9): 939-947

Zhu, H.-H.; Jiang, L.-L. 2012: Serum inter-cellular adhesion molecule 1 is an early marker of diagnosis and prediction of severe acute pancreatitis. World Journal of Gastroenterology 18(20): 2554-2560

Liu, K.; Casey, J.; Pichichero, M. 2010: Serum intercellular adhesion molecule 1 variations in young children with acute otitis media. Clinical and Vaccine Immunology: Cvi 17(12): 1909-1916

Furuya, N.; Kamai, T.; Shirataki, H.; Yanai, Y.; Fukuda, T.; Mizuno, T.; Nakamura, F.; Kambara, T.; Nakanishi, K.; Abe, H.; Yoshida, K-Ichiro. 2011: Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunology Immunotherapy: Cii 60(6): 793-808

Utsal, L.; Tillmann, V.; Zilmer, M.; Mäestu, J.; Purge, P.; Saar, M.; Lätt, E.; Jürimäe, T.; Maasalu, K.; Jürimäe, J. 2014: Serum interferon gamma concentration is associated with bone mineral density in overweight boys. Journal of Endocrinological Investigation 37(2): 175-180

Abdallah, M.A.; Abdel-Hamid, M.F.; Kotb, A.M.; Mabrouk, E.A. 2009: Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis 84(3): 163-168

Matsuura, K.; Watanabe, T.; Iijima, S.; Murakami, S.; Fujiwara, K.; Orito, E.; Iio, E.; Endo, M.; Kusakabe, A.; Shinkai, N.; Miyaki, T.; Nojiri, S.; Joh, T.; Tanaka, Y. 2014: Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C. Hepatology Research: the Official Journal of the Japan Society of Hepatology 44(12): 1208-1216

Gong, Y.; Wei, S.-H.; Zhang, M.-N.; Jin, X.; Hou, B.-K.; Wang, D. 2010: Serum interferon-gamma/interleukin-4 imbalance in patients with Eales' disease. Clinical and Experimental Optometry 93(4): 228-232

Horai, Y.; Koga, T.; Fujikawa, K.; Takatani, A.; Nishino, A.; Nakashima, Y.; Suzuki, T.; Kawashiri, S.-y.; Iwamoto, N.; Ichinose, K.; Tamai, M.; Nakamura, H.; Ida, H.; Kakugawa, T.; Sakamoto, N.; Ishimatsu, Y.; Mukae, H.; Hamaguchi, Y.; Fujimoto, M.; Kuwana, M.; Origuchi, T.; Kohno, S.; Kawakami, A. 2015: Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis. Modern Rheumatology 25(1): 85-89

Umemura, T.; Joshita, S.; Yoneda, S.; Katsuyama, Y.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Ota, M.; Tanaka, E. 2011: Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C. Antiviral Therapy 16(7): 1073-1080

Brodacki, B.; Staszewski, J.; Toczyłowska, B.; Kozłowska, E.; Drela, N.; Chalimoniuk, M.łg.; Stepien, A. 2008: Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neuroscience Letters 441(2): 158-162

Sahin, A.; Calhan, T.; Cengiz, M.; Kahraman, R.; Aydin, K.; Ozdil, K.; Korachi, M.; Sokmen, H.M. 2014: Serum interleukin 17 levels in patients with Crohn's disease: real life data. Disease Markers 2014: 690853

Yang, D.-x.; Li, N.; Zhang, X.-l.; Wang, Q. 2012: Serum interleukin 18 and 33 levels and its clinical significance in asthma patients. Zhonghua Jie he He Hu Xi Za Zhi 35(7): 493-496

Shimizu, M.; Nakagishi, Y.; Yoshida, A.; Yachie, A. 2014: Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis. Journal of Rheumatology 41(11): 2328-2330

Groblewska, M.; Mroczko, B.; Wereszczyńska-Siemiatkowska, U.; Kedra, B.ła.; Lukaszewicz, M.; Baniukiewicz, A.; Szmitkowski, M. 2008: Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clinical Chemistry and Laboratory Medicine 46(10): 1423-1428

Chowdhury, I.H.; Choudhuri, S.; Sen, A.; Bhattacharya, B.; Ahmed, A.M.; Hazra, A.; Pal, N.K.; Bahar, B. 2015: Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy. Molecular Immunology 63(2): 601-602

Shimamoto, K.; Ito, T.; Ozaki, Y.; Amuro, H.; Tanaka, A.; Nishizawa, T.; Son, Y.; Inaba, M.; Nomura, S. 2013: Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. Journal of Rheumatology 40(7): 1074-1081

De Lauretis, A.; Sestini, P.; Pantelidis, P.; Hoyles, R.; Hansell, D.M.; Goh, N.S.L.; Zappala, C.J.; Visca, D.; Maher, T.M.; Denton, C.P.; Ong, V.H.; Abraham, D.J.; Kelleher, P.; Hector, L.; Wells, A.U.; Renzoni, E.A. 2013: Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. Journal of Rheumatology 40(4): 435-446

Kalambokis, G.N.; Mouzaki, A.; Rodi, M.; Pappas, K.; Korantzopoulos, P.; Tsianos, E.V. 2011: Serum interleukin 6 levels and cirrhosis-associated pulmonary hypertension. Angiology 62(4): 344-345

Nara, M.; Komatsuda, A.; Omokawa, A.; Togashi, M.; Okuyama, S.; Sawada, K.-I.; Wakui, H. 2014: Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Modern Rheumatology 24(4): 633-636

Mikłaszewska, M.; Korohoda, P.ła.; Zachwieja, K.; Mroczek, T.; Drożdż, D.; Sztefko, K.; Moczulska, A.; Pietrzyk, J.A. 2013: Serum interleukin 6 levels as an early marker of acute kidney injury on children after cardiac surgery. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 22(3): 377-386

Boskabadi, H.; Maamouri, G.; Afshari, J.T.; Ghayour-Mobarhan, M.; Shakeri, M.-T. 2010: Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis. Iranian Journal of Pediatrics 20(1): 41-47

Ciprandi, G. 2010: Serum interleukin 9 in allergic rhinitis. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 104(2): 180-181

Yanaba, K.; Yoshizaki, A.; Asano, Y.; Kadono, T.; Sato, S. 2011: Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. Journal of Rheumatology 38(10): 2193-2197

Semeniuk, J.; Wasilewska, J.; Kaczmarski, M. 2012: Serum interleukin--4 and tumor necrosis factor alpha concentrations in children with primary acid gastroesophageal reflux and acid gastroesophageal reflux secondary to cow's milk allergy. Advances in Medical Sciences 57(2): 273-281

Morteza, A.; Nakhjavani, M.; Ghadiri-Anari, A.; Esteghamati, A.; Khalilzadeh, O. 2011: Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes. European Cytokine Network 22(2): 107-112

Gounaris, A.; Zagouri, F.; Sergentanis, T.N.; Provatopoulou, X.; Kalogera, E.; Zografos, G.C. 2007: Serum interleukin-1 in mastalgia. Pain Practice: the Official Journal of World Institute of Pain 7(4): 372

Liu, J.; Jia, Y.; Li, X.; Xu, R.; Zhu, C.; Guo, Y.; Wu, N.; Li, J. 2014: Serum interleukin-10 levels and adverse events in patients with acute coronary syndrome: a systematic review and meta-analysis. Chinese Medical Journal 127(1): 150-156

Ameglio, F.; Alvino, S.; Trento, E.; Marcucci, M.; Pimpinelli, F.; Tong, A.; Gandolfo, G.; Greco, C. 1995: Serum interleukin-10 levels in patients affected with multiple-myeloma - correlation with the monoclonal component and disease progression. International Journal of Oncology 6(6): 1189-1192

Tung, K.-H.; Huang, Y.-S.; Yang, K.-C.; Perng, C.-L.; Lin, H.-C.; Lee, S.-D. 2010: Serum interleukin-12 levels in alcoholic liver disease. Journal of the Chinese Medical Association: Jcma 73(2): 67-71

Quaglino, P.; Caproni, M.; Osella-Abate, S.; Torchia, D.; Comessatti, A.; Del Bianco, E.; Antiga, E.; Frezzolini, A.; Schena, D.; Marzano, A.; De Simone, C.; Parodi, A.; Fabbri, P.; Bernengo, M.G. 2008: Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme. British Journal of Dermatology 158(1): 184-186

Ueda, T. 2008: Serum interleukin-15 level in patients with severe acute pancreatitis. Surgery 143(5): 695-696

Sun, J.-M.; Sun, L.-Z.; Liu, J.; Su, B.-h.; Shi, L. 2013: Serum interleukin-15 levels are associated with severity of pain in patients with knee osteoarthritis. Disease Markers 35(3): 203-206

Martínez-Hernández, P.L.; Hernanz-Macías, Án.; Gómez-Candela, C.; Grande-Aragón, C.; Feliu-Batlle, J.; Castro-Carpeño, J.; Martínez-Muñoz, I.; Zurita-Rosa, L.; Villarino-Sanz, M.; Prados-Sánchez, C.ón.; Sánchez García-Girón, J.ín. 2012: Serum interleukin-15 levels in cancer patients with cachexia. Oncology Reports 28(4): 1443-1452

Mysliwiec, J.; Palyga, I.; Nikolajuk, A.; Kowalska, A.; Gorska, M. 2012: Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy. Endokrynologia Polska 63(2): 92-96

Miletic, M.; Stojanovic, R.; Pajic, O.; Bugarski, D.; Mojsilovic, S.; Cokic, V.; Milenkovic, P. 2012: Serum interleukin-17 and nitric oxide levels in patients with primary Sjögren's syndrome. Indian Journal of Medical Research 135(4): 513-519

Xu, C.; Hao, K.; Yu, L.; Zhang, X. 2014: Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 19(4): 287-290

Ciprandi, G.; De Amici, M.; Murdaca, G.; Fenoglio, D.; Ricciardolo, F.; Marseglia, G.; Tosca, M. 2009: Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64(9): 1375-1378

Lin, C-Yu.; Chang, C-Hsiang.; Fan, P-Chun.; Tian, Y-Chung.; Chang, M-Yang.; Jenq, C-Chyi.; Hung, C-Chieh.; Fang, J-Tseng.; Yang, C-Wei.; Chen, Y-Chang. 2013: Serum interleukin-18 at commencement of renal replacement therapy predicts short-term prognosis in critically ill patients with acute kidney injury. Plos one 8(5): E66028

Fujita, T.; Shimizu, C.; Fuke, Y.; Satomura, A.; Abe, M.; Kaizu, K.; Matsumoto, K.; Soma, M. 2011: Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Diabetes Research and Clinical Practice 92(3): E66-E69

Hossny, E.M.; El-Sayed, S.S.; El-Hadidi, E.S.; Moussa, S.R. 2009: Serum interleukin-18 expression in children with bronchial asthma. World Allergy Organization Journal 2(5): 63-68

Tedeschi, A.; Lorini, M.; Suli, C.; Asero, R. 2007: Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clinical and Experimental Dermatology 32(5): 568-570

Matveeva, L.V.; Mosina, L.M. 2013: Serum interleukin-18 level in precancerous conditions and gastric cancer. Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 21-24

Oda, K.; Miyatake, N.; Sakano, N.; Saito, T.; Miyachi, M.; Tabata, I.; Numata, T. 2013: Serum interleukin-18 levels are associated with physical activity in Japanese men. Plos one 8(12): E81497

Dong, G.; Liang, L.; Fu, J.; Zou, C. 2007: Serum interleukin-18 levels are raised in diabetic ketoacidosis in Chinese children with type 1 diabetes mellitus. Indian Pediatrics 44(10): 732-736

Mohran, Z.Y.; Ali-Eldin, F.A.; Abdel Aal, H.A. 2011: Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?. Arab Journal of Gastroenterology: the Official Publication of the Pan-Arab Association of Gastroenterology 12(1): 29-33

Mahyar, A.; Ayazi, P.; Orangpour, R.; Daneshi-Kohan, M.M.; Sarokhani, M.R.; Javadi, A.; Habibi, M.; Talebi-Bakhshayesh, M. 2014: Serum interleukin-1beta and tumor necrosis factor-alpha in febrile seizures: is there a link?. Korean Journal of Pediatrics 57(10): 440-444

Mahajan, B.; Vijayan, V.Kandi.; Agarwal, M.Kumar.; Bansal, S.Kumar. 2008: Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 13(7): 713-727

Daponte, A.; Pournaras, S.; Deligeoroglou, E.; Skentou, H.; Messinis, I.E. 2012: Serum interleukin-1β, interleukin-8 and anti-heat shock 60 Chlamydia trachomatis antibodies as markers of ectopic pregnancy. Journal of Reproductive Immunology 93(2): 102-108

Ruggeri, R.M.; Minciullo, P.; Saitta, S.; Giovinazzo, S.; Certo, R.; Campennì, A.; Trimarchi, F.; Gangemi, S.; Benvenga, S. 2014: Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones 13(3): 338-344

Shimauchi, T.; Hirakawa, S.; Suzuki, T.; Yasuma, A.; Majima, Y.; Tatsuno, K.; Yagi, H.; Ito, T.; Tokura, Y. 2013: Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis. Journal of Dermatology 40(10): 805-812

Ruggeri, R.M.; Saitta, S.; Cristani, M.; Giovinazzo, S.; Tigano, V.; Trimarchi, F.; Benvenga, S.; Gangemi, S. 2014: Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis. Endocrine Journal 61(4): 359-363

Mohammadi, M.; Hayatbakhsh, M.M.; Zahedi, M.J.; Jalalpour, M.R.; Pakgohar, A. 2011: Serum interleukin-23 levels in patients with ulcerative colitis. Iranian Journal of Immunology: Iji 8(3): 183-188

Miyagaki, T.; Sugaya, M.; Shibata, S.; Ohmatsu, H.; Fujita, H.; Tamaki, K. 2010: Serum interleukin-27 levels in patients with cutaneous T-cell lymphoma. Clinical and Experimental Dermatology 35(4): E143-E144

Li, C.; Ji, H.; Cai, Y.; Ayana, D.A.; Lv, P.; Liu, M.; Jiang, Y. 2013: Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 33(10): 612-618

Taki, H.; Shinoda, K.; Hounoki, H.; Ogawa, R.; Ishizawa, S.; Sugiyama, E.; Tobe, K. 2010: Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid. Scandinavian Journal of Rheumatology 39(4): 341-343

Burton, A.B.; Wagner, B.; Erb, H.N.; Ainsworth, D.M. 2009: Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals. Veterinary Immunology and Immunopathology 132(2-4): 122-128

Ikeguchi, M.; Hatada, T.; Yamamoto, M.; Miyake, T.; Matsunaga, T.; Fukumoto, Y.; Yamada, Y.; Fukuda, K.; Saito, H.; Tatebe, S. 2009: Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 12(2): 95-100

Matsumoto, M.; Tsujino, T.; Lee-Kawabata, M.; Naito, Y.; Sakoda, T.; Ohyanagi, M.; Masuyama, T. 2010: Serum interleukin-6 and C-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction. Cytokine 49(3): 264-268

Liu, K.D.; Altmann, C.; Smits, G.; Krawczeski, C.D.; Edelstein, C.L.; Devarajan, P.; Faubel, S. 2009: Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Critical Care 13(4): R104

Villacis, D.; Merriman, J.A.; Yalamanchili, R.; Omid, R.; Itamura, J.; Rick Hatch, G.F. 2014: Serum interleukin-6 as a marker of periprosthetic shoulder infection. Journal of Bone and Joint Surgery. American Volume 96(1): 41-45

Hoejberg, L.; Bastholt, L.; Johansen, J.S.; Christensen, I.J.; Gehl, J.; Schmidt, H. 2012: Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma. Melanoma Research 22(4): 287-293

Hudzik, B.; Szkodzinski, J.; Danikiewicz, A.; Romanowski, W.; Lekston, A.; Polonski, L.; Zubelewicz-Szkodzinska, B. 2010: Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. European Cytokine Network 21(2): 129-135

Hudzik, B.; Szkodzinski, J.; Romanowski, W.; Danikiewicz, A.; Wilczek, K.; Lekston, A.; Polonski, L.; Zubelewicz-Szkodzinska, B. 2011: Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease. Cytokine 54(3): 266-271

Yang, M.; Cen, X.; Xie, Q.; Zuo, C.; Shi, G.; Yin, G. 2013: Serum interleukin-6 expression level and its clinical significance in patients with dermatomyositis. Clinical and Developmental Immunology 2013: 717808

Tumminello, F.M.; Badalamenti, G.; Incorvaia, L.; Fulfaro, F.; D'Amico, C.; Leto, G. 2009: Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. Medical Oncology 26(1): 10-15

Yang, J.-J.; Wang, N.; Yang, C.; Shi, J.-Y.; Yu, H.-Y.; Hashimoto, K. 2015: Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. Biological Psychiatry 77(3): E19-E20

Liao, W-Chih.; Lin, J-Town.; Wu, C-Ying.; Huang, S-Pei.; Lin, M-Tsan.; Wu, A.Sing-Huei.; Huang, Y-Jie.; Wu, M-Shiang. 2008: Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(2): 428-434

Ohtsuka, T. 2010: Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis. Journal of Dermatology 37(9): 801-806

Ueyama, M.; Nakagawa, M.; Sakamoto, N.; Onozuka, I.; Funaoka, Y.; Watanabe, T.; Nitta, S.; Kiyohashi, K.; Kitazume, A.; Murakawa, M.; Nishimura-Sakurai, Y.; Sekine-Osajima, Y.; Itsui, Y.; Azuma, S.; Kakinuma, S.; Watanabe, M. 2011: Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin. Antiviral Therapy 16(7): 1081-1091

Knüpfer, H.; Preiss, R. 2010: Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. International Journal of Colorectal Disease 25(2): 135-140

Kovács, R.át.ó; Czudar, A.; Horváth, L.ás.ó; Szakács, L.; Majoros, L.ás.ó; Kónya, J.óz. 2014: Serum interleukin-6 levels in murine models of Candida albicans infection. Acta Microbiologica et Immunologica Hungarica 61(1): 61-69

Elango, T.; Dayalan, H.; Subramanian, S.; Gnanaraj, P.; Malligarjunan, H. 2012: Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients. Clinica Chimica Acta; International Journal of Clinical Chemistry 413(19-20): 1652-1656

Kuo, L.-T.; Yang, N.-I.; Cherng, W.-J.; Verma, S.; Hung, M.-J.; Wang, S.-Y.; Liu, M.-h.; Chen, S.-y.; Wang, C.-H. 2008: Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. International Heart Journal 49(4): 391-402

Passoja, A.; Knuuttila, M.; Hiltunen, L.; Karttunen, R.; Niemelä, O.; Raunio, T.; Vainio, O.; Hedberg, P.; Tervonen, T. 2011: Serum interleukin-6 may modulate periodontal inflammation in type 1 diabetic subjects. Journal of Clinical Periodontology 38(8): 687-693

Wang, X.S.; Shi, Q.; Williams, L.A.; Cleeland, C.S.; Mobley, G.M.; Reuben, J.M.; Lee, B.-N.; Giralt, S.A. 2008: Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 113(8): 2102-2109

Pulsatelli, L.; Boiardi, L.; Pignotti, E.; Dolzani, P.; Silvestri, T.; Macchioni, P.; Cantini, F.; Salvarani, C.; Facchini, A.; Meliconi, R. 2008: Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk. Arthritis and Rheumatism 59(8): 1147-1154

Mahmoud, M.A.; Ali, M.H.; Hassoba, H.M.; Elhadidy, G.S. 2010: Serum interleukin-8 and insulin like growth factor-1 in Egyptian bladder cancer patients. Cancer Biomarkers: Section a of Disease Markers 6(2): 105-110

Ohata, Y.; Harada, T.; Miyakoda, H.; Taniguchi, F.; Iwabe, T.; Terakawa, N. 2008: Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertility and Sterility 90(4): 994-999

Sanmamed, M.F.; Carranza-Rua, O.; Alfaro, C.; Oñate, C.; Martín-Algarra, S.; Perez, G.; Landazuri, S.F.; Gonzalez, A.; Gross, S.; Rodriguez, I.; Muñoz-Calleja, C.; Rodríguez-Ruiz, M.ía.; Sangro, B.; López-Picazo, J.é M.; Rizzo, M.; Mazzolini, G.; Pascual, J.I.; Andueza, M.P.; Perez-Gracia, J.L.; Melero, I. 2014: Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(22): 5697-5707

Mojtahedi, Z.; Khademi, B.; Hashemi, S.B.; Abtahi, S.M.B.; Ghasemi, M.A.; Fattahi, M.J.; Ghaderi, A. 2011: Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathology Oncology Research: Por 17(1): 7-10

Ghaffari, J.; Rafiei, A.R.; Ajami, A.; Mahdavi, M.; Hoshiar, B. 2011: Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?. Caspian Journal of Internal Medicine 2(2): 226-228

Dundar, Z.Defne.; Cander, B.; Gul, M.; Karabulut, K.Ucar.; Kocak, S.; Girisgin, S.; Mehmetoglu, I.; Toy, H. 2012: Serum intestinal fatty acid binding protein and phosphate levels in the diagnosis of acute intestinal ischemia: an experimental study in rabbits. Journal of Emergency Medicine 42(6): 741-747

Levin, I.; Klein, T.; Shapira, Y.; Lurie, H.; Kfir, B.; Narinsky, R.; Lehmann, J.; Klein, B. 1994: Serum intracellular adhesion molecule-1 (sicam-1) and soluble hla class-1 antigens in breast-cancer patients in relation to tumor burden. Oncology Reports 1(1): 217-220

Bruno, J.G.; Carrillo, M.P.; Phillips, T.; Edge, A. 2012: Serum inverts and improves the fluorescence response of an aptamer beacon to various vitamin D analytes. Luminescence: the Journal of Biological and Chemical Luminescence 27(1): 51-58

Winkler, A.W.; Riggs, D.S. 1946: Serum iodine in hyperthyroidism, with particular reference to the effects of subtotal thyroidectomy. Journal of Clinical Investigation 25: 404-412

Hur, C.I.; Yoon, T.R.; Cho, S.G.; Song, E.K.; Seon, J.K. 2008: Serum ion level after metal-on-metal THA in patients with renal failure. Clinical Orthopaedics and Related Research 466(3): 696-699

Itai, K.; Onoda, T.; Nohara, M.; Ohsawa, M.; Tanno, K.; Sato, T.; Kuribayashi, T.; Okayama, A. 2010: Serum ionic fluoride concentrations are related to renal function and menopause status but not to age in a Japanese general population. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(3-4): 263-266

Jain, B.K.; Singh, D.; Singh, H.; Narang, A.P.; Sobti, P.C.; Gupta, A. 2000: Serum ionised calcium in birth asphyxia. Indian Journal of Clinical Biochemistry: Ijcb 15(1): 36-39

Payne, M.E.; Pierce, C.W.; McQuoid, D.R.; Steffens, D.C.; Anderson, J.J.B. 2013: Serum ionized calcium may be related to white matter lesion volumes in older adults: a pilot study. Nutrients 5(6): 2192-2205

Freaney, R.; Casey, O.M.; Quinn, T.; Muldowney, F.P. 1986: Serum ionized calcium: evaluation of the Analyte +2 calcium analyser in a clinical chemistry laboratory. Journal of Automatic Chemistry 8(4): 197-201

Barbagallo, M.; Di Bella, G.; Brucato, V.; D'Angelo, D.; Damiani, P.; Monteverde, A.; Belvedere, M.; Dominguez, L.J. 2014: Serum ionized magnesium in diabetic older persons. Metabolism, Clinical and Experimental 63(4): 502-509

Kuzmicki, M.; Telejko, B.; Lipinska, D.; Pliszka, J.; Szamatowicz, M.; Wilk, J.; Zbucka-Kretowska, M.; Laudanski, P.; Kretowski, A.; Gorska, M.; Szamatowicz, J. 2014: Serum irisin concentration in women with gestational diabetes. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(9): 636-639

Ruchala, M.; Zybek, A.; Szczepanek-Parulska, E. 2014: Serum irisin levels and thyroid function--newly discovered association. Peptides 60: 51-55

Emanuele, E.; Minoretti, P.; Pareja-Galeano, H.; Sanchis-Gomar, F.; Garatachea, N.; Lucia, A. 2014: Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity. American Journal of Medicine 127(9): 888-890

Farhoudi, M.; Taheraghdam, A.; Farid, G.A.; Talebi, M.; Pashapou, A.; Majidi, J.; Goldust, M. 2012: Serum iron and ferritin level in idiopathic Parkinson. Pakistan Journal of Biological Sciences: Pjbs 15(22): 1094-1097

Gonul, M.; Gul, U.; Cakmak, S.K.; Soylu, S.; Kilic, A. 2010: Serum iron and ferritin levels in Behçet's disease. Indian Journal of Dermatology Venereology and Leprology 76(1): 85

Baydar, E.; Dabak, M. 2014: Serum iron as an indicator of acute inflammation in cattle. Journal of Dairy Science 97(1): 222-228

Budzyń, M.; Iskra, M.; Krasiński, Z.; Dzieciuchowicz, Łu.; Kasprzak, M.; Gryszczyńska, B. 2011: Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(12): Cr719-Cr727

Huang, C.-H.; Chang, C.-C.; Kuo, C.-L.; Huang, C.-S.; Chiu, T.-W.; Lin, C.-S.; Liu, C.-S. 2014: Serum iron concentration, but not hemoglobin, correlates with TIMi risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction. Plos one 9(8): E104495

Mostert, V.; Nakayama, A.; Austin, L.M.; Levander, X.A.; Ferris, C.D.; Hill, K.E.; Burk, R.F. 2007: Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice. Drug Metabolism Reviews 39(2-3): 619-626

Pichler, I.; Del Greco M, F.; Gögele, M.; Lill, C.M.; Bertram, L.; Do, C.B.; Eriksson, N.; Foroud, T.; Myers, R.H.; Nalls, M.; Keller, M.F.; Benyamin, B.; Whitfield, J.B.; Pramstaller, P.P.; Hicks, A.A.; Thompson, J.R.; Minelli, C.; Plagnol, V.; Hernandez, D.G.; Sharma, M.; Sheerin, U.-M.; Saad, M.; Simón-Sánchez, J.; Schulte, C.; Lesage, S.; Arepalli, S.; Barker, R.; Ben-Shlomo, Y.; Berendse, H.W.; Berg, D.; Bhatia, K.; de Bie, R.M.A.; Biffi, A.; Bloem, B.; Bochdanovits, Z.; Bonin, M.; Bras, J.M.; Brockmann, K.; Brooks, J.; Burn, D.J.; Charlesworth, G.; Chen, H.; Chinnery, P.F.; Chong, S.; Clarke, C.E.; Cookson, M.R.; Cooper, J.M.; Corvol, J.C.; Counsell, C.; Damier, P.; Dartigues, J.-F.ço.; Deloukas, P.; Deuschl, G.ün.; Dexter, D.T.; 2013: Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. Plos Medicine 10(6): E1001462

Ochiai, T.; Nishimura, K.; Watanabe, T.; Kitajima, M.; Nakatani, A.; Inou, T.; Shibata, H.; Sato, T.; Kishine, K.; Seo, S.; Okubo, S.; Futagawa, S.; Mashiko, S.; Nagaoka, I. 2013: Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs. Molecular and Clinical Oncology 1(5): 805-810

Ferrari, P.; Kulkarni, H.; Dheda, S.; Betti, S.; Harrison, C.; St Pierre, T.G.; Olynyk, J.K. 2011: Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. Clinical Journal of the American Society of Nephrology: Cjasn 6(1): 77-83

Vagu, C.; Sultana, C.; Ruta, S. 2013: Serum iron markers in patients with chronic hepatitis C infection. Hepatitis Monthly 13(10): E13136

Gupta, R.; Lahan, V.; Goel, D. 2013: Serum iron may not be linked with migraine. Annals of Indian Academy of Neurology 16(3): 462

Cui, R.; Gale, R.P.; Zhu, G.; Xu, Z.; Qin, T.; Zhang, Y.; Huang, G.; Li, B.; Fang, L.; Zhang, H.; Pan, L.; Hu, N.; Qu, S.; Xiao, Z. 2014: Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. Leukemia Research 38(5): 545-550

Baggott, J.E.; Tamura, T. 2011: Serum iron parameters and plasma total homocysteine concentrations. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 66(6): 656; Author Reply 657-8

Wójtowicz-Chomicz, K.; Cichoz-Lach, H.; Lis, E.; Kowalik, A.; Słomka, M.; Celiński, K. 2013: Serum iron parameters in chronic liver diseses. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 35(206): 77-81

Büyükaşik, N.S.; Nadır, I.şıl.; Akin, F.E.; Cakal, B.şa.; Kav, T.; Ersoy, O.; Büyükaşik, Y. 2011: Serum iron parameters in cirrhosis and chronic hepatitis: detailed description. Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology 22(6): 606-611

Fernández-Ruiz, M.; López-Medrano, F.; Andrés, A.; Morales, J.M.; Lumbreras, C.; San-Juan, R.; Polanco, N.; González, E.; Aguado, J.M. 2013: Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients. Transplant Infectious Disease: An Official Journal of the Transplantation Society 15(6): 600-611

Schiepers, O.J.G.; van Boxtel, M.P.J.; de Groot, R.H.M.; Jolles, J.; de Kort, W.L.A.M.; Swinkels, D.W.; Kok, F.J.; Verhoef, P.; Durga, J. 2010: Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 65(12): 1312-1321

Sivakolundu, S.; Mannela, U.D.; Jain, S.; Srikantam, A.; Peri, S.; Pandey, S.D.; Sritharan, M. 2013: Serum iron profile and ELISA-based detection of antibodies against the iron-regulated protein HupB of Mycobacterium tuberculosis in TB patients and household contacts in Hyderabad (Andhra Pradesh), India. Transactions of the Royal Society of Tropical Medicine and Hygiene 107(1): 43-50

Akodu, S.O.; Diaku-Akinwumi, I.N.; Kehinde, O.A.; Njokanma, O.F. 2013: Serum iron status of under-five children with sickle cell anaemia in lagos, Nigeria. Anemia 2013: 254765

Upadhyaya, C.; Mishra, S.; Ajmera, P.; Sharma, P. 2004: Serum iron, copper and zinc status in maternal and cord blood. Indian Journal of Clinical Biochemistry: Ijcb 19(2): 48-52

Mander, A.; Gouttefangeas, C.; Ottensmeier, C.; Welters, M.J.P.; Low, L.; van der Burg, S.H.; Britten, C.M. 2010: Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program. Cancer Immunology Immunotherapy: Cii 59(4): 619-627

Gunduz, A.; Mentese, A.; Turedi, S.; Karahan, S.C.; Mentese, U.; Eroglu, O.; Turkmen, S.; Turan, I.; Ucar, U.; Russell, R.; Balaban, F. 2008: Serum ischaemia-modified albumin increases in critical lower limb ischaemia. Emergency Medicine Journal: Emj 25(6): 351-353

Caliskan, A.; Yavuz, C.; Karahan, O.; Demirtas, S.; Yazici, S.; Guclu, O.; Mavitas, B. 2014: Serum ischaemia-modified albumin level is an irrelevant predictive factor for ischaemic duration in mesenteric ischaemia. Perfusion 29(3): 226-230

Reddy, V.S.; Rao, P.V.L.N.S.; Suchitra, M.M.; Garg, R. 2014: Serum ischaemic-modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism. Endocrine 46(1): 169-170

Soiberman, U.; Levy, R.; Schwartz, S.; Goldstein, M.; Loewenstein, A.; Barak, A. 2014: Serum ischemia modified albumin and vascular endothelial growth factor levels following intravitreal bevacizumab injections. European Journal of Ophthalmology 24(4): 570-575

Güzelmansur, I.; Ustün, Y.; Engin-Ustün, Y.; Oztürk, O.; Yaman, H. 2012: Serum ischemia modified albumin levels in pregnancies with neural tube defects. Journal of Reproductive Medicine 57(1-2): 49-52

Aran, T.; Guven, S.; Unsal, M.A.; Alver, A.; Mentese, A.; Yulug, E. 2010: Serum ischemia-modified albumin as a novel marker of ovarian torsion: an experimental study. European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 72-75

Baysal, T.; Alp, H.; Koç, N.; Atabek, M.Emre.; Eklioğlu, B.Selver.; Karaarslan, S. 2012: Serum ischemia-modified albumin level and its association with cardiovascular risk factors in obese children and adolescents. Journal of Pediatric Endocrinology and Metabolism: Jpem 25(9-10): 935-944

Yerlikaya, F.H.üm.; Kurban, S.; Mehmetoglu, I.; Annagur, A.; Altunhan, H.; Erbay, E.; Ors, R. 2014: Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 27(17): 1723-1727

Dundar, Z.D.; Cander, B.; Gul, M.; Karabulut, K.U.; Girisgin, S. 2010: Serum ischemia-modified albumin levels in an experimental acute mesenteric ischemia model. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 17(11): 1233-1238

Kocaoglu, C.; Caksen, H.; Atabek, M.E.; Kurku, H.; Arslan, S. 2014: Serum ischemia-modified albumin levels in children with epileptic seizures. Pediatric Emergency Care 30(6): 394-396

Lazzeri, M.; Haese, A.; de la Taille, A.; Palou Redorta, J.; McNicholas, T.; Lughezzani, G.; Scattoni, V.; Bini, V.; Freschi, M.; Sussman, A.; Ghaleh, B.; Le Corvoisier, P.; Alberola Bou, J.; Esquena Fernández, S.; Graefen, M.; Guazzoni, G. 2013: Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study. European Urology 63(6): 986-994

Grein, J.D.; Mathisen, G.E.; Donovan, S.; Fleckenstein, L. 2010: Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report. Scandinavian Journal of Infectious Diseases 42(3): 234-236

Eissa, A.; Cretu, D.; Soosaipillai, A.; Thavaneswaran, A.; Pellett, F.; Diamandis, A.; Cevikbas, F.; Steinhoff, M.; Diamandis, E.P.; Gladman, D.; Chandran, V. 2013: Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine 51(2): 317-325

Tang, T.; Muneta, T.; Ju, Y.-J.; Nimura, A.; Miyazaki, K.; Masuda, H.; Mochizuki, T.; Sekiya, I. 2008: Serum keratan sulfate transiently increases in the early stage of osteoarthritis during strenuous running of rats: protective effect of intraarticular hyaluronan injection. Arthritis Research and Therapy 10(1): R13

Chatziantoniou, I.; Giamarellos-Bourboulis, E.J.; Diakos, G.; Lallos, S.N.; Tsaganos, T.; Korres, D.S.; Efstathopoulos, N.E. 2011: Serum kinetics of soluble triggering receptor expressed on myeloid cells-1 differs in relation to the type of arthroplasty. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 16(7): 600-604

Lee, Y.; Kim, P.; Yoon, J.; Lee, B.; Choi, K.; Kil, K-Hyun.; Park, K. 2013: Serum kinetics, distribution and excretion of silver in rabbits following 28 days after a single intravenous injection of silver nanoparticles. Nanotoxicology 7(6): 1120-1130

Rhie, Y.J.; Lee, K.H.; Eun, S.H.; Choi, B.M.; Chae, H.W.; Kwon, A.R.; Lee, W.J.; Kim, J.H.; Kim, H.-S. 2011: Serum kisspeptin levels in Korean girls with central precocious puberty. Journal of Korean Medical Science 26(7): 927-931

Sagan, D.; Kocki, T.; Kocki, J.; Szumilo, J. 2012: Serum kynurenic acid: possible association with invasiveness of non-small cell lung cancer. Asian Pacific journal of cancer prevention: APJCP 13(9): 4241-4244

Rodríguez-Blanco, G.; Burgers, P.C.; Dekker, L.J.M.; Vredenbregt-van den Berg, M.S.; Ijzermans, J.N.M.; Schenk-Braat, E.A.M.; Jenster, G.; Luider, T.M. 2014: Serum kynurenine/tryptophan ratio is not a potential marker for detecting prostate cancer. Clinical Biochemistry 47(13-14): 1347-1348

Callaway, D.W.; Shapiro, N.I.; Donnino, M.W.; Baker, C.; Rosen, C.L. 2009: Serum lactate and base deficit as predictors of mortality in normotensive elderly blunt trauma patients. Journal of Trauma 66(4): 1040-1044

Sirikutt, P.; Kalayanarooj, S. 2014: Serum lactate and lactate dehydrogenase as parameters for the prediction of dengue severity. Journal of the Medical Association of Thailand 97(Suppl 6): S220-S231

Kintu-Luwaga, R.; Galukande, M.; Owori, F.N. 2013: Serum lactate and phosphate as biomarkers of intestinal ischemia in a Ugandan tertiary hospital: a cross-sectional study. International Journal of Emergency Medicine 6(1): 44

Freund, Y.; Delerme, S.; Goulet, H.él.èn.; Bernard, M.; Riou, B.; Hausfater, P. 2012: Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 17(7): 590-596

Pacheco-Rosas, D.O.; Huelgas-Plaza, A.C.; Miranda-Novales, M.ía.G. 2014: Serum lactate as a biomarker of severe sepsis in children with cancer, neutropenia and fever. Revista Medica del Instituto Mexicano del Seguro Social 52(Suppl 2): S24-S29

Amorini, A.M.; Nociti, V.; Petzold, A.; Gasperini, C.; Quartuccio, E.; Lazzarino, G.; Di Pietro, V.; Belli, A.; Signoretti, S.; Vagnozzi, R.; Lazzarino, G.; Tavazzi, B. 2014: Serum lactate as a novel potential biomarker in multiple sclerosis. Biochimica et Biophysica Acta 1842(7): 1137-1143

Mariappan, R.; Venkatraghavan, L.; Vertanian, A.; Agnihotri, S.; Cynthia, S.; Reyhani, S.; Tung, T.; Khan, O.H.; Zadeh, G. 2015: Serum lactate as a potential biomarker of malignancy in primary adult brain tumours. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 22(1): 144-148

Okello, M.; Makobore, P.; Wangoda, R.; Upoki, A.; Galukande, M. 2014: Serum lactate as a predictor of early outcomes among trauma patients in Uganda. International Journal of Emergency Medicine 7: 20

Trzeciak, S.; Dellinger, R.P.; Chansky, M.E.; Arnold, R.C.; Schorr, C.; Milcarek, B.; Hollenberg, S.M.; Parrillo, J.E. 2007: Serum lactate as a predictor of mortality in patients with infection. Intensive Care Medicine 33(6): 970-977

Jabbari, A.; Banihashem, N.; Alijanpour, E.; Vafaey, H.R.; Alereza, H.; Rabiee, S.M. 2013: Serum lactate as a prognostic factor in coronary artery bypass graft operation by on pump method. Caspian Journal of Internal Medicine 4(2): 662-666

Reed, L.; Carroll, J.; Cummings, A.; Markwell, S.; Wall, J.; Duong, M. 2013: Serum lactate as a screening tool and predictor of outcome in pediatric patients presenting to the emergency department with suspected infection. Pediatric Emergency Care 29(7): 787-791

Rocha, T.ís.S.d.; Silveira, A.S.d.; Botta, A.M.; Ricachinevsky, C.áu.P.; Dalle Mulle, L.; Nogueira, A. 2010: Serum lactate as mortality and morbidity marker in infants after Jatene's operation. Revista Brasileira de Cirurgia Cardiovascular: Orgao Oficial da Sociedade Brasileira de Cirurgia Cardiovascular 25(3): 350-358

Marconato, L.; Crispino, G.; Finotello, R.; Mazzotti, S.; Salerni, F.; Zini, E. 2009: Serum lactate dehydrogenase activity in canine malignancies. Veterinary and Comparative Oncology 7(4): 236-243

Caputo, D.; Caricato, M.; Vincenzi, B.; La Vaccara, V.; Mascianà, G.; Coppola, R. 2014: Serum lactate dehydrogenase alone is not a helpful prognostic factor in resected colorectal cancer patients. Updates in Surgery 66(3): 211-215

Hafiz, M.G.; Rahman, M.M.; Mannan, M.A. 2008: Serum lactate dehydrogenase as a prognostic marker of childhood acute lymphoblastic leukemia. Mymensingh Medical Journal: Mmj 17(2): 169-173

Gao, B. 2012: Serum lactate dehydrogenase as an early marker of posterior reversible encephalopathy syndrome. Anaesthesia and Intensive Care 40(5): 902-903

Vargas, M.; Servillo, G. 2013: Serum lactate dehydrogenase as an early marker of posterior reversible encephalopathy syndrome: keep your eyes open on the score of severity brain oedema. Anaesthesia and Intensive Care 41(3): 436-437

Vargas, M.; Servillo, G.; Striano, P. 2012: Serum lactate dehydrogenase as early marker of posterior reversible encephalopathy syndrome: keep your eyes open. Anaesthesia and Intensive Care 40(3): 570-571

Santotoribio, J.D.; Cañavate-Solano, C.; Garcia-de la Torre, A.; Arce-Matute, F.; Perez-Ramos, S. 2014: Serum lactate dehydrogenase in combination with free-to-total serum prostate specific antigen ratio for diagnosis of prostate cancer. Clinical Laboratory 60(6): 1055-1058

Yun, S.J.; Choi, M.-S.; Piao, M.S.; Lee, J.-B.; Kim, S.-J.; Won, Y.H.; Lee, S.-C. 2008: Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis. Dermatology 217(3): 254-259

Brown, J.E.; Cook, R.J.; Lipton, A.; Coleman, R.E. 2012: Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(22): 6348-6355

Hafiz, M.G.; Mannan, M.A. 2007: Serum lactate dehydrogenase level in childhood acute lymphoblastic leukemia. Bangladesh Medical Research Council Bulletin 33(3): 88-91

Azuma, M.; Shi, M.; Danenberg, K.D.; Gardner, H.; Barrett, C.; Jacques, C.J.; Sherod, A.; Iqbal, S.; El-Khoueiry, A.; Yang, D.; Zhang, W.; Danenberg, P.V.; Lenz, H.-J. 2007: Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. Pharmacogenomics 8(12): 1705-1713

Seki, K.; Tsuduki, Y.; Ioroi, T.; Yamane, M.; Yamauchi, H.; Shiraishi, Y.; Ogawa, T.; Nakata, I.; Nishiguchi, K.; Matsubayashi, T.; Takakubo, Y.; Yamamori, M.; Kuwahara, A.; Okamura, N.; Sakaeda, T. 2014: Serum lactate dehydrogenase levels as a predictive marker of oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer. International Journal of Medical Sciences 11(6): 641-645

Deniz, O.; Gumus, S.; Ors, F.; Yaman, H.; Battal, B.; Karaman, B.; Acikel, C.H.; Ucar, E.; Cakir, E.; Tozkoparan, E.; Bilgic, H. 2012: Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting. Clinical Chemistry and Laboratory Medicine 50(3): 483-488

Jung, S.-H.; Yang, D.-H.; Ahn, J.-S.; Kim, Y.-K.; Kim, H.-J.; Lee, J.-J. 2015: Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma. Acta Haematologica 133(1): 10-17

Elstrom, R. 2010: Serum lactate in febrile neutropenia: what can it tell us?. Cancer Biology and Therapy 9(8): 590-591

Londoño, J.; León, A.Luz.; Rodríguez, F.; Barrera, L.; de la Rosa, G.; Dennis, R.; Dueñas, C.; Granados, M.; Londoño, D.; Molina, F.; Ortiz, G.; Jaimes, Fán. 2013: Serum lactate in the emergency department as a prognostic factor in patients with sepsis without hypotension. Medicina Clinica 141(6): 246-251

Rodrigo, G.J. 2014: Serum lactate increase during acute asthma treatment: a new piece of the puzzle. Chest 145(1): 6-7

Green, J.P.; Berger, T.; Garg, N.; Shapiro, N.I. 2011: Serum lactate is a better predictor of short-term mortality when stratified by C-reactive protein in adult emergency department patients hospitalized for a suspected infection. Annals of Emergency Medicine 57(3): 291-295

Uzoigwe, C.E.; Venkatesan, M.; Smith, R.; Burnand, H.G.F.; Young, P.S.; Cheesman, C.L.; Middleton, R.G. 2012: Serum lactate is a prognostic indicator in patients with hip fracture. Hip International: the Journal of Clinical and Experimental Research on Hip Pathology and Therapy 22(5): 580-584

Tirado-Sánchez, A.és.; Vázquez-González, D.; Ponce-Olivera, R.M.ía.; Montes de Oca-Sánchez, G. 2012: Serum lactate is a useful predictor of death in severe sepsis in patients with pemphigus vulgaris. Acta Dermatovenerologica Alpina Pannonica et Adriatica 21(1): 7-9

Mikkelsen, M.E.; Miltiades, A.N.; Gaieski, D.F.; Goyal, M.; Fuchs, B.D.; Shah, C.V.; Bellamy, S.L.; Christie, J.D. 2009: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Critical Care Medicine 37(5): 1670-1677

Patki, A. 2011: Serum lactate levels and tissue hypoperfusion in complex corrective paediatric cardiac surgeries. Indian Journal of Anaesthesia 55(4): 423

Jat, K.Ram.; Jhamb, U.; Gupta, V.K. 2011: Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 15(2): 102-107

Widgren, B.R.; Grunstra, M. 2011: Serum lactate--useful indicator in emergency care. Lakartidningen 108(9): 475-477

Khokhlova, Z.A.; Saryglar, A.A.; Lykova, O.F.; Konysheva, T.V. 2011: Serum lactoferrin levels in children with viral hepatitis a. Klinicheskaia Laboratornaia Diagnostika 3: 14-16

Shihabi, Z.K. 1999: Serum lamotrigine analysis. Methods in Molecular Medicine 27: 153-156

Hon, K.L.; Ching, G.K.; Hung, E.C.; Leung, T.F. 2009: Serum lead levels in childhood eczema. Clinical and Experimental Dermatology 34(7): E508-E509

Loukidi-Bouchenak, B.; Lamri-Senhadji, M.Y.; Merzouk, S.; Merzouk, H.; Belarbi, B.; Prost, J.; Belleville, J.; Bouchenak, M. 2008: Serum lecithin: cholesterol acyltransferase activity, HDL2 and HDL3 composition in hypertensive mothers and their small for gestational age newborns. European Journal of Pediatrics 167(5): 525-532

Md Sayed, A.S.; Zhao, Z.; Guo, L.; Li, F.; Deng, X.; Deng, H.; Xia, K.; Yang, T. 2014: Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome. Iranian Red Crescent Medical Journal 16(8): E12106

Shi, H.; Wu, J.; Ji, M.; Zhou, Q.; Li, Z.; Zheng, X.; Xu, B.; Deng, H.; Zhao, W.; Wu, C.; Jiang, J. 2013: Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis. Medical Oncology 30(4): 754

Wang, B.; Yang, C.; Tang, K. 2013: Serum leptin and 5-hydroxytryptamine measurements for the diagnosis and treatment of premature ejaculation. Urology 82(6): 1336-1340

Hsueh, K.-C.; Lin, Y.-J.; Lin, H.C.; Lin, C.-Y. 2010: Serum leptin and adiponectin levels correlate with severity of allergic rhinitis. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 21(1 Part 2): E155-E159

Oh, Y.J.; Lim, H.K.; Choi, J.H.; Lee, J.W.; Kim, N.I. 2014: Serum leptin and adiponectin levels in Korean patients with psoriasis. Journal of Korean Medical Science 29(5): 729-734

Madeddu, G.; Spanu, A.; Chessa, F.; Calia, G.M.; Lovigu, C.; Mannazzu, M.; Falchi, A.; Sanna, D.; Mura, M.S.; Madeddu, G. 2009: Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 53(3): 290-301

Ghonemy, T.A.; Salim, E.M.; Atia, M.; Fekry, A.; Shawky, K. 2011: Serum leptin and bone mineral density in hemodialysis patients with or without liver diseases. Arab Journal of Nephrology and Transplantation 4(3): 131-136

Chandralekha, G.; Jeganathan, R.; Viswanathan; Charan, J.C. 2005: Serum leptin and corticosterone levels after exposure to noise stress in rats. Malaysian Journal of Medical Sciences: Mjms 12(1): 51-56

Pavlidis, C.; Panoutsopoulos, G.I.; Tiniakos, D.; Koutsounas, S.; Vlachogiannakos, J.; Zouboulis-Vafiadis, I. 2011: Serum leptin and ghrelin in chronic hepatitis C patients with steatosis. World Journal of Gastroenterology 17(46): 5097-5104

Roemmler, J.; Otto, B.; Steffin, B.; Bidlingmaier, M.; Schopohl, J. 2009: Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance test. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 117(3): 135-141

Panek, J.óz.; Bonior, J.; Pieton, J.; Jaworek, J. 2014: Serum leptin and ghrelin levels in patients in the early stages of acute biliary pancreatitis and different degrees of severity. Polski Przeglad Chirurgiczny 86(5): 211-217

Braclik, M.; Marcisz, C.ła.; Giebel, S.; Orzeł, A. 2008: Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid: Official Journal of the American Thyroid Association 18(5): 545-550

Baban, R.S.; Ali, N.M.; Al-Moayed, H.A. 2010: Serum leptin and insulin hormone level in recurrent pregnancy loss. Oman Medical Journal 25(3): 203-207

Al-Daghri, N.M.; Al-Attas, O.S.; Al-Rubeaan, K.; Mohieldin, M.; Al-Katari, M.; Jones, A.F.; Kumar, S. 2007: Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis. Cardiovascular Diabetology 6: 18

Al-Shoumer, K.A.; Al-Asousi, A.A.; Doi, S.A.; Vasanthy, B.A. 2008: Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus. Annals of Saudi Medicine 28(5): 367-370

Nurjono, M.; Neelamekam, S.; Lee, J. 2014: Serum leptin and its relationship with psychopathology in schizophrenia. Psychoneuroendocrinology 50: 149-154

Huang, X.-D.; Fan, Y.; Zhang, H.; Wang, P.; Yuan, J.-P.; Li, M.-J.; Zhan, X.-Y. 2008: Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World Journal of Gastroenterology 14(18): 2888-2893

Nakamura, Y.; Ueshima, H.; Okuda, N.; Murakami, Y.; Miura, K.; Kita, Y.; Okamura, T.; Okayama, A.; Turin, T.C.; Choudhry, S.R.; Rodriguez, B.; David Curb, J.; Stamler, J. 2013: Serum leptin and total dietary energy intake: the INTERLIPID Study. European Journal of Nutrition 52(6): 1641-1648

Chitwood, M.C.; Phillips, S.P.; Whisnant, S.; Tyndall, J.; Lashley, M.A.; DePerno, C.S. 2014: Serum leptin as an indicator of fat levels in white-tailed deer (Odocoileus virginianus) in the southeastern USA. Journal of Wildlife Diseases 50(4): 887-890

Xi, H.; Zhang, L.; Guo, Z.; Zhao, L. 2011: Serum leptin concentration and its effect on puberty in Naqu Tibetan adolescents. Journal of Physiological Anthropology 30(3): 111-117

Jmal, A.; Bouyahya, O.; Ayadi, I.èn.; Occhi, H.èn.; Feki, M.; Kaabachi, N.; Sammoud, A.; Abdennebi, M.; Boukthir, S. 2010: Serum leptin concentration in Tunisian non obese children. Annales de Biologie Clinique 68(3): 311-315

Iwamoto, J.; Takeda, T.; Sato, Y.; Matsumoto, H. 2011: Serum leptin concentration positively correlates with body weight and total fat mass in postmenopausal Japanese women with osteoarthritis of the knee. Arthritis 2011: 580632

Peltz, G.; Sanderson, M.; Pérez, A.; Sexton, K.; Ochoa Casares, D.; Fadden, M.Kay. 2007: Serum leptin concentration, adiposity, and body fat distribution in Mexican-Americans. Archives of Medical Research 38(5): 563-570

Dzwonek, A.B.; Novelli, V.; Schwenk, A. 2007: Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy. HIV Medicine 8(7): 433-438

Ganji, V.; Kafai, M.R.; McCarthy, E. 2009: Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Nutrition and Metabolism 6: 3

Einollahi, N.; Dashti, N.; Nabatchian, F. 2010: Serum leptin concentrations during the menstrual cycle in Iranian healthy women. Acta Medica Iranica 48(5): 300-303

Ozdilek, B.; Kenangil, G. 2014: Serum leptin concentrations in Turkish Parkinson's disease population. Parkinson's Disease 2014: 576020

Czaja-Bulsa, G.; Garanty-Bogacka, B.; Gebala, A.; Syrenicz, M.łg.; Krupa, B. 2010: Serum leptin concentrations in children with mild and moderate malnutrition. Annales Academiae Medicae Stetinensis 56(2): 22-27

Karul, A.; Ertabaklar, H.; Karataş, E.; Ertuğ, S. 2009: Serum leptin concentrations in patients with intestinal parasites. Turkiye Parazitolojii Dergisi 33(3): 207-211

Zuo, H.; Shi, Z.; Dai, Y.; Yuan, B.; Wu, G.; Luo, Y.; Hussain, A. 2014: Serum leptin concentrations in relation to dietary patterns in Chinese men and women. Public Health Nutrition 17(7): 1524-1530

Fungfuang, W.; Nakada, T.; Nakao, N.; Terada, M.; Yokosuka, M.; Gizurarson, S.; Hau, J.; Moon, C.; Saito, T.R. 2013: Serum leptin concentrations, leptin mRNA expression, and food intake during the estrous cycle in rats. Laboratory Animal Research 29(1): 1-6

Günebakmaz, O.ür.; Duran, M.; Akpek, M.; Zencir, C.; Elcik, D.; Oğuzhan, A.; Kaya, M.G.ün.ör. 2013: Serum leptin has no effect on coronary collateral development in patients with non-ST-elevation acute coronary syndromes: an observational study. Anadolu Kardiyoloji Dergisi: Akd 13(7): 655-661

Olama, S.M.; Elsaid, T.O.; El-Arman, M. 2013: Serum leptin in Egyptian patients with fibromyalgia syndrome: relation to disease severity. International Journal of Rheumatic Diseases 16(5): 583-589

Teixeira, P.íc.F.S.; Cabral, M.ôn.D.; Silva, N.A.; Soares, D.éb.V.; Braulio, V.ér.B.; Couto, A.P.C.B.; Henriques, J.él.L.M.; Costa, A.ôn.J.L.; Buescu, A.; Vaisman, M.ár. 2009: Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition. Thyroid: Official Journal of the American Thyroid Association 19(5): 443-450

Rafieian-Kopaei, M.; Nasri, H. 2013: Serum leptin in renal transplant patients. Journal of Renal Injury Prevention 2(2): 55-57

García-Jiménez, S.; Bernal Fernández, G.; Martínez Salazar, M.F.; Monroy Noyola, A.; Toledano Jaimes, C.; Meneses Acosta, A.; Gonzalez Maya, L.; Aveleyra Ojeda, E.; Terrazas Meraz, M.A.; Boll, M.-C.; Sánchez-Alemán, M.A. 2015: Serum leptin is associated with metabolic syndrome in obese Mexican subjects. Journal of Clinical Laboratory Analysis 29(1): 5-9

Yun, J.Eun.; Kimm, H.; Jo, J.; Jee, S.Ha. 2010: Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism, Clinical and Experimental 59(3): 424-429

Hipmair, G.; Böhler, N.; Maschek, W.; Soriguer, F.; Rojo-Martínez, G.; Schimetta, W.; Pichler, R. 2010: Serum leptin is correlated to high turnover in osteoporosis. Neuro Endocrinology Letters 31(1): 155-160

Teunissen, C.E.; van der Flier, W.M.; Scheltens, P.; Duits, A.; Wijnstok, N.; Nijpels, G.; Dekker, J.M.; Blankenstein, R.M.A.; Heijboer, A.C. 2015: Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease. Journal of Alzheimer's Disease: Jad 44(3): 809-813

Holden, K.F.; Lindquist, K.; Tylavsky, F.A.; Rosano, C.; Harris, T.B.; Yaffe, K. 2009: Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiology of Aging 30(9): 1483-1489

Liu, S-Qin.; Wu, J.; Mo, J.; Sun, Z-Xiang.; Yang, H-Bo.; Huang, C-Wen.; Lei, M-Xiang.; Peng, L-Wu.; Xu, L. 2009: Serum leptin level and its association with bone mineral density in obese children. Zhongguo Dang Dai Er Ke Za Zhi 11(9): 745-748

Seirafian, S.; Momeni, A.; Taheri, S.; Mortazavi, M.; Paknahad, Z. 2012: Serum leptin level has a positive correlation with BMI and creatinine clearance in CAPD patients. Bratislavske lekarske listy 113(8): 486-489

Yilmaz, M.; Kis, C.; Ceylan, N.O.; Okan, V.; Pehlivan, M.; Kuçukosmanoglu, E.; Yilmaz, F.; Tarakcioglu, M. 2008: Serum leptin level in acute myeloid leukemia patients. Hematology 13(1): 21-23

Shabat, S.; Nyska, M.; Eintacht, S.; Lis, M.; Bogomolni, A.; Berner, Y.; Kestanbaum-Shainkin, R. 2009: Serum leptin level in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling. Archives of Gerontology and Geriatrics 48(2): 250-253

Kamyabi, Z.; Mansouri, G.; Azizzian, F. 2011: Serum leptin level in the first trimester in ectopic versus normal pregnancies. Saudi Medical Journal 32(4): 376-378

Chakrabarti, J. 2013: Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone. Annals of Medical and Health Sciences Research 3(2): 191-196

Mohammadzadeh, G.; Zarghami, N. 2013: Serum leptin level is reduced in non-obese subjects with type 2 diabetes. International Journal of Endocrinology and Metabolism 11(1): 3-10

Koethe, J.R.; Bian, A.; Shintani, A.K.; Boger, M.Sean.; Mitchell, V.J.; Erdem, H.; Hulgan, T. 2012: Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy. Aids Research and Human Retroviruses 28(6): 552-557

Yamborisut, U.; Riabroy, N.; Phonrat, B.; Tungtrongchitr, R. 2009: Serum leptin levels and body composition in obese Thai children. Southeast Asian Journal of Tropical Medicine and Public Health 40(3): 544-552

Semnani, S.; Roshandel, G.; Keshtkar, A.; Najafi, L.; Amiriani, T.; Farajollahi, M.; Moradi, A.; Joshaghani, H. 2009: Serum leptin levels and irritable bowel syndrome: a new hypothesis. Journal of Clinical Gastroenterology 43(9): 826-830

Erel, F.; Gulec, M.; Kartal, O.; Caliskaner, Z.; Ozturk, S.; Yaman, H.; Kurt, Y.; Gocgeldic, E.; Ors, F.; Karaayvaz, M. 2007: Serum leptin levels and lipid profiles in patients with allergic rhinitis and mild asthma. Allergologia et Immunopathologia 35(6): 232-238

Ahrens, K.; Mumford, S.L.; Schliep, K.C.; Kissell, K.A.; Perkins, N.J.; Wactawski-Wende, J.; Schisterman, E.F. 2014: Serum leptin levels and reproductive function during the menstrual cycle. American Journal of Obstetrics and Gynecology 210(3): 248.E1-9

Miyazaki, M.; Kaetsu, A.; Momose, Y.; Une, H. 1999: Serum leptin levels and their association with several factors related to arteriosclerosis among medical students in Japan. Environmental Health and Preventive Medicine 3(4): 215-217

Singh, D.K.; Sakhuja, P.; Rastogi, A.; Singh, A.; Gondal, R.; Sarin, S.K. 2013: Serum leptin levels correlate with body mass index but not with histologic disease severity in Indian patients with non-alcoholic steatohepatitis: a pilot study. Indian Journal of Medical Research 137(5): 986-987

Pehlivanov, B.; Mitkov, M. 2009: Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 14(2): 153-159

Ciprandi, G.; De Amici, M.; Tosca, M.A.; Marseglia, G. 2009: Serum leptin levels depend on allergen exposure in patients with seasonal allergic rhinitis. Immunological Investigations 38(8): 681-689

Oner, S.Y.; Volkan, O.; Oner, C.; Mengi, A.; Direskeneli, H.; Tasan, D.A. 2015: Serum leptin levels do not correlate with disease activity in rheumatoid arthritis. Acta Reumatologica Portuguesa 40(1): 50-54

Neuteboom, R.F.; Verbraak, E.; Voerman, J.S.A.; van Meurs, M.; Steegers, E.A.P.; de Groot, C.J.M.; Laman, J.D.; Hintzen, R.Q. 2009: Serum leptin levels during pregnancy in multiple sclerosis. Multiple Sclerosis 15(8): 907-912

Gezici, A.Riza.; Ergun, R.; Karakas, A.; Gunduz, B. 2009: Serum leptin levels following acute experimental spinal cord injury. Journal of Spinal Cord Medicine 32(4): 416-421

Caner, I.; Selimoglu, M.A.; Yazgi, H.; Ertekin, V. 2006: Serum leptin levels in children with acute viral hepatitis a. West Indian Medical Journal 55(6): 409-413

Farooq, R.; Lutfullah, S.; Ahmed, M. 2014: Serum leptin levels in obese infertile men and women. Pakistan Journal of Pharmaceutical Sciences 27(1): 67-71

Gu, X.; Chen, Z.; El Bayoumy, I. 2014: Serum leptin levels in obese women with and without type 2 diabetes mellitus. Minerva Endocrinologica 39(3): 223-229

Fisher, A.A.; Goh, S.L.; Srikusalankul, W.; Southcott, E.N.; Davis, M.W. 2009: Serum leptin levels in older patients with hip fracture--impact on peri-operative myocardial injury. American Heart Hospital Journal 7(1): 9-16

Bountouris, I.; Paraskevas, K.I.; Koutouzis, M.; Tzavara, V.; Nikolaou, N.; Nomikos, A.; Barbatis, C.; Andrikopoulos, V.; Mikhailidis, D.P.; Andrikopoulou, M.; Kyriakides, Z.S.; Georgopoulos, S.; Michail, P.O.; Bastounis, E. 2009: Serum leptin levels in patients undergoing carotid endarterectomy: a pilot study. Angiology 60(6): 698-704

Akram, S.; Ahmed, Z.; Fayyaz, I.; Mehmood, S.; Ghani, M.; Choudhary, A.M.; Shah, I. 2011: Serum leptin levels in patients with coronary artery disease. Journal of Ayub Medical College Abbottabad: Jamc 23(4): 13-14

Yalçindağ, F.N.üf.; Kisa, U.çl.; Batioğlu, F.; Yalçindağ, A.; Ozdemir, O.; Cağlayan, O. 2007: Serum leptin levels in patients with ocular and nonocular Behçet's disease. Mediators of Inflammation 2007: 31986

Ciprandi, G.; Filaci, G.; Negrini, S.; De Amici, M.; Fenoglio, D.; Marseglia, G. 2009: Serum leptin levels in patients with pollen-induced allergic rhinitis. International Archives of Allergy and Immunology 148(3): 211-218

Mozafari, N.; Robati, R.M.; Younespour, S. 2014: Serum leptin levels in pemphigus: a case control study. Biomed Research International 2014: 853705

Saeed, Z.; Haleh, S.; Afsaneh, M.; Soheila, A.; Amir Hassan, Z.; Farah, I.; Banafsheh, T.; Elham, S.S.; Narges, M.B.; Mahmood, J.-T. 2010: Serum leptin levels in women with immunological recurrent abortion. Journal of Reproduction and Infertility 11(1): 47-52

Dingiloglu, B.S.; Gungor, T.; Ozdal, B.; Cavkaytar, S.; Bilge, U.; Mollamahmutoglu, L. 2007: Serum leptin levels in women with uterine leiomyomas. Taiwanese Journal of Obstetrics and Gynecology 46(1): 33-37

Fujita, Y.; Watanabe, K.; Maki, K. 2012: Serum leptin levels negatively correlate with trabecular bone mineral density in high-fat diet-induced obesity mice. Journal of Musculoskeletal and Neuronal Interactions 12(2): 84-94

Lee, M.-C.; Chen, Y.-C.; Ho, G.-J.; Shih, M.-H.; Chou, K.-C.; Hsu, B.-G. 2014: Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. Transplantation Proceedings 46(2): 353-358

Alexander, C.; Cochran, C.J.; Gallicchio, L.; Miller, S.R.; Flaws, J.A.; Zacur, H. 2010: Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertility and Sterility 94(3): 1037-1043

Afroze, D.; Yousuf, A.; Ali, R.; Kawoosa, F.; Akhtar, T.; Reshi, S.; Shah, Z.A. 2015: Serum leptin levels, leptin receptor gene (LEPR) polymorphism, and the risk of systemic lupus erythematosus in Kashmiri population. Immunological Investigations 44(2): 113-125

Kazmi, A.; Sattar, A.; Hashim, R.; Khan, S.P.; Younus, M.; Khan, F.A. 2013: Serum leptin values in the healthy obese and non-obese subjects of Rawalpindi. JPMA. Journal of the Pakistan Medical Association 63(2): 245-248

Jiang, Y.-x.; Tang, S.-y.; Wu, X.-p.; Yang, L.-f.; Liao, E.-y. 2007: Serum leptin with bone mineral density and body fat mass in males. Zhong Nan da Xue Xue Bao. Yi Xue Ban 32(6): 1075-1079

Ma, Y.; Liu, Z.; Zhang, Y.; Lu, B. 2013: Serum leptin, adiponectin and endometrial cancer risk in Chinese women. Journal of Gynecologic Oncology 24(4): 336-341

Margoni, A.; Perrea, D.N.; Vlachos, I.; Prokopaki, G.; Pantopoulou, A.; Fotis, L.; Kostaki, M.; Papavassiliou, A.G. 2011: Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus. Molecular Medicine 17(1-2): 36-40

Atwa, M.; Emara, A.; Balata, M.; Youssef, N.; Bayoumy, N.; Sherif, A.; Fiala, L. 2014: Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease. International Journal of Dermatology 53(10): E410-E420

Kumor, A.; Daniel, P.; Pietruczuk, M.ła.; Małecka-Panas, E. 2009: Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. International Journal of Colorectal Disease 24(3): 275-281

Li, Z.-P.; Zhang, T.; Zhou, G.-Y.; Gao, J.; Li, S.-Q.; An, Z.-M. 2013: Serum leptin, adiponectin, visfatin levels in adult GHD patients and correlation studies. Sichuan da Xue Xue Bao. Yi Xue Ban 44(4): 588-591

Gorpelioglu, C.; Erdal, E.; Ardicoglu, Y.; Adam, B.; Sarifakioglu, E. 2009: Serum leptin, atherogenic lipids and glucose levels in patients with skin tags. Indian Journal of Dermatology 54(1): 20-22

Pezzilli, R.; Barassi, A.; Corsi, M.M.; Morselli-Labate, A.M.; Campana, D.; Casadei, R.; Santini, D.; Corinaldesi, R.; D'Eril, G.M. 2010: Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Scandinavian Journal of Gastroenterology 45(1): 93-99

Telles, S.; Naveen, V.K.; Balkrishna, A. 2010: Serum leptin, cholesterol and blood glucose levels in diabetics following a yoga and diet change program Comment to: Statins and beta-cell function Lei Qian, Lihong Xu, Yi Lin, Yongde Peng Med Sci Monit, 2010; 16(1): HY1-2. Medical science monitor: international medical journal of experimental and clinical research 16(3): LE4-LE5

Zhao, Z.-J. 2011: Serum leptin, energy budget, and thermogenesis in striped hamsters exposed to consecutive decreases in ambient temperatures. Physiological and Biochemical Zoology: Pbz 84(6): 560-572

Cantarini, L.; Obici, L.; Simonini, G.; Cimaz, R.; Bacarelli, M.R.; Merlini, G.; Vitale, A.; Lucherini, O.M.; Brizi, M.G.; Galeazzi, M.; Fioravanti, A. 2012: Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Clinical and Experimental Rheumatology 30(3 Suppl 72: S108-S114

Ashizawa, N.; Yahata, T.; Quan, J.; Adachi, S.; Yoshihara, K.; Tanaka, K. 2010: Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecologic Oncology 119(1): 65-69

Singh, S.K.; Grifson, J.J.; Mavuduru, R.S.; Agarwal, M.M.; Mandal, A.K.; Jha, V. 2010: Serum leptin: a marker of prostate cancer irrespective of obesity. Cancer Biomarkers: Section a of Disease Markers 7(1): 11-15

George, W.H.; Gurling, K.J.; Macrkenzie, I. 1966: Serum leucine amino peptidase activity in carcinoma of the stomach with metastases. British Medical Journal 1(5493): 981

Shen, Y.; Qin, Q.; Xu, Z.; Shen, K. 2014: Serum leukotrienes, circulating neutrophils, and high sensitivity C-reactive protein in Chinese children with sleep-disordered breathing. International Immunopharmacology 22(1): 120-125

Shakour-Shahabi, L.; Abbasali-Zadeh, S.; Rashtchi-Zadeh, N. 2010: Serum level and antioxidant activity of ceruloplasmin in preeclampsia. Pakistan Journal of Biological Sciences: Pjbs 13(13): 621-627

Tang, R.-g.; Wei, Y.-s.; Chen, H.-m.; Fang, W.-z.; Long, X.-k.; Yuan, X.-h. 2007: Serum level and genotype of interleukin-6 in patients with esophageal cancer. Zhonghua Yi Xue Za Zhi 87(16): 1126-1128

Fujita, N.; Okegawa, T.; Terado, Y.; Tambo, M.; Higashihara, E.; Nutahara, K. 2014: Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma. Bmc Research Notes 7: 369

Martinez, G.Lago.; Koury, J.Correa.; Martins, M.Anjos.; Nogueira, F.; Fischer, R.Guimarães.; Gustafsson, A.; Figueredo, C.Marcelo.S. 2014: Serum level changes of long chain-polyunsaturated fatty acids in patients undergoing periodontal therapy combined with one year of omega-3 supplementation: a pilot randomized clinical trial. Journal of Periodontal and Implant Science 44(4): 169-177

Mihaylova, Z.; Ludovini, V.; Gregorg, V.; Floriani, I.; Pistola, L.; Toffaneti, F.; Ferraldeschi, M.; Spreafico, A.; Ceresoli, G.L.; Bellet, M.; Darwish, S.; Tonato, M.; Raynov, J. 2007: Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients. Journal of Buon: Official Journal of the Balkan Union of Oncology 12(1): 105-111

Zhang, C.-h.; Shen, S.; Wang, S.-x. 2012: Serum level of 25(OH)D and its relevant influencing factors in patients on maintenance hemodialysis. Zhonghua Yi Xue Za Zhi 92(24): 1690-1693

Gheita, T.A.; Raafat, H.; Khalil, H.; Hussein, H. 2013: Serum level of APRIL/BLyS in Behçet's disease patients: clinical significance in uveitis and disease activity. Modern Rheumatology 23(3): 542-546

Plönes, T.; Krohn, A.; Burger, M.; Veelken, H.; Passlick, B.; Müller-Quernheim, J.; Zissel, G. 2012: Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas. Plos one 7(7): E41746

Molica, S.; Digiesi, G.; Mirabelli, R.; Cutrona, G.; Antenucci, A.; Molica, M.; Giannarelli, D.; Sperduti, I.; Morabito, F.; Neri, A.; Baldini, L.; Ferrarini, M. 2009: Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia. European Journal of Haematology 83(3): 208-214

Van Heerde, M.J.; Buijs, J.; Hansen, B.E.; de Waart, M.; van Eijck, C.H.J.; Kazemier, G.; Pek, C.J.; Poley, J.W.; Bruno, M.J.; Kuipers, E.J.; van Buuren, H.R. 2014: Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma. Digestive Diseases and Sciences 59(6): 1322-1329

Dong, L.-l.; Qu, L.-y.; Chu, L.-y.; Zhang, X.-H.; Liu, Y.-h. 2014: Serum level of DKK-1 and its prognostic potential in non-small cell lung cancer. Diagnostic Pathology 9: 52

Liu, H.-B.; Fan, X.-G.; Huang, J.-J.; Li, N.; Peng, J.-P.; Li, S.-L.; Wang, H. 2007: Serum level of HMGB1 in patients with hepatitis B and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 15(11): 812-815

Tajtakova, M.; Pidanicova, A.; Valansky, L.; Lachvac, L.; Nagy, V.; Sivonova, M.; Dobrota, D.; Kliment, J.; Petrovicova, J. 2010: Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer. Neoplasma 57(2): 118-122

Suen, J.-L.; Chang, Y.; Chiu, P.-R.; Hsieh, T.-H.; Hsi, E.; Chen, Y.-C.; Chen, Y.-F.; Tsai, E.-M. 2014: Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model. American Journal of Pathology 184(2): 464-471

Zhang, X.-L.; Zhang, W.-H.; Fan, X.-H.; Wei, F.; Zhang, M. 2012: Serum level of IL-17 in patients with multiple myeloma and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(4): 930-932

Beinhardt, S.; Aberle, J.H.; Strasser, M.; Dulic-Lakovic, E.; Maieron, A.; Kreil, A.; Rutter, K.; Staettermayer, A.F.; Datz, C.; Scherzer, T.M.; Strassl, R.; Bischof, M.; Stauber, R.; Bodlaj, G.; Laferl, H.; Holzmann, H.; Steindl-Munda, P.; Ferenci, P.; Hofer, H. 2012: Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection. Gastroenterology 142(1): 78-85.E2

Zhang, J.-l.; Yao, Q.; Chen, J.-h.; Wang, T.; Wang, H.; Fan, J.; Wang, L. 2012: Serum level of MMP-2 in early breast cancer and its correlation with circulating tumor cells. Zhonghua Yi Xue Za Zhi 92(16): 1104-1106

Tadbir, A.Andisheh.; Purshahidi, S.; Ebrahimi, H.; Khademi, B.; Malekzadeh, M.; Mardani, M.; Taghva, M.; Sardari, Y. 2012: Serum level of MMP-3 in patients with oral squamous cell carcinoma--lack of association with clinico-pathological features. Asian Pacific journal of cancer prevention: APJCP 13(9): 4545-4548

Levada, O.A.; Traïlin, A.V. 2012: Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness. Likars'ka Sprava 2012(3-4): 53-59

Kohut, M.; Kacperek-Hartleb, T.; Sojka, D.; Hartleb, M. 2010: Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 28(168): 454-458

Lebensztejn, D.M.; Skiba, E.; Werpachowska, I.; Sobaniec-Łotowska, M.E.; Kaczmarski, M. 2007: Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B. Advances in Medical Sciences 52: 120-124

Pohl, D.; Andrýs, C.; Borská, L.; Fiala, Z.; Hamaková, K.; Ettler, K.; Krejsek, J. 2011: Serum level of a soluble form of endoglin (CD105) is decreased after Goeckerman's therapy of psoriasis. Acta Medica 54(2): 59-62

Arano, T.; Nakagawa, H.; Tateishi, R.; Ikeda, H.; Uchino, K.; Enooku, K.; Goto, E.; Masuzaki, R.; Asaoka, Y.; Kondo, Y.; Goto, T.; Shiina, S.; Omata, M.; Yoshida, H.; Koike, K. 2011: Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. International Journal of Cancer 129(9): 2226-2235

Meng, Q.-H.; Duan, Z.-H.; Lin, Z.-H.; Yu, H.-W.; Li, J.; Liu, Y. 2009: Serum level of adiponectin correlated with gender and genotype in patients with chronic hepatitis C. Digestive Diseases and Sciences 54(5): 1120-1127

Takahashi, H.; Tsuji, H.; Ishida-Yamamoto, A.; Iizuka, H. 2013: Serum level of adiponectin increases and those of leptin and resistin decrease following the treatment of psoriasis. Journal of Dermatology 40(6): 475-476

Meyer, M.; Sellam, J.ér.ém.; Fellahi, S.; Kotti, S.; Bastard, J.-P.; Meyer, O.; Lioté, F.éd.ér.; Simon, T.; Capeau, J.; Berenbaum, F. 2013: Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Research and Therapy 15(6): R210

Zhao, M.-Q.; Zhao, H.-G. 2007: Serum level of angiogenesis-related cytokins in patients with myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15(3): 519-522

Kazemi, A.; Koosha, A.; Rafizadeh, B.; Mousavinasab, N.; Mahram, M. 2008: Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth. Eastern Mediterranean Health Journal 14(4): 960-965

Dehghani-Firouzabadi, R.; Tayebi, N.; Asgharnia, M. 2008: Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles. Archives of Iranian Medicine 11(4): 371-376

Zolotova, T.V.; Grebeniuk, I.E. 2010: Serum level of anti-neurotrophine antibodies and activity of proteolytic enzymes in patients with sensorineural loss of hearing. Vestnik Otorinolaringologii 4: 25-28

Borska, L.; Andrys, C.; Krejsek, J.; Palicka, V.; Chmelarova, M.; Hamakova, K.; Kremlacek, J.; Borsky, P.; Fiala, Z. 2014: Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs. Journal of Immunology Research 2014: 834389

Rabie, M.A.; Mohsen, M.; Ibrahim, M.; El-Sawy Mahmoud, R. 2014: Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder. Journal of Affective Disorders 162: 67-72

Oliveira, N.S.; Silva, V.R.; Castelo, J.S.' A.; Elias-Neto, J.; Pereira, F.E.L.; Carvalho, W.B. 2008: Serum level of cardiac troponin i in pediatric patients with sepsis or septic shock. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 9(4): 414-417

Miyake, H.; Muramaki, M.; Furukawa, J.; Kurahashi, T.; Fujisawa, M. 2010: Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension. Urology 75(2): 454-459

Bashir, S.; Halepoto, D.M.; Al-Ayadhi, L. 2014: Serum level of desert hedgehog protein in autism spectrum disorder: preliminary results. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 23(1): 14-17

Sakamoto, Y.; Dai, N.; Hagiwara, Y.; Satoh, K.; Ohashi, N.; Fukamachi, K.; Tsuda, H.; Hirose, A.; Nishimura, T.; Hino, O.; Ogata, A. 2010: Serum level of expressed in renal carcinoma (ERC)/ mesothelin in rats with mesothelial proliferative lesions induced by multi-wall carbon nanotube (MWCNT). Journal of Toxicological Sciences 35(2): 265-270

Yano, T.; Sogawa, K.; Umemura, H.; Sakao, S.; Kasahara, Y.; Tanabe, N.; Kodera, Y.; Takiguchi, Y.; Tatsumi, K.; Nomura, F. 2011: Serum level of fibrinogen Aα chain fragment increases in chronic thromboembolic pulmonary hypertension. Circulation Journal: Official Journal of the Japanese Circulation Society 75(11): 2675-2682

Sánchez Fructuoso, A.I.; Maestro, M.L.; Pérez-Flores, I.; Valero, R.ía.; Rafael, S.; Veganzones, S.; Calvo, N.; De la Orden, V.; De la Flor, J.C.; Valga, F.; Vidaurreta, M.; Fernández-Pérez, C.; Barrientos, A. 2012: Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27(11): 4227-4235

Ide, H.; Terado, Y.; Sakamaki, K.; Inoue, M.; Nakajima, A.; Lu, Y.; Hisasue, S.; Yamaguchi, R.; Muto, S.; Horie, S. 2013: Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer. Prostate International 1(3): 109-112

Kawaguchi, T.; Itou, M.; Taniguchi, E.; Sakata, M.; Abe, M.; Koga, H.; Oriishi, T.; Imamura, Y.; Kato, T.; Yamada, K.; Sata, M. 2011: Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study. Hepato-Gastroenterology 58(105): 103-108

Sakaki, M.; Oka, N.; Nakanishi, R.; Yamaguchi, K.; Fukumori, T.; Kanayama, H.-O. 2008: Serum level of galectin-3 in human bladder cancer. Journal of Medical Investigation: Jmi 55(1-2): 127-132

Abdel Hakeem, A.H.A.; Saed, S.Z.; El Rehany, M.A.; Yassin, E.E. 2012: Serum level of ghrelin in umbilical cord in small and appropriate for gestational age newborn infants and its relationship to anthropometric measures. Journal of Clinical Neonatology 1(3): 135-138

Al-Hadi, H.A.; William, B.; Fox, K.A. 2009: Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure. Sultan Qaboos University Medical Journal 9(3): 311-314

Gorjipour, F.; Asadi, Y.; K Osguei, N.; Effatkhah, M.; Samadikuchaksaraei, A. 2013: Serum level of homocysteine, folate and vitamin-B12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis. Iranian Red Crescent Medical Journal 15(3): 249-253

Løken, M.O.; Jeansson, S.; Jenum, P.ål.A.; Eskild, A. 2010: Serum level of immunoglobulin e during pregnancy - does offspring sex matter?. Paediatric and Perinatal Epidemiology 24(1): 75-78

Grzegorzewska, A.E.; Młot-Michalska, M. 2007: Serum level of intact parathyroid hormone and other markers of bone metabolism in dialyzed patients. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 23: 162-165

Abdelrazik, N.; Fouda, M.; Zaghloul, M.H.E.-D.; Abbas, D. 2008: Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 17(3): 233-238

Cai, L.-S.; Wang, S.-Q.; Luo, L.; Dai, Y.; Zhu, L.-L.; Bi, S.; Che, S.-W. 2013: Serum level of intercellular adhesion molecule-1 in patients with clonorchiasis and its impact on liver function. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 31(5): 382-384; 389

Kim, D-Jun.; Baek, S-Ye.; Park, M-Kyung.; Park, K-Su.; Lee, J.Ho.; Park, S-Hwan.; Kim, H-Youn.; Kwok, S-Ki. 2013: Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease. Journal of Korean Medical Science 28(8): 1145-1153

Younan, D.N.A.; Agamia, N.; Elshafei, A.; Ebeid, N. 2015: Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease. Journal of Clinical Laboratory Analysis 29(1): 74-79

Jaafari-Ashkavandi, Z.; Khademi, B.; Akbari, S.; Malekzadeh, M. 2013: Serum level of mast cell tryptase in patients with oral squamous cell carcinoma: lack of correlation with clinicopathologic factors. Asian Pacific Journal of Cancer Prevention: Apjcp 14(5): 2955-2958

Farzin, M.; Mardani, M.; Ghabanchi, J.; Fattahi, M.J.; Rezaee, M.; Heydari, S.T.; Andisheh Tadbir, A. 2012: Serum level of matrix metalloproteinase-3 in patients with oral lichen planus. Iranian Red Crescent Medical Journal 14(1): 10-13

Ji, H.-I.; Lee, S.-H.; Song, R.; Yang, H.-I.; Lee, Y.-A.; Hong, S.-J.; Kim, S.; Park, Y.-B.; Lee, S.-K.; Yoo, M.C.; Kim, K.S. 2014: Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis. Clinical Rheumatology 33(3): 397-402

Shiraki, M.; Yamazaki, Y.; Kuroda, T.; Tanaka, S.; Miyata, K. 2011: Serum level of pepsinogen significantly associated with gastric distress induced by amino-bisphosphonates. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 22(6): 1717-1723

Nakamura, K.; Yamagishi, S.-i.; Adachi, H.; Matsui, T.; Kurita, Y.; Inoue, H. 2009: Serum level of pigment epithelium derived factor (PEDF) is an independent determinant of resting heart rate in Japanese subjects. International Journal of Cardiology 136(2): 245-247

Liu, H-lin.; Tian, Q.; Hong, T-pei.; Liu, G-hua.; Pan, H.; Wang, H-ning.; Gao, H-wei. 2013: Serum level of programmed cell death 5 protein levels in patients with sepsis. Beijing da Xue Xue Bao. Yi Xue Ban 45(2): 238-241

Freedberg, A.S.; Ureles, A.; Hertz, S. 1949: Serum level of protein bound radioactive iodine (I131) in the diagnosis of hyperthyroidism. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 70(4): 679-682

Tajtáková, M.; Semanová, Z.; Ivancová, G.; Petrovicová, J.; Donicová, V.; Zemberová, E. 2007: Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin. Vnitrni Lekarstvi 53(9): 960-963

Kolackova, M.; Lonsky, V.; Trojackova Kudlova, M.; Mandak, J.; Kunes, P.; Svitek, V.; Jankovicova, K.; Vlaskova, D.; Andrys, C.; Krejsek, J. 2009: Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery. Perfusion 24(4): 263-269

Ctirad, A.; Jan, K.; Lenka, B.; Zdenek, F.; Kveta, H.; Michal, B.; Karel, E. 2011: Serum level of sCD30 molecule but not sCD30L in patients with psoriasis is reduced by Goeckerman's therapy. International Journal of Dermatology 50(8): 1033-1035

Kopczyńska, M.; Franek, A.; Błaszczak, E.; Dworak, J.; Kopczyński, P.ła.; Hrycek, A. 2013: Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(203): 251-254

Kocsis, J.; Madaras, B.áz.; Tóth, E.K.; Füst, G.; Prohászka, Z.án. 2010: Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress and Chaperones 15(2): 143-151

Firneisz, G.; Somogyi, A. 2012: Serum level of soluble CD26/dieptidyl peptidase-4 (DPP-4) activity correlates with other liver disease biomarkers both in Asian and European patients. Translational Research: the Journal of Laboratory and Clinical Medicine 160(1): 95-96

Aso, Y.; Ozeki, N.; Terasawa, T.; Naruse, R.; Hara, K.; Suetsugu, M.; Takebayashi, K.; Shibazaki, M.; Haruki, K.; Morita, K.; Inukai, T. 2012: Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea. Translational Research: the Journal of Laboratory and Clinical Medicine 159(1): 25-31

Krepuska, M.ós.; Szeberin, Z.án.; Sótonyi, P.ét.; Sarkadi, H.; Fehérvári, M.át.ás.; Apor, A.; Rimely, E.; Prohászka, Z.án.; Acsády, G.ör. 2011: Serum level of soluble Hsp70 is associated with vascular calcification. Cell Stress and Chaperones 16(3): 257-265

Park, Y.; Yong, P.; Kim, S.Jin.; Lee, S.Jin.; Kim, B.Soo. 2008: Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?. Leukemia and Lymphoma 49(8): 1623-1626

Sungprem, K.; Khongphatthanayothin, A.; Kiettisanpipop, P.; Chotivitayatarakorn, P.; Poovorawan, Y.; Lertsapcharoen, P. 2009: Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease. Pediatric Cardiology 30(4): 472-476

Kahbazi, M.; Rezapour, H.; Jafari, F.; Arjomandzadegan, M.; Sofian, M.; Zarinfar, N.; Sarmadiayan, H.; Najmi, A.R. 2012: Serum level of soluble interleukin-2 receptor alpha as a predictor of treatment response in brucellosis. Journal of Ayub Medical College Abbottabad: Jamc 24(2): 44-46

El-Seify, M.Y.H.; Fouda, E.M.; Nabih, E.S. 2014: Serum level of soluble receptor for advanced glycation end products in asthmatic children and its correlation to severity and pulmonary functions. Clinical Laboratory 60(6): 957-962

Okugawa, Y.; Miki, C.; Toiyama, Y.; Koike, Y.; Inoue, Y.; Kusunoki, M. 2009: Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma. Diseases of the Colon and Rectum 52(7): 1330-1336

Diaz-Sanchez, A.; Matilla, A.; Nuñez, O.; Rincon, D.; Lorente, R.; Lo Iacono, O.; Merino, B.; Hernando, A.; Campos, R.; Clemente, G.; Bañares, R. 2013: Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease. Annals of Hepatology 12(2): 236-247

Najafian, B.; Shohrati, M.; Harandi, A.A.; Mahyar, S.; Khaheshi, I.; Ghanei, M. 2014: Serum level of substance P in patients with lung injuries due to sulfur mustard. Advanced Biomedical Research 3: 137

Corbo, G.M.; Di Marco Berardino, A.; Mancini, A.; Inchingolo, R.; Smargiassi, A.; Raimondo, S.; Valente, S. 2014: Serum level of testosterone, dihydrotestosterone and IGF-1 during an acute exacerbation of COPD and their relationships with inflammatory and prognostic indices: a pilot study. Minerva Medica 105(4): 289-294

Koussih, L.; Ali, A.; Shan, L.; Becker, A.; Gounni, A.S. 2012: Serum level of thymic stromal lymphopoietin in allergic asthmatic children. Clinical Immunology 145(2): 92-93

Durak-Nalbantic, A.; Resic, N.; Kulic, M.; Pecar, E.; Zvizdic, F.; Dzubur, A.; Dilic, M.; Gojak, R.; Sokolovic, S.; Hodzic, E.; Brdjanovic, S. 2013: Serum level of tumor marker carbohydrate antigen-CA125 in heart failure. Medical Archives 67(4): 241-244

Ma, J.; Xu, Y.; Zhang, Z.; Liu, H.; Xiong, W.; Xu, S. 2007: Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome. Journal of Huazhong University of Science and Technology. Medical Sciences 27(2): 157-160

Uysalol, M.; Uysalol, E.Pasli.; Yilmaz, Y.; Parlakgul, G.; Ozden, T.Ayse.; Ertem, H.Vehid.; Omer, B.; Uzel, N. 2014: Serum level of vitamin D and trace elements in children with recurrent wheezing: a cross-sectional study. Bmc Pediatrics 14: 270

Ory, E.M.; Wilcox, C.; Finland, M. 1946: Serum levels after repository injections of penicillin. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 62: 86-88

Kosacka, M.; Weryńska, B.; Gołecki, M.; Porebska, I.; Passowicz-Muszyńska, E.; Jankowska, R. 2007: Serum levels analysis of TGF-Beta and VEGF in patients with cancer anorexia-cachexia syndrome in lung cancer. Wiadomosci Lekarskie 60(7-8): 335-340

Dursun, O.; Yilmaz, A.ça.; Ayaz, L.; Tamer, L.ül.üf. 2012: Serum levels and H/L gene polymorphism of mannose-binding lectin in primary open angle glaucoma. Current Eye Research 37(3): 212-217

Bao, Y-Shi.; Ji, Y.; Zhao, S-Lei.; Ma, L-Lin.; Xie, R-Juan.; Na, S-Ping. 2013: Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 18(5): 379-385

Zhen, L.; Gu, R.-j.; Zhang, P. 2008: Serum levels and clinical significance of IL in patients with delayed encephalopathy after acute carbon monoxide poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26(9): 561-562

Mi, H.; Guo, J.; Xie, H.; Wang, L.; Li, A. 2014: Serum levels and clinical significance of high mobility group protein B1 in patients with delayed encephalopathy after acute carbon monoxide poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 32(7): 539-541

Rodríguez-Rodríguez, E.; Sánchez-Juan, P.; Mateo, I.; Llorca, J.; Infante, J.; García-Gorostiaga, I.; Berciano, J.; Combarros, O. 2007: Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease. Acta Neurologica Scandinavica 116(6): 409-412

Ferrarotti, I.; Thun, G.A.; Zorzetto, M.; Ottaviani, S.; Imboden, M.; Schindler, C.; von Eckardstein, A.; Rohrer, L.; Rochat, T.; Russi, E.W.; Probst-Hensch, N.M.; Luisetti, M. 2012: Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax 67(8): 669-674

Rodrigues, V.S.; Milanski, M.; Fagundes, J.J.; Torsoni, A.S.; Ayrizono, M.L.S.; Nunez, C.E.C.; Dias, C.B.; Meirelles, L.R.; Dalal, S.; Coy, C.S.R.; Velloso, L.A.; Leal, R.F. 2012: Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Clinical and Experimental Immunology 170(3): 358-364

Silvello, D.; Narvaes, L.B.; Albuquerque, L.C.; Forgiarini, L.F.; Meurer, L.; Martinelli, N.C.; Andrades, M.E.; Clausell, N.; dos Santos, K.át.G.ça.; Rohde, L.E. 2014: Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 19(1): 49-55

Guan, W.; Li, X.; Yang, Y-zhong.; Wang, J.; Feng, X-ying.; Xu, J-hua. 2013: Serum levels and significance of HIF-1α and HIF-2α in healthy Tibetan and Han residents at different altitudes. Zhonghua yi xue za zhi 93(38): 3057-3059

Groblewska, M.; Mroczko, B.; Gryko, M.; Pryczynicz, A.; Guzińska-Ustymowicz, K.; Kędra, B.ła.; Kemona, A.; Szmitkowski, M. 2014: Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(4): 3793-3802

Kimoto, S.; Sato, K.; Watanabe, T.; Suguro, T.; Koyama, T.; Shichiri, M. 2010: Serum levels and urinary excretion of salusin-alpha in renal insufficiency. Regulatory Peptides 162(1-3): 129-132

Salaru, D.L.; Albert, C.; Königsmark, U.; Brandt, S.; Halloul, Z.; Heller, A.; Heidecke, H.; Dragun, D.; Mertens, P.R. 2014: Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy. International Angiology: a Journal of the International Union of Angiology 33(4): 372-378

Lima, G.A.B.; Gadelha, M.ôn.R.; Strasburger, C.J.; Wu, Z. 2010: Serum levels of 20K-hGH and 22K-hGH isoforms in acromegalic patients. Frontiers of Hormone Research 38: 87-93

Ma, X.-L.; Zhen, Y.-F. 2011: Serum levels of 25-(OH)D(3) and total IgE in children with asthma. Zhongguo Dang Dai Er Ke Za Zhi 13(7): 551-553

Jiang, Z.-G.; Wu, J.; Liu, L.; Lin, Y.; Yang, C.-Y. 2012: Serum levels of 25-(OH)D3 and immunoglobulin in children with bronchiolitis. Zhongguo Dang Dai Er Ke Za Zhi 14(8): 578-580

Azizi, E.; Pavlotsky, F.; Kudish, A.; Flint, P.; Solomon, A.; Lerman, Y.; Oberman, B.; Sadetzki, S. 2012: Serum levels of 25-hydroxy-vitamin D3 among sun-protected outdoor workers in Israel. Photochemistry and Photobiology 88(6): 1507-1512

Björkhem-Bergman, L.; Nylén, H.; Norlin, A-Carin.; Lindh, J.D.; Ekström, L.; Eliasson, E.; Bergman, P.; Diczfalusy, U. 2013: Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(4): 704-708

Yoshimura, N.; Muraki, S.; Oka, H.; Nakamura, K.; Kawaguchi, H.; Tanaka, S.; Akune, T. 2015: Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 26(1): 151-161

Chen, R.-h.; Zhao, X.-h.; Gu, Z.; Gu, P.-l.; Zhou, B.; Zhu, Z.-h.; Xu, L.-y.; Zou, Y.-f.; Jiang, X.-z. 2014: Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults. Endocrine 45(2): 319-324

Fernell, E.; Barnevik-Olsson, M.; Bågenholm, G.; Gillberg, C.; Gustafsson, S.; Sääf, M. 2010: Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatrica 99(5): 743-747

Zhou, X.; Han, J.; Song, Y.; Zhang, J.; Wang, Z. 2012: Serum levels of 25-hydroxyvitamin D, oral health and chronic obstructive pulmonary disease. Journal of Clinical Periodontology 39(4): 350-356

Murakami, K.; Nakanishi, Y.; Wakamatsu, K.; Yamamoto, K.; Kohriyama, N.; Hasegawa, M.; Tomita, M.; Nabeshima, K.; Hiki, Y.; Asano, S.; Kawashima, S.; Ito, Y.; Fujita, Y.; Asada, H.; Nakai, S.; Sugiyama, S.; Ito, S. 2009: Serum levels of 5-s-cysteinyldopa are correlated with skin colors in hemodialysis patients but not in peritoneal dialysis patients. Blood Purification 28(3): 209-215

Wysokiński, A.; Kaźmierski, J.; Kłoszewska, I. 2015: Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy. Metabolic Brain Disease 30(2): 529-535

Guzmán-Lepe, S.; Anaya-Prado, R. 2008: Serum levels of Apo-Ai and B as markers of synthetic graft stenosis after bypass for peripheral artery disease. Cirugia y Cirujanos 76(3): 225-233

Yang, C.; Li, N.; Wang, Y.; Zhang, P.; Zhu, Q.; Li, F.; Han, Q.; Lv, Y.; Yu, L.; Wei, P.; Liu, Z. 2014: Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 34(10): 787-794

Nagai, M.; Hirayama, K.; Ebihara, I.; Shimohata, H.; Kobayashi, M.; Koyama, A. 2011: Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron. Clinical practice 118(4): c339-c345

Nishino, Y.; Tamai, M.; Kawakami, A.; Koga, T.; Makiyama, J.; Maeda, Y.; Jiuchi, Y.; Miyashita, T.; Izumi, Y.; Eguchi, K.; Migita, K. 2010: Serum levels of BAFF for assessing the disease activity of Takayasu arteritis. Clinical and Experimental Rheumatology 28(1 Suppl 57: 14-17

Pollard, R.P.E.; Abdulahad, W.H.; Vissink, A.; Hamza, N.; Burgerhof, J.G.M.; Meijer, J.M.; Visser, A.; Huitema, M.G.; Spijkervet, F.K.L.; Kallenberg, C.G.M.; Bootsma, H.; Kroese, F.G.M. 2013: Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Annals of the Rheumatic Diseases 72(1): 146-148

Song, X.; Fan, X.; Li, X.; Kennedy, D.; Pang, L.; Quan, M.; Chen, X.; Gao, J.; Zhang, W.; Zhang, J.; Lv, L. 2014: Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia. Schizophrenia Research 159(1): 51-55

Eroglu, S.; Elif Sade, L.; Yildirir, A.; Demir, O.; Bozbas, H.; Muderrisoglu, H. 2009: Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X. Acta Cardiologica 64(2): 207-211

López, R.; Baelum, V.; Hedegaard, C.J.; Bendtzen, K. 2011: Serum levels of C-reactive protein in adolescents with periodontitis. Journal of Periodontology 82(4): 543-549

Saely, C.H.; Rein, P.; Vonbank, A.; Drexel, H. 2010: Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective. International Journal of Cardiology 144(3): 448-449

Marzetti, E.; Calvani, R.; Lorenzi, M.; Marini, F.; D'Angelo, E.; Martone, A.M.; Celi, M.; Tosato, M.; Bernabei, R.; Landi, F. 2014: Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients. Experimental Gerontology 60: 79-82

Estakhri, R.; Ghahramanzade, A.; Vahedi, A.; Nourazarian, A. 2013: Serum levels of CA15-3, AFP, CA19-9 and CEA tumor markers in cancer care and treatment of patients with impaired renal function on hemodialysis. Asian Pacific Journal of Cancer Prevention: Apjcp 14(3): 1597-1599

Ri, G.; Ohno, S.; Yamamoto, T.; Ito, E.; Furutani, M.; Furutani, Y.; Umeda, Y.; Tsukahara, T.; Hagita, N.; Matsuoka, R. 2009: Serum levels of CA15-3, KL-6 and BCA225 are positively correlated with each other in the general population. Anticancer Research 29(10): 4239-4242

Kodama, T.; Satoh, H.; Ishikawa, H.; Ohtsuka, M. 2007: Serum levels of CA19-9 in patients with nonmalignant respiratory diseases. Journal of Clinical Laboratory Analysis 21(2): 103-106

Uchi, H.; Hayashida, S.; Takahara, M.; Moroi, Y.; Furue, M. 2012: Serum levels of CC chemokine receptor 4 and CXC chemokine receptor 3 ligands in CD8(+) Sézary syndrome. Acta Dermato-Venereologica 92(3): 280-281

Jiang, F.; Wang, P.; Zhao, F.-l.; Han, L.; Lü, Y.-m. 2012: Serum levels of CC-Chemokine ligand 18 in the patients with pneumoconiosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 30(9): 678-680

Jasiewicz, M.; Kowal, K.; Kowal-Bielecka, O.; Knapp, M.; Skiepko, R.; Bodzenta-Lukaszyk, A.; Sobkowicz, B.; Musial, W.J.; Kaminski, K.A. 2014: Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension. Cytokine 66(1): 40-45

Dede, D.S.; Arslan, C.; Altundag, K. 2010: Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis. Medical Oncology 27(4): 1429

Wu, S.-g.; He, Z.-y.; Zhou, J.; Sun, J.-y.; Li, F.-y.; Lin, Q.; Guo, L.; Lin, H.-x. 2014: Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer. Breast 23(1): 88-93

Fitzpatrick, E.; Mitry, R.R.; Quaglia, A.; Hussain, M.J.; DeBruyne, R.; Dhawan, A. 2010: Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. Journal of Pediatric Gastroenterology and Nutrition 51(4): 500-506

Festa, E.D.; Hankiewicz, K.; Kim, S.; Skurnick, J.; Wolansky, L.J.; Cook, S.D.; Cadavid, D. 2009: Serum levels of CXCL13 are elevated in active multiple sclerosis. Multiple Sclerosis 15(11): 1271-1279

Huang, H.; Xu, X.; Yao, C.; Cai, M.; Qian, Y.; Wang, X.; Shi, B. 2014: Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation. Molecular Medicine Reports 9(1): 45-50

Rava, M.; Tares, L.; Lavi, I.; Barreiro, E.; Zock, J.-P.; Ferrer, A.; Muniozguren, N.; Nadif, R.; Cazzoletti, L.; Kauffmann, F.; Anto, J.M.; Guerra, S. 2013: Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population. Journal of Allergy and Clinical Immunology 132(1): 230-232

Asare, G.A.; Nani, A. 2010: Serum levels of Cu, Se, and Zn in adult rural/urban residents in Ghana: paradigm shift?. Biological trace element research 137(2): 139-149

Lin, Z.; Wu, Z.; Yin, X.; Liu, Y.; Yan, X.; Lin, S.; Xiao, J.; Wang, X.; Feng, W.; Li, X. 2010: Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. Plos one 5(12): E15534

Bordbar, E.; Malekzadeh, M.; Ardekani, M.T.F.; Doroudchi, M.; Ghaderi, A. 2012: Serum levels of G-CSF and IL-7 in Iranian breast cancer patients. Asian Pacific Journal of Cancer Prevention: Apjcp 13(10): 5307-5312

Amiri, S.; Ghazanfari, T.; Yaraee, R.; Salimi, H.; Ebtekar, M.; Shams, J.; Ghasemi, H.; Pourfarzam, S.; Moin, A.; Sharifnia, Z.; Soroush, M.R.; Faghihzadeh, S.; Hassan, Z.M. 2009: Serum levels of GM-CSF 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. International Immunopharmacology 9(13-14): 1499-1503

Zhou, Y.; Wang, L.; Li, M.-X. 2011: Serum levels of HIF-1α, ET-1 and Ca(2+) in neonates with hypoxic pulmonary hypertension. Zhongguo Dang Dai Er Ke Za Zhi 13(3): 181-184

Pullerits, R.; Urbonaviciute, V.; Voll, R.E.; Forsblad-D'Elia, H.; Carlsten, H. 2011: Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics. Journal of Rheumatology 38(7): 1523-1525

Naumnik, W.; Nilklińska, W.ła.; Ossolińska, M.; Chyczewska, E. 2009: Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy. Folia Histochemica et Cytobiologica 47(4): 703-709

Zagouri, F.; Sergentanis, T.N.; Provatopoulou, X.; Kalogera, E.; Chrysikos, D.; Lymperi, M.; Papadimitriou, C.A.; Zografos, E.; Bletsa, G.; Kalles, V.S.; Zografos, G.C.; Gounaris, A. 2011: Serum levels of HSP90 in the continuum of breast ductal and lobular lesions. In Vivo 25(4): 669-672

Palenkić, H.; Bačun, T.; Ćosić, A.; Lovričević, I.; DeSyo, D.; Drenjančević, I. 2014: Serum levels of ICAM-1, VCAM-1 and E-selectin in early postoperative period and three months after eversion carotid endarterectomy. Medicinski Glasnik: Official Publication of the Medical Association of Zenica-Doboj Canton Bosnia and Herzegovina 11(2): 313-319

Sugiyama-Nakagiri, Y.; Naoe, A.; Ohuchi, A.; Kitahara, T. 2011: Serum levels of IGF-1 are related to human skin characteristics including the conspicuousness of facial pores. International Journal of Cosmetic Science 33(2): 144-149

Pasanisi, P.; Bruno, E.; Venturelli, E.; Manoukian, S.; Barile, M.; Peissel, B.; De Giacomi, C.; Bonanni, B.; Berrino, J.; Berrino, F. 2011: Serum levels of IGF-i and BRCA penetrance: a case control study in breast cancer families. Familial Cancer 10(3): 521-528

Rinaldi, S.; Cleveland, R.; Norat, T.; Biessy, C.; Rohrmann, S.; Linseisen, J.; Boeing, H.; Pischon, T.; Panico, S.; Agnoli, C.; Palli, D.; Tumino, R.; Vineis, P.; Peeters, P.H.M.; van Gils, C.H.; Bueno-de-Mesquita, B.H.; Vrieling, A.; Allen, N.E.; Roddam, A.; Bingham, S.; Khaw, K.-T.; Manjer, J.; Borgquist, S.; Dumeaux, V.; Torhild Gram, I.; Lund, E.; Trichopoulou, A.; Makrygiannis, G.; Benetou, V.; Molina, E.; Donate Suárez, I.; Barricarte Gurrea, A.; Gonzalez, C.A.; Tormo, M.-J.; Altzibar, J.M.; Olsen, A.; Tjonneland, A.; Grønbaek, H.; Overvad, K.; Clavel-Chapelon, F.ço.; Boutron-Ruault, M.-C.; Morois, S.; Slimani, N.; Boffetta, P.; Jenab, M.; Riboli, E.; Kaaks, R. 2010: Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. International Journal of Cancer 126(7): 1702-1715

Pérez-Muñuzuri, A.; Fernández-Lorenzo, J.R.; Couce-Pico, M.L.; Blanco-Teijeiro, M.J.; Fraga-Bermúdez, J.M. 2010: Serum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatrica 99(4): 519-525

Koike, Y.; Kuwatsuka, Y.; Shimizu, K.; Utani, A. 2013: Serum levels of IL-10 and IL-35 in Yusho patients. Fukuoka Igaku Zasshi 104(4): 91-94

Raeiszadeh Jahromi, S.; Mahesh, P.A.; Jayaraj, B.S.; Madhunapantula, S.R.V.; Holla, A.D.; Vishweswaraiah, S.; Ramachandra, N.B. 2014: Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case-control study. Journal of Asthma: Official Journal of the Association for the Care of Asthma 51(10): 1004-1013

Shen, J.; Hong, S. 2010: Serum levels of IL-12, IL-4 and pathologic changes by scanning electron microscope of nasal mucous inflammation. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24(20): 913-917

Liu, W.-D.; Lu, J.-R. 2008: Serum levels of IL-12, TGFbeta1 and IgE in children with asthma. Zhongguo Dang Dai Er Ke Za Zhi 10(2): 146-148

Li, Y.-F.; Yu, Y.; Lu, Z.-F. 2010: Serum levels of IL-13 and TNF-alpha in children with Mycoplasma pneumoniae pneumonia. Zhongguo Dang Dai Er Ke Za Zhi 12(4): 275-277

Caproni, M.; Antiga, E.; Melani, L.; Volpi, W.; Del Bianco, E.; Fabbri, P. 2009: Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. Journal of Clinical Immunology 29(2): 210-214

Zicari, A.M.; Nebbioso, M.; Zicari, A.; Mari, E.; Celani, C.; Occasi, F.; Tubili, F.; Duse, M. 2013: Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. European review for medical and pharmacological sciences 17(9): 1242-1244

Pavlovic, V.; Dimic, A.; Milenkovic, S.; Krtinic, D. 2014: Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 19(1): 18-22

Bălaşa, R.; Bajko, Z.; Huţanu, A. 2013: Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β. Multiple Sclerosis 19(7): 885-890

Lee, D.; Hong, S.-K.; Park, S.-W.; Hur, D.-Y.; Shon, J.-H.; Shin, J.-G.; Hwang, S.-W.; Sung, H.-S. 2010: Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids. Experimental Dermatology 19(2): 145-147

Aghdashi, M.; Aribi, S.; Salami, S. 2013: Serum levels of IL-18 in Iranian females with systemic lupus erythematosus. Medical Archives 67(4): 237-240

Yan, D.; Kang, P.; Shen, B.; Yang, J.; Zhou, Z.; Duan, L.; Pei, F. 2010: Serum levels of IL-1β, IL-6 and TNF-α in rats fed with Kashin-Beck disease-affected diet. International Journal of Rheumatic Diseases 13(4): 406-411

Kuwatsuka, Y.; Koike, Y.; Shimizu, K.; Utani, A. 2013: Serum levels of IL-21 and TGF-beta in the Yusho patients. Fukuoka Igaku Zasshi 104(4): 88-90

Li, G.-X.; Wang, S.; Duan, Z.-H.; Zeng, Z.; Pan, F.-M. 2013: Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis. Scandinavian Journal of Rheumatology 42(3): 226-231

Mok, M.Yin.; Huang, F.Ping.; Ip, W.Ki.; Lo, Y.; Wong, F.Yi.; Chan, E.Yuk.Tat.; Lam, K.Fai.; Xu, D. 2010: Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 49(3): 520-527

Kunz, M.; Ceresér, K.M.; Goi, P.D.; Fries, G.R.; Teixeira, A.L.; Fernandes, B.S.õe.; Belmonte-de-Abreu, P.S.; Kauer-Sant'Anna, M.ár.; Kapczinski, F.; Gama, C.S. 2011: Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Revista Brasileira de Psiquiatria 33(3): 268-274

Dobrzycka, B.; Mackowiak-Matejczyk, B.; Terlikowska, K.M.; Kulesza-Bronczyk, B.; Kinalski, M.; Terlikowski, S.J. 2013: Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer. European Cytokine Network 24(3): 106-113

Pourfarzam, S.; Ghazanfari, T.; Yaraee, R.; Ghasemi, H.; Hassan, Z.M.; Faghihzadeh, S.; Ardestani, S.K.; Kariminia, A.; Fallahi, F.; Soroush, M.R.; Merasizadeh, J.; Mahlojirad, M.; Naghizadeh, M.M.; Ghanei, M. 2009: Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. International Immunopharmacology 9(13-14): 1482-1488

Kawashima, S.-T.; Tagami, T.; Nakao, K.; Nanba, K.; Tamanaha, T.; Usui, T.; Naruse, M.; Minamiguchi, S.; Mori, Y.; Tsuji, J.; Tanaka, I.; Shimatsu, A. 2014: Serum levels of IgG and IgG4 in Hashimoto thyroiditis. Endocrine 45(2): 236-243

Da Cunha, J.; Ferreira Maselli, L.M.; Treitinger, A.íc.; Monteiro, A.M.; Gidlund, M.; Maranhão, R.C.; Spada, C.; Bydlowski, S.ér.P. 2013: Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine 51(2): 371-378

Qian, L.; Lu, J.-R. 2007: Serum levels of IgG subclasses and vitamin a in children with recurrent respiratory tract infection. Zhongguo Dang Dai Er Ke Za Zhi 9(6): 557-558

Takao, Y.; Yamada, A.; Yutani, S.; Ono, T.; Nagao, Y.; Ando, E.; Ide, T.; Itoh, K.; Sata, M. 2007: Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients. Medical microbiology and immunology 196(3): 157-164

Sakamoto, A.; Ishizaka, N.; Imai, Y.; Nagai, R. 2012: Serum levels of IgG4 and soluble interleukin-2 receptor in patients with abdominal and thoracic aortic aneurysm who undergo coronary angiography. Atherosclerosis 221(2): 602-603

Tas, F.; Karabulut, S.; Ciftci, R.; Sen, F.; Sakar, B.; Disci, R.; Duranyildiz, D. 2014: Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. Cancer ChemoTherapy and Pharmacology 73(6): 1163-1171

Hwang, Y.J.; Jung, H.J.; Kim, M.J.; Roh, N.K.; Jung, J.W.; Lee, Y.W.; Choe, Y.B.; Ahn, K.J. 2014: Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis. Mediators of Inflammation 2014: 268257

Yan, D.; Pei, F.; Song, Y. 2014: Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. Journal of Orthopaedic Surgery and Research 9: 78

Chuenchitra, T.; Wasi, C.; de Souza, M.; Nitayaphan, S.; Louisirirotchanakul, S.; Sutthent, R.; Brown, A.E.; Birx, D.L.; Polonis, V.R. 2008: Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression. Southeast Asian Journal of Tropical Medicine and Public Health 39(5): 856-862

Yan, D.; Dai, H.; Liu, J.-W. 2011: Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. Bmc Cancer 11: 151

Wendling, D.; Cedoz, J.-P.; Racadot, E. 2008: Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy. Joint Bone Spine 75(5): 559-562

Onal, I.K.; Altun, B.; Onal, E.D.; Kirkpantur, A.; Gul Oz, S.; Turgan, C. 2009: Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment. European Journal of Internal Medicine 20(4): 369-372

Engin, A.; Ugurlu, S.; Caglar, E.; Oztop, A.Y.; Inan, D.; Elaldi, N.; Dokmetas, I.; Bakir, M. 2010: Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever. Vector Borne and Zoonotic Diseases 10(10): 1037-1041

Ruggieri, M.; Serpino, C.; Ceci, E.; Sciruicchio, V.; Franco, G.; Pica, C.; Trojano, M.; Livrea, P.; de Tommaso, M. 2012: Serum levels of N-acetylaspartate in Huntington's disease: preliminary results. Movement Disorders: Official Journal of the Movement Disorder Society 27(2): 329-330

Bodlaj, G.; Hubmann, R.; Saleh, K.; Biesenbach, G.; Pohanka, E.; Stojakovic, T.; Berg, J.ör. 2009: Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants. Wiener Klinische Wochenschrift 121(19-20): 631-637

Determann, R.M.; Royakkers, A.A.N.M.; Schaefers, J.; de Boer, A.M.; Binnekade, J.M.; van Straalen, J.P.; Schultz, M.J. 2013: Serum levels of N-terminal proB-type natriuretic peptide in mechanically ventilated critically ill patients--relation to tidal volume size and development of acute respiratory distress syndrome. Bmc Pulmonary Medicine 13: 42

Logan, R.M.; Stringer, A.M.; Bowen, J.M.; Gibson, R.J.; Sonis, S.T.; Keefe, D.M.K. 2008: Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biology and Therapy 7(7): 1139-1145

Lehrke, S.; Steen, H.; Kristen, A.V.; Merten, C.; Lossnitzer, D.; Dengler, T.J.; Katus, H.A.; Giannitsis, E. 2009: Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 16(4): 187-195

Goranova-Marinova, V.; Goranov, S.; Pavlov, P.; Tzvetkova, T. 2007: Serum levels of OPG, RANKL and RANKL/OPG ratio in newly-diagnosed patients with multiple myeloma. Clinical correlations. Haematologica 92(7): 1000-1001

Iwata, Y.; Tsuchiya, K.J.; Mikawa, S.; Nakamura, K.; Takai, Y.; Suda, S.; Sekine, Y.; Suzuki, K.; Kawai, M.; Sugihara, G.; Matsuzaki, H.; Hashimoto, K.; Tsujii, M.; Sugiyama, T.; Takei, N.; Mori, N. 2008: Serum levels of P-selectin in men with high-functioning autism. British Journal of Psychiatry: the Journal of Mental Science 193(4): 338-339

Hoggard, N.; Agouni, A.; Mody, N.; Delibegovic, M. 2012: Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes. International journal of general medicine 5: 403-411

Chaves, M.ár.L.; Camozzato, A.L.; Ferreira, E.D.; Piazenski, I.; Kochhann, R.; Dall'Igna, O.; Mazzini, G.S.; Souza, D.O.; Portela, L.V. 2010: Serum levels of S100B and NSE proteins in Alzheimer's disease patients. Journal of Neuroinflammation 7: 6

Lee, J.S.; Shin, J.H.; Lee, K.M.; Hwang, J.-H.; Baek, J.E.; Kim, J.H.; Choi, B.-S. 2014: Serum levels of TGF-β1 and MCP-1 as biomarkers for progressive coal workers' pneumoconiosis in retired coal workers: a three-year follow-up study. Industrial Health 52(2): 129-136

Balouchi, S.; Gharagozloo, M.; Esmaeil, N.; Mirmoghtadaei, M.; Moayedi, B. 2014: Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy. Immunopharmacology and Immunotoxicology 36(4): 271-274

El-Far, M.; El-Sayed, I.H.; El-Motwally, A.E.; Hashem, I.A.; Bakry, N. 2009: Serum levels of TNF-alpha and antioxidant enzymes and placental TNF-alpha expression in unexplained recurrent spontaneous miscarriage. Journal of Physiology and Biochemistry 65(2): 175-181

Ebrahimi, A.A.; Noshad, H.; Sadreddini, S.; Hejazi, M.S.; Mohammadzadeh Sadigh, Y.; Eshraghi, Y.; Ghojazadeh, M. 2009: Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRIi and IL-12 in treated rheumatoid arthritis patients. Iranian Journal of Immunology: Iji 6(3): 147-153

Llauradó, G.; González-Clemente, J.é-M.; Maymó-Masip, E.; Subías, D.; Vendrell, J.; Chacón, M.R. 2012: Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study. Plos one 7(8): E43919

Jiang, S.; Liu, X.; Luo, L.; Qu, B.; Huang, X.; Lin, Y.; Ye, S.; Liu, Y. 2011: Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Molecular Vision 17: 1425-1430

Nakazato, J.; Kishida, M.; Kuroiwa, R.; Fujiwara, J.; Shimoda, M.; Shinomiya, N. 2008: Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 19(7): 605-613

Dobrzycka, B.; Terlikowski, S.J.; Kowalczuk, O.; Kulikowski, M.; Niklinski, J. 2011: Serum levels of VEGF and VEGF-C in patients with endometrial cancer. European Cytokine Network 22(1): 45-51

Pavlisa, G.; Pavlisa, G.; Kusec, V.; Kolonic, S.O.; Markovic, A.S.; Jaksic, B. 2010: Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. European Cytokine Network 21(2): 92-98

Schiavon, L.L.; Narciso-Schiavon, J.L.; Carvalho Filho, R.J.; Sampaio, J.P.; Medina-Pestana, J.O.; Lanzoni, V.P.; Silva, A.E.B.; Ferraz, M.L.G. 2008: Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis 15(9): 666-674

Nguyen, H.P.; Björkqvist, M.; Bode, F.J.; Stephan, M.; von Hörsten, S. 2010: Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease. Plos Currents 2: Rrn1190

Krakowski, L.; Krawczyk, C.H.; Kostro, K.; Stefaniak, T.; Novotny, F.; Obara, J. 2011: Serum levels of acute phase proteins: SAA, Hp and progesterone (P4) in mares with early embryonic death. Reproduction in Domestic Animals 46(4): 624-629

Mai, M.; Tönjes, A.; Kovacs, P.; Stumvoll, M.; Fiedler, G.M.; Leichtle, A.B. 2013: Serum levels of acylcarnitines are altered in prediabetic conditions. Plos one 8(12): E82459

Taşkin, S.; Taşkin, E.A.; Seval, M.M.; Atabekoğlu, C.S.; Berker, B.; Söylemez, F. 2009: Serum levels of adenosine deaminase and pregnancy-related hormones in hyperemesis gravidarum. Journal of Perinatal Medicine 37(1): 32-35

Jublanc, C.; Beaudeux, J.L.; Aubart, F.; Raphael, M.; Chadarevian, R.; Chapman, M.J.; Bonnefont-Rousselot, D.; Bruckert, E. 2011: Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 21(10): 817-822

Kralisch, S.; Stepan, H.; Kratzsch, J.ür.; Verlohren, M.; Verlohren, H.-J.; Drynda, K.; Lössner, U.; Blüher, M.; Stumvoll, M.; Fasshauer, M. 2009: Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. European Journal of Endocrinology 160(1): 33-38

Sommer, G.; Ziegelmeier, M.; Bachmann, A.; Kralisch, S.; Lossner, U.; Kratzsch, J.ür.; Blüher, M.; Stumvoll, M.; Fasshauer, M. 2008: Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clinical Endocrinology 69(6): 901-905

Bao, Y.; Lu, Z.; Zhou, M.; Li, H.; Wang, Y.; Gao, M.; Wei, M.; Jia, W. 2011: Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. Plos one 6(4): E19115

Selig, L.; Reiche, M.; Ebert, T.; Krehl, D.; Kralisch, S.; Lossner, U.; Stach, B.; Blüher, M.; Stumvoll, M.; Bödeker, H.; Keim, V.; Mössner, J.; Fasshauer, M. 2012: Serum levels of adipocyte fatty acid-binding protein are decreased in chronic pancreatitis. Pancreas 41(8): 1230-1234

Balci, M.M.üc.; Arslan, U.ğu.; Firat, H.; Kocaoğlu, I.; Vural, M.G.ök.; Balci, K.G.ül.; Maden, O.; Gürbüz, O.ğu.A.; Ardiç, S.; Yeter, E. 2012: Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 60(7): 1020-1026

Tokuda, F.; Sando, Y.; Matsui, H.; Koike, H.; Yokoyama, T. 2008: Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Internal Medicine 47(21): 1843-1849

Papavasileiou, V.; Liakopoulos, V.; Sakkas, G.K.; Hadjigeorgiou, G.M.; Koukoulis, G.; Stefanidis, I. 2008: Serum levels of adipokine retinol-binding protein-4 in relation to renal function: response to Ziegelmeier et al. Diabetes Care 31(4): E23; Author Reply E24

de Castro, I.Fernández.; Berenguer, J.; Micheloud, D.; Guzmán-Fulgencio, Mía.; Cosín, J.; Alvarez, E.; López, J.Carlos.; Miralles, P.; García-Álvarez, Mónica.; Resino, S. 2010: Serum levels of adipokines in HIV/HCV co-infected patients and their association with insulin resistance and liver disease severity. Journal of Infection 61(6): 499-501

Tiftikci, A.; Atug, O.; Yilmaz, Y.; Eren, F.; Ozdemir, F.T.; Yapali, S.; Ozdogan, O.; Celikel, C.A.; Imeryuz, N.; Tozun, N. 2009: Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis. Archives of Medical Research 40(4): 294-298

Sălăgeanu, A.; Tucureanu, C.; Lerescu, L.; Caraş, I.; Pitica, R.; Gangurà, G.; Costea, R.; Neagu, S. 2010: Serum levels of adipokines resistin and leptin in patients with colon cancer. Journal of Medicine and Life 3(4): 416-420

Miras, M.; Ochetti, M.; Martín, S.; Silvano, L.; Sobrero, G.; Castro, L.; Onassis, M.; Tolosa de Talamoni, N.; Pérez, A.; Picotto, G.; Díaz de Barboza, G.; Muñoz, L. 2010: Serum levels of adiponectin and leptin in children born small for gestational age: relation to insulin sensitivity parameters. Journal of Pediatric Endocrinology and Metabolism: Jpem 23(5): 463-471

Zietz, B.; Buechler, C.; Kobuch, K.; Neumeier, M.; Schölmerich, J.; Schäffler, A. 2008: Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 116(9): 532-536

Landgraeber, S.; Wegner, A.; Canbay, A.; von Knoch, M. 2010: Serum levels of adiponectin in patients with aseptic loosening after total hip replacement. Journal of Biomedical Materials Research. Part a 93(2): 748-752

Elfayomy, A.K.; Habib, F.A.; Almasry, S.M.; Safwat, M.D.; Eldomiaty, M.A. 2013: Serum levels of adrenomedullin and inflammatory cytokines in women with term idiopathic intrauterine growth restriction. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(2): 135-139

Tahara, N.; Yamagishi, S.-I.; Matsui, T.; Takeuchi, M.; Nitta, Y.; Kodama, N.; Mizoguchi, M.; Imaizumi, T. 2012: Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovascular Therapeutics 30(1): 42-48

Ueda, S.; Yamagishi, S.-i.; Matsui, T.; Noda, Y.; Ueda, S.-i.; Jinnouchi, Y.; Sasaki, K.-i.; Takeuchi, M.; Imaizumi, T. 2012: Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects. Cardiovascular Therapeutics 30(4): 249-254

Perkins, B.A.; Rabbani, N.; Weston, A.; Ficociello, L.H.; Adaikalakoteswari, A.; Niewczas, M.; Warram, J.; Krolewski, A.S.; Thornalley, P. 2012: Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. Plos one 7(4): E35655

Ozenırler, S.; Erkan, G.ül.; Gülbahar, O.; Bostankolu, O.; Ozbaş Demırel, O.; Bılgıhan, A.şe.; Akyol, G.ül. 2011: Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C. Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology 22(1): 47-53

Tejos, R.; Padilla, O.; Pizarro, M.; Solís, N.; Arab, J.Pablo.; Margozzini, P.; Miquel, J.Francisco.; Riquelme, A.; Arrese, M. 2013: Serum levels of alanine aminotransferase in Chilean population: analysis of results of the national health survey 2009-2010. Revista medica de Chile 141(7): 909-916

Yamamoto, K.; Shimada, H.; Koh, H.; Ataka, S.; Miki, T. 2014: Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease. Geriatrics and Gerontology International 14(3): 716-723

Zhang, L.; Han, C.; Sun, C.; Meng, H.; Ye, F.; Na, S.; Chen, F.; Zhang, D.; Jin, X. 2013: Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch-Schonlein purpura nephritis. Translational Research: the Journal of Laboratory and Clinical Medicine 161(1): 26-36

Emri, S.; Kilickap, S.; Kadilar, C.; Halil, M.G.; Akay, H.; Besler, T. 2012: Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pacific Journal of Cancer Prevention: Apjcp 13(7): 3025-3029

Evsen, M.S.; Sak, M.E.; Soydinc, H.E.; Guven, S.; Basaranoglu, S.; Hatipoglu, N.K.; Evliyaoglu, O.; Gul, T. 2014: Serum levels of androgens and prostate-specific antigen in endometriosis. Clinical and Experimental Obstetrics and Gynecology 41(4): 432-435

Sharma, B.K.; Srinivasan, R.; Kapil, S.; Singla, B.; Saini, N.; Chawla, Y.K.; Chakraborti, A.; Duseja, A.; Kalra, N.; Dhiman, R.K. 2013: Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Molecular and Cellular Biochemistry 383(1-2): 103-112

Ria, R.; Cirulli, T.; Giannini, T.; Bambace, S.; Serio, G.; Portaluri, M.; Ribatti, D.; Vacca, A.; Dammacco, F. 2008: Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas. Clinical and Experimental Medicine 8(3): 141-145

Przepiera-Będzak, H.; Fischer, K.; Brzosko, M. 2013: Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome. Polskie Archiwum Medycyny Wewnetrznej 123(6): 297-302

Szarvas, T.; Jäger, T.; Droste, F.; Becker, M.; Kovalszky, I.; Romics, I.; Ergün, S.ül.; Rübben, H. 2009: Serum levels of angiogenic factors and their prognostic relevance in bladder cancer. Pathology Oncology Research: Por 15(2): 193-201

Duranyildiz, D.; Camlica, H.; Soydinc, H.O.; Derin, D.; Yasasever, V. 2009: Serum levels of angiogenic factors in early breast cancer remain close to normal. Breast 18(1): 26-29

Figueroa-Vega, N.é; Sanz-Cameno, P.; Moreno-Otero, R.; Sánchez-Madrid, F.; González-Amaro, R.; Marazuela, M.ón. 2009: Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features. Journal of Clinical Endocrinology and Metabolism 94(4): 1145-1153

Karapınar, H.; Esen, O.; Emiroğlu, Y.; Akçakoyun, M.; Pala, S.çu.; Kargın, R.; Izgi, A.ın.; Kirma, C.; Esen, A.M. 2011: Serum levels of angiopoietin-1 in patients with pulmonary hypertension due to mitral stenosis. Heart and Vessels 26(5): 536-541

Naumnik, W.; Chyczewska, E.; Ossolinska, M. 2009: Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy. Cancer Investigation 27(7): 741-746

Pappa, C.A.; Tsirakis, G.; Samiotakis, P.; Tsigaridaki, M.; Alegakis, A.; Goulidaki, N.; Alexandrakis, M.G. 2013: Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Investigation 31(6): 385-389

Kawaguchi, M.; Sugaya, M.; Suga, H.; Miyagaki, T.; Ohmatsu, H.; Fujita, H.; Asano, Y.; Tada, Y.; Kadono, T.; Sato, S. 2014: Serum levels of angiopoietin-2, but not angiopoietin-1, are elevated in patients with erythrodermic cutaneous T-cell lymphoma. Acta Dermato-Venereologica 94(1): 9-13